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Summary    IV 
Summary 
Streptococcus pyogenes is a highly specific human pathogen which has been associated with 
clinical manifestation of invasive diseases. Invasive infections have a characteristic feature of 
impaired neutrophil infiltration in the local area of bacterial infection. One pathogenic 
mechanism behind the lack of neutrophil influx is based on the proteolytic activity of a 
recently discovered S. pyogenes serine protease, streptococcal chemokine protease C (ScpC). 
ScpC cleaves the major neutrophil attracting chemokine IL-8 and thus renders it functionally 
inactive to cause transendothelial migration of neutrophils. 
This study now identifies ScpC as a cell surface protein which plays an essential role in the 
invasion process of M3 serotype S. pyogenes into human umbilical vein endothelial cells 
(HUVEC). Biologically active full-length ScpC was expressed in and purified from 
Escherichia coli. Recombinant ScpC (rScpC) coated latex beads were efficiently internalized 
by HUVEC in vitro and ultimately fused with lysosomes, as shown by the co-localization of 
ScpC coated beads with the late endosomal/lysosomal marker protein LAMP-1, indicating 
that lysosomes are the terminal cellular compartment for rScpC carriers. By utilizing several 
rScpC subfragments, it could be demonstrated that the N-terminal PR-domain (putative 
catalytic domain) per se can mediate the internalization of latex beads into HUVEC. In 
contrast to this, a larger ScpC fragment encompassing both the PR-domain and the flanking 
A-domain was shown here to be required for the IL-8 degrading activity. By raising a highly 
specific antiserum against ScpC in rabbit, an IgG fraction was obtained that could efficiently 
block the interaction of ScpC coated beads with endothelial cells, while having no effect on 
its IL-8 proteolytic activity. This indicates that the invasion-mediating activity of ScpC is 
independent of its protease activity. Next, the HUVEC invasion kinetics of a M3 serotype S. 
pyogenes strain and its isogenic ∆scpC mutant strain were assessed. The WT strain invaded 
but subsequently escaped from the endothelial cells via exocytosis whereas the ∆scpC mutant 
strain accumulated within the cells, revealing impaired exocytosis. This suggests that ScpC 
may play an important role in the transcytosis of S. pyogenes across the endothelial 
monolayer. 
Finally, by using the herein generated anti-ScpC antiserum and a set of WT S. pyogenes 
strains as well as their respective isogenic ∆scpC mutant strains it could be demonstrated that 
ScpC is the first LPXTG motif-anchored surface protein with the ability to reassociate back to 
the bacterial cell surface after its secretion into the extracellular environment.  
Summary    V 
This study identified novel functions of ScpC, dissected the functional domains, and may thus 
help to understand the molecular mechanism of action of this genetically conserved large 
surface protein during S. pyogenes infections. 
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Zusammenfassung 
Streptococcus pyogenes ist ein hochspezifischer humanpathogener Krankheitserreger der auch 
als Auslöser schwerer invasiver Erkrankungen vorkommt. Ein charakteristisches Merkmal  
invasiver Streptokokkeninfektionen ist die mangelhafte Rekrutierung von Neutrophilen in die 
bakteriell infizierten Zonen. Dem molekularen Mechanismus dafür liegt die vor kurzem 
identifizierte proteolytische Aktivität der S. pyogenes Serinprotease ScpC (streptococcal 
chemokine protease C) zugrunde. ScpC spaltet das Chemokin IL-8, ein wichtiges Neutrophil-
rekrutierendes Botenmolekül, welches durch die proteolytische Spaltung inaktiviert wird. 
Im Rahmen dieser Arbeit konnte nun gezeigt werden, dass ScpC eine essenzielle Rolle beim 
Invasionsprozess von Serotyp M3 Streptokokken in humane Endothelzellen (HUVEC) spielt. 
Rekombinante ScpC (rScpC) konnte in voller Länge und in biologisch aktiver Form aus 
Escherichia coli Extrakten gereinigt werden. In vitro Studien mit HUVEC und rScpC  
ummantelten Latexpartikeln zeigten, dass rScpC die effiziente Aufnahme in Endothelzellen 
vermittelt. Durch Kolokalisationsstudien mit LAMP-1, einem späten 
endosomalen/lysosomalen Markerprotein, wurden Lysosomen als terminale zelluläre 
Kompartimente des rScpC Transports identifiziert. Durch Generierung unterschiedlicher 
rScpC Subfragmente und deren Einsatz in Internalisierungsexperimenten konnte die 
invasionsvermittelnde Domäne eingeschränkt und der N-terminalen PR Domäne (katalytische 
Domäne, per Def.) zugeordnet werden. Im Gegensatz dazu war ein größeres ScpC Fragment, 
das sowohl die PR Domäne als auch die flankierende A Domäne umfasst, für die IL-8 
degradierende Aktivität notwendig. Mit Hilfe eines im Kaninchen erzeugten spezifischen 
Antiserums gegen rScpC konnte eine IgG Fraktion gewonnen werden, die effizient die 
Aufnahme von rScpC ummantelten Partikeln, jedoch nicht die IL-8 spezifische proteolytische 
Aktivität inhibieren konnte. Dies deutet darauf hin, dass die invasionsvermittelnde Aktivität 
unabhängig von der proteolytischen Aktivität ist. Als nächstes wurden die Invasionskinetiken 
eines Serotyp M3 S. pyogenes Stammes und seiner isogenen ∆scpC Deletionsmutante 
bestimmt. Während der Wildtypstamm effizient von den Endothelzellen aufgenommen wurde 
und sie im weiteren Verlauf der Infektion mittels Exozytose wieder verließ, akkumulierte der 
ScpC defiziente Stamm intrazellulär, was auf eine gestörte Exozytose schließen lässt. Damit 
spielt ScpC nicht nur bei der Aufnahme in Endothelien sondern auch bei der Transzytose über 
den Endothelmonolayer in vitro eine Rolle. 
Ein weiteres wichtiges Ergebnis dieser Arbeit resultierte aus dem Einsatz des hier generierten 
anti-ScpC Antiserums und zwei S. pyogenes Isolaten unterschiedlichen Serotyps und ihrer 
jeweiligen isogenen ScpC defizienten Mutanten. Es konnte demonstriert werden, dass ScpC 
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das erste LPXTG Motif-verankerte Oberflächenprotein ist, das nach seiner vollständigen 
Sekretion in die Umgebung an die Bakterienoberfläche rückassoziiert werden kann. 
Diese Studie erlaubt Einblicke in neue Funktionen von ScpC und trägt somit zum erweiterten 
Verständnis der molekularen Mechanismen dieser großen und genetisch hoch konservierten 
Serinprotease im Infektionsgeschehen  bei. 
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1 Introduction 
 
The genus Streptococcus is made up of non-motile, non-spore forming Gram-positive cocci 
that grow in chains due to the cell division occurring in one plane with each crosswall made 
perpendicular to the long axis of the developing chain. Streptococci have an anaerobic 
metabolism and obtain energy by fermentation. Some are facultative anaerobes and others are 
strictly anaerobes. The principle end product of fermentation is lactic acid, thus, streptococci 
are more acid tolerant than most other bacteria. Streptococci are classified on the basis of their 
hemolysis pattern on the blood agar plate. The Group A streptococcus (GAS, Streptococcus 
pyogenes) belongs to β-hemolytic streptococci, displaying complete lysis of erythrocytes 
when grown on blood agar. The Lancefield classification system groups the β-hemolytic 
streptococci according to the carbohydrate antigens present on the surface of the bacterium. 
Streptococcus pyogenes (S. pyogenes) is defined by the presence of a polysaccharide 
composed of a polymer of N-acetyl D-glucosamine and L-rhamnose associated with the cell 
wall of the bacterium. S. pyogenes are further serologically differentiated into M serotypes on 
the basis of M protein present on the surface of the bacteria. More than 100 distinct serotypes 
of S. pyogenes have been identified based on the N-terminal hypervariable region of M 
protein (Bisno et al., 2003). 
 
S. pyogenes is present as a part of the normal flora 
of the mouth and upper respiratory tract. S. 
pyogenes is a highly specific human pathogen 
which can cause diseases ranging from mild 
infections like pharyngitis, erysipelas, scarlet fever 
and impetigo (pyoderma) to life threatening 
invasive infections such as streptococcal toxic 
shock syndrome, myositis and necrotizing 
fasciitis. S. pyogenes infection can also lead to the 
development of non-suppurative post-
streptococcal sequelae including 
glomerulonephritis and acute rheumatic fever 
associated with subsequent onset of rheumatic heart disease. Acute rheumatic fever and 
rheumatic heart disease are the most serious autoimmune sequelae, which are highly 
predominant among children.  
Figure 1.  Surface replica of critical point 
dried whole group A streptococcus 
representing M-protein projections on the 
cell surface (Fischetti, 1991). 
Introduction    2 
 
1.1 Epidemiology of S. pyogenes infections 
 
The diseases caused by S. pyogenes are highly prevalent, with an estimated 18·1 million cases 
of severe S. pyogenes infections, responsible for over 500,000 deaths per year. Among these 
incidences, the overall mortality due to invasive diseases remains significantly high (Carapetis 
et al., 2005). An epidemiology study based on the incidence of invasive S. pyogenes 
infections in Canada, conducted from 1995-2001, shows an average of 2.4 cases per 100,000 
persons per year, with a 14% death rate (Hollm-Delgado et al., 2005). A similar rate of 
incidence of invasive S. pyogenes diseases was identified from other countries indicating the 
significant contribution of S. pyogenes to serious diseases (O'Brien et al., 2002; Zurawski et 
al., 1998). Incidence of S. pyogenes bacteremia in children under the age of 15 years from 
Kenya was found to be quite high with 13.0 cases per 10,000 persons per year (Berkley et al., 
2005). Various clinical reports have shown that certain M serotypes are associated with 
specific disease manifestations. S. pyogenes strains that cause pyoderma differ in serotype and 
other biological characteristics from strains classically associated with acute streptococcal 
pharyngotonsillitis (Wannamaker, 1970). S. pyogenes strains of serotype M1 and M3 are more 
frequently associated with severe invasive S. pyogenes infections than other serotypes (Hoge 
et al., 1993; Hollm-Delgado et al., 2005). Schwartz et al. (1990) have shown that the 
proportion of  invasive S. pyogenes infections caused by M1 and M3 serotypes increased over 
period of 1972-1988 in the USA and these serotypes were more likely to cause fatal infections 
while M4 and M12 serotypes were found to be less invasive. However, S. pyogenes strains 
associated with invasive diseases can also be isolated from asymptomatic carriers indicating 
that environmental factors or host factors might contribute to the outcome of invasive diseases 
(Hollm-Delgado et al., 2005). 
 
1.2 Necrotizing Fasciitis 
 
Necrotizing fasciitis highly contributes to the mortality and morbidity due to S. pyogenes 
infections. The overall mortality of patients with necrotizing fasciitis is 20% - 60%, (Davies et 
al., 1996; Kaul et al., 1997; Stevens et al., 1989). Necrotizing fasciitis is a rare infection of the 
deeper layers of skin and subcutaneous tissues, frequently associated with systemic infection 
symptoms. During deep tissue infection, S. pyogenes rapidly progress across the fascial plane 
involving fascial necrosis, thrombosis in the subcutaneous blood vessels and vascular 
degeneration. Treatment of necrotizing fasciitis requires the surgical debridement of necrotic 
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tissue in addition to the use of antibiotics. Several studies have suggested that the lack of an 
acute inflammatory response may lead to the outcome of deep seated skin infection (Bakleh et 
al., 2005; Bisno and Stevens, 1996; Cockerill et al., 1998a; Taylor et al., 1999). 
Histopathological analysis of infected tissue from the patients with necrotizing fascitiis has 
revealed a correlation between the paucity of neutrophils and the outcome of invasive skin 
infections (Bakleh et al., 2005). The mortality rate was found to be significantly higher in 
patients with little or no neutrophil response along with the presence of large concentrations 
of streptococci in infected tissue. In a primate model of necrotizing fasciitis, out of 13 baboon 
inoculated intramuscularly with S. pyogenes, 2 animals died due to severe invasive S. 
pyogenes infection. The necrotic muscle tissue from animals with severe invasive infection 
exhibited extensive bacteria along with intravascular aggregation of neutrophils (Figure 2B). 
However, the neutrophils failed to transmigrate through the endothelial cells and the basement 
membrane into the infected tissue (Taylor et al., 1999).  
 
A B
 
 
Figure 2.  A) Arm of a patient with necrotizing fasciitis showing muscle tissue with extensive necrotic fascia. B) 
Aggregation of neutrophils in the blood vessel present in the margin of lesion with extensive soft tissue 
streptococcal infection in a baboon model of necrotizing fasciitis. Images are taken from Hidalgo-Grass et al. 
(2004) and Taylor et al. (1999), respectively. 
 
The underlying pathogenic mechanism for the lack of inflammatory response is not clearly 
understood. The outcome of severe invasive diseases due to S. pyogenes infection may 
involve both S. pyogenes virulence factors and host susceptibility to infection. S. pyogenes 
expresses several cell surface-associated and secreted factors including hyaluronic acid 
capsule, M protein, streptococcal chemokine protease C, streptococcal fibronectin binding 
protein 1, streptococcal pyrogenic exotoxins and streptolysins, to resist clearance by the host 
innate immune response. These virulence factors perform diverse functions during infection 
and their expression is regulated to adapt to diverse physiological conditions in the host. The 
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S. pyogenes virulence determinants involved in impairing neutrophil recruitment can be 
potential targets for identifying therapeutic agents and/or vaccines against severe 
streptococcal soft-tissue infections. 
  
1.3 S. pyogenes virulence factors involved in impairing phagocytic 
defence mechanism of the host 
 
Neutrophils are the most important effector cells of the host innate immune response, which 
provide the first line of defence against infecting pathogens. The recruitment of neutrophils at 
the site of infection is essential to efficiently resolve the infection by fighting against the 
invading pathogen. S. pyogenes has evolved various virulence mechanisms to avoid clearance 
by neutrophil-mediated killing. To evade the host immune system, S. pyogenes impair 
neutrophil recruitment, block opsonization with complement proteins and antibodies, employ 
molecular mimicry and enhance survival inside the neutrophils (Staali et al., 2006; Voyich et 
al., 2003). Furthermore, S. pyogenes can evade killing by neutrophil extracellular traps and 
induce premature neutrophil apoptosis (Buchanan et al., 2006; Kobayashi et al., 2003). S. 
pyogenes express several virulence factors to enhance survival in the host, the important 
virulence factors of S. pyogenes involved in evading phagocytosis are discussed below.  
 
1.3.1 Hyaluronic acid capsule 
The S. pyogenes mucoid colony morphology is due to the presence of the capsular 
polysaccharide, hyaluronic acid which is a repeating unit of D-glucuronic acid and N-
acetylglucosamine. Several studies have evidenced the association of highly encapsulated S. 
pyogenes strains with outbreaks of acute rheumatic fever and other severe infections 
suggesting a role of the hyaluronic acid capsule in S. pyogenes virulence (Marcon et al., 
1988). The genetic has locus required for capsule synthesis is highly conserved among S. 
pyogenes strains. The high expression of hyaluronic acid capsule contributes to the virulence 
of S. pyogenes by enhancing its resistance to phagocytosis. An acapsular mutant of a 
mucoidal S. pyogenes strain of M18 serotype, derived by transposon insertional mutagenesis, 
was found to be more sensitive to in vitro phagocytic killing by neutrophils and less virulent 
in a mouse model of streptococcal infection (Wessels et al., 1991). Moses et al. (1997) further 
confirmed the antiphagocytic function of hyaluronic acid capsule by studying the contribution 
of M protein and hyaluronic acid capsule separately in conferring resistance to phagocytosis. 
In vitro opsonophagocytic assays indicated that a poorly encapsulated strain was more 
susceptible to killing despite the presence of M protein, while a highly encapsulated strain 
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survived in 10% serum. Another study with M18 and M24 serotype of S. pyogenes indicates 
that the presence of capsule on the surface of S. pyogenes confers protection to phagocytosis 
despite being equally opsonized with C3 (Dale et al., 1996). Thus, the mechanism of 
protection might be due to the function of capsule as a physical barrier that blocks the access 
of complements proteins deposited on the S. pyogenes cell surface to phagocytes. 
Hyaluronic acid capsule can play a major role in invasive soft-tissue infections. Schrager et al. 
(1996) have reported that isogenic acapsular mutant strains of highly encapsulated M18 and 
M24 S. pyogenes entered keratinocytes 1000-5000 fold greater in number than the parental 
encapsulated strain. The parental encapsulated S. pyogenes strains were poorly cell invasive 
and developed a rapidly spreading soft-tissue infection with extensive local necrosis in a 
mouse model of skin infection whereas the isogenic acapsular mutant strains developed only 
minor superficial inflammation. Furthermore, Cywes and Wessels (2001) have demonstrated 
that the interaction of the hyaluronic acid capsule with CD44 receptor present on 
keratinocytes triggered cytoskeletal rearrangements that led to the disruption of intercellular 
junctions, thus enhancing translocation of highly encapsulated S. pyogenes across the 
epithelial cell layer into deeper tissues. This observation further supports the important role of 
hyaluronic acid capsule in enhancing S. pyogenes pathogenicity to cause severe invasive 
infections. 
 
1.3.2 M protein 
M protein is an important cell wall-bound virulence determinant of S. pyogenes, which was 
first identified by Lancefield (1962). The presence of M protein alpha-helical coiled coils 
extending from the streptococcal surface accounts for its fibrillar morphology under the 
microscope. M protein has a multi-domain structure with the N-terminal half of the protein 
highly variable and the C-terminal half conserved among different M serotypes. The 
streptococcal M protein plays a major role in conferring resistance to phagocytosis by 
polymorphonuclear leukocytes. M protein may exert its antiphagocytic activity via various 
mechanisms in the absence of type specific antibodies. It has been demonstrated that M 
protein interferes with the alternative complement pathway by reducing deposition of C3b 
protein of the complement system on the S. pyogenes cell surface (Bisno, 1979). C3b 
deposition on S. pyogenes is required for complement activation and subsequent phagocytic 
clearance by neutrophils. S. pyogenes with reduced C3b deposition on the cell surface cannot 
interact with the C3b receptor on phagocytes. Studies of Horstmann et al. (1988) suggested 
that the binding of M protein with factor H, a regulatory protein of the alternative complement 
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pathway, can be another route of bacteria-induced impairment of complement activation and 
phagocytic clearance. Factor H prevents C3 activation rendering C3b susceptible to cleavage 
by factor 1, thus controlling the deposition of C3b on the surface of bacteria. Also, other 
studies have reported phagocytosis evasion via M protein-mediated binding to fibrinogen 
(Fg). Interaction of M protein with fibrinogen restricts deposition of C3, thus preventing 
complement-mediated opsonization of S. pyogenes (Whitnack and Beachey, 1982).  
 
1.3.3 C5a peptidase/ScpA 
C5a peptidase, also known as ScpA, is highly conserved among S. pyogenes strains. C5a 
peptidase is a cell surface-anchored serine protease that shares sequence similarity with 
various cell envelope proteases of Gram-positive pathogens. Analysis of C5a peptidase amino 
acid sequence revealed the presence of a conserved 31-residue signal peptide, a putative cell 
wall-spanning region and membrane anchor domain (Chen and Cleary, 1989). C5a peptidase 
contributes to S. pyogenes virulence by retarding complement activation. The complement 
system helps in fighting infection by either activating the classical or alternative pathway via 
generating C5 convertase, which proteolytically produces chemotaxin C5a. C5a peptidase 
cleaves chemotaxin C5a specifically at the His67-Lys68 bond near the carboxyl-terminus, thus 
impairing the binding of C5a to its receptor located on polymorphonuclear leukocytes 
(PMNs). As a result, C5a peptidase impairs neutrophil influx into the areas of S. pyogenes 
infection allowing bacteria to colonize and subsequently invade into deeper tissues (Cleary et 
al., 1992). By investigating the persistence of ScpA+ and ScpA- S. pyogenes in a mouse air sac 
model, Ji et al. (1996) have shown that the function of C5a peptidase is to retard the clearance 
of bacteria during the early stage of infection. In addition, antibody raised against C5a 
peptidase can neutralize its proteolytic activity and prevent bacterial colonization suggesting 
the potential role of C5a peptidase as a vaccine candidate (Ji et al., 1997; O'Connor et al., 
1991). 
 
1.3.4 Streptolysins 
In addition to other virulence factors, S. pyogenes produce two well known cytolytic 
exotoxins: streptolysin O (SLO) and streptolysin S (SLS). SLO is a well-characterized 
cholesterol-dependent, oxygen labile bacterial exotoxin. A second exotoxin, SLS is a non-
immunogenic, oxygen-stable oligopeptide which is responsible for the characteristic zone of 
lysis of erythrocytes (beta-hemolysis) surrounding S. pyogenes colonies grown on blood-agar 
medium. SLO can be found in cell free culture medium in the secreted form which can bind to 
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cell membranes containing cholesterol (Kehoe et al., 1987). It causes membrane damage by 
forming large transmembrane pores with a diameter of around 30 nm. After initial binding 
with surface cholesterol, SLO spontaneously oligomerizes to form rod shaped structures 
which can penetrate the cell membrane to form transmembrane channels (Bhakdi et al., 1985). 
Purified SLO and SLS are highly potent cytolysins, while sublethal concentrations of these 
toxins have various subtle effects on target cells. In vitro experiments using a SLO-deficient 
mutant strain in the background of both adherent and non adherent S. pyogenes, have shown 
that SLO acts synergistically with S. pyogenes surface adhesins to induce membrane injury 
and enhance the expression of pro-inflammatory cytokines by human karatinocytes (Ruiz et 
al., 1998). SLO deficient mutants in the adherent background fail to stimulate expression of 
proinflammatory cytokines by keratinocytes, indicating the key role of SLO-mediated 
membrane damage in the induction of proinflammatory cytokines.  
SLO is required for the translocation of S. pyogenes NAD-glycohydrolase (NADase) into 
human epithelial cells. NAD-glycohydrolase is a bacterial toxin, which augment SLO-
mediated cytotoxicity and induce apoptosis of skin keratinocytes. SLO and NAD-
glycohydrolase enhance extracellular survival of S. pyogenes by blocking the internalization 
of S. pyogenes, as shown by significantly reduced internalization of virulent WT M3 serotype 
S. pyogenes in comparison to isogenic SLO and NAD-glycohydrolase mutant strains (Bricker 
et al., 2002). 
 
1.3.5 Streptococcal chemokine protease C (ScpC/SpyCEP) 
1.3.5.1 Cleavage of chemokine interleukin-8 by ScpC 
The migration of neutrophils from the bloodstream into damaged/infected tissue forms the 
first line of defence against infection. Several studies have suggested that a lack of PMN 
infiltration might be a major cause of persistence and dissemination of S. pyogenes in the host 
which leads to the outcome of invasive deep seated skin infections (Bakleh et al., 2005; 
Cockerill et al., 1998a; Taylor et al., 1999). In 2004, Hidalgo-Grass et al. first described a new 
virulence mechanism, whereby S. pyogenes evades phagocytosis by impairing chemokine 
activity. The S. pyogenes cell surface protein, ScpC cleaves the host-derived chemotactic 
factor interleukin-8 (IL-8), which is the major chemoattractant responsible for the neutrophil 
activation and migration into the infected tissue. Host cells infected with invasive S. pyogenes 
in vitro stimulated the transcription of IL-8, however very little IL-8 was detected in the 
culture supernatant of host cells when infected with an invasive S. pyogenes strain. In vitro 
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experiments performed with WT M14 serotype S. pyogenes, isogenic ∆scpA mutant and 
isogenic ∆scpC/∆scpA double mutant demonstrated that WT M14 S. pyogenes and the 
isogenic ∆scpA mutant strain can efficiently cleave IL-8 whereas the scpC mutant strain did 
not cleave IL-8 indicating that ScpC is responsible for the IL-8 degrading activity of S. 
pyogenes (Hidalgo-Grass et al., 2006). ScpC specifically cleaves IL-8 between Gln59-Arg60 in 
the C-terminal α helix (Edwards et al., 2005). Cleaved IL-8 lacks 13 amino acids of the C-
terminus and is biologically incapable of stimulating neutrophil transmigration. The reduced 
ability of cleaved IL-8 to stimulate neutrophil chemotaxis was demonstrated in vitro with an 
observation of significantly reduced migration of neutrophils across the transwell (5 µm pore 
size) in response to cleaved IL-8, as compared to intact IL-8 (Edwards et al., 2005). 
Middleton et al. (1997) have described that IL-8 lacking its C-terminus is unable to interact 
with heparan sulfate glycosaminoglycans present on the endothelial cell surface, impairing 
IL-8 transcytosis and presentation to circulating neutrophils. This in turn leads to reduced 
neutrophil arrest and transendothelial migration suggesting that cleavage of IL-8 by ScpC 
may contribute directly to the reduced transendothelial migration of neutrophils. This has 
been demonstrated recently by Zinkernagel et al. (2008) by showing significantly reduced in 
vitro migration of neutrophils across the human microvascular endothelial cells in response to 
IL-8 co-incubated with a WT M1T1 S. pyogenes strain in comparison to the migration of 
neutrophils in response to IL-8 co-incubated with isogenic ∆scpC mutant strain. This confirms 
that ScpC can retard the IL-8 dependent transendothelial migration of neutrophils and thus 
impair neutrophil recruitment into the areas of microbial invasion. 
 
1.3.5.2  Role of ScpC in S. pyogenes pathogenicity in a murine model of soft-tissue 
infection 
ScpC enhances S. pyogenes virulence in a murine model of streptococcal deep tissue infection 
by interfering with the host inflammatory response towards infection. This was shown by 
increased survival of mice after subcutaneous infection with an M14 S. pyogenes 
∆scpC/∆scpA mutant strain as compared to mice infected with either wildtype (WT) M14 
serotype S. pyogenes or an isogenic ∆scpA mutant strain. Mice inoculated subcutaneously 
with the highly invasive WT M14 serotype S. pyogenes developed a deep necrotic lesion and 
died within 2-4 days. Histopathological analysis of necrotic tissue from mice infected with the 
WT M14 S. pyogenes strain identified very few neutrophils at the site of injection along with 
intensive streptococcal infection in the fascia. However, analysis of necrotic tissue from mice 
infected with M14 ∆scpC/∆scpA strain identified a large number of infiltrating neutrophils. A 
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paucity of infiltrating neutrophils in the muscle tissue of mice was observed when inoculated 
with M14 ∆scpA mutant strain, similar to the pathological findings of necrotic tissue of mice 
infected with the WT parental strain. This suggests that ScpA is unlikely to contribute to a 
reduced inflammatory response (Hidalgo-Grass et al., 2006). A similar pathological outcome 
of differential neutrophil infiltration was observed in the skin lesion of mice when injected 
with a globally disseminated M1T1 serotype S. pyogenes and the isogenic scpC mutant strain 
(Zinkernagel et al., 2008).  
A previous study has reported ScpC protein as a potential vaccine candidate against 
streptococcal infections. A comprehensive analysis of surface exposed proteins of highly 
virulent M23 serotype S. pyogenes, identified 17 proteins, of which 14 proteins were 
recombinantly expressed in E. coli and tested for their potential to protect against infection of 
M23 serotype S. pyogenes. By immunizing mice intraperitoneally with recombinant proteins, 
among the 14 surface exposed proteins of S. pyogenes, ScpC encoded by spy0416 and M 
protein provided highest protection against streptococcal infection, suggesting the potential 
role of ScpC as a new protective antigen (Rodriguez-Ortega et al., 2006). 
The ScpC-mediated paucity of infiltrating neutrophils is localized to the site of S. pyogenes 
infection. This was shown by differential neutrophil infiltration in lesions generated by 
injecting the same mouse on opposite flanks with an equivalent inoculum of WT M14 S. 
pyogenes and isogenic ∆scpC/∆scpA mutant strain. The myeloperoxidase activity (MPO), 
measured as a marker for neutrophil activity, was significantly lower in the lesion of mouse 
injected with WT parental strain in comparison to mice injected with isogenic ∆scpC/∆scpA 
mutant strain. Further, the mice injected with WT S. pyogenes developed a larger lesion with 
necrotic subcutaneous muscle tissue in comparison to lesion generated after inoculating with 
isogenic ∆scpC/∆scpA mutant strain. These findings were further supported by the presence 
of similar level of chemokines in the spleen and serum of mice inoculated with WT M14 S. 
pyogenes and isogenic ∆scpC/∆scpA mutant strain despite having differential chemokine 
degradation rate in the skin of mice (Hidalgo-Grass et al., 2006). The localized recruitment of 
neutrophils plays a major role in limiting proliferation and systemic spread of bacteria from 
the initial site of infection, thus, by degrading host chemokines in the infected tissue, ScpC 
plays a significant role in enhancing S. pyogenes pathogenicity.  
 
1.3.5.3  ScpC impairs the function of murine chemokines  
In addition to human IL-8, ScpC can also cleave the murine CXC chemokines; KC, 
macrophage inflammatory protein-2 (MIP-2) and granulocyte chemotactic protein 2 (GCP-2). 
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KC and MIP-2 are two major neutrophil activators and chemoattractants produced by a wide 
variety of immune cells in response to infection in mice (Bozic et al., 1995). KC and MIP-2 
are murine counterparts of the human chemokine GRO which can act as substituent of human 
IL-8 in mouse (Hidalgo-Gras et al., 2006). The cleavage site of MIP-2 is analogous to that in 
IL-8 (Edwards et al., 2005). ScpC cleaves MIP-2 between 60Gln-61Lys in its C-terminus 
suggesting that the cleavage of chemokines by ScpC is dependent upon the presence of 
specific amino acids and the overall structural conformation of its ligand. In vivo studies have 
shown that the amount of KC and MIP-2 in the skin biopsies of mice infected with M14 S. 
pyogenes ∆scpC/∆scpA mutant was significantly higher than the level measured in the skin of 
mice infected with WT M14 serotype S. pyogenes or the isogenic ∆scpA mutant (Hidalgo-
Grass et al., 2006). The specific cleavage of murine chemokines by ScpC may lead to the 
observed lack of inflammatory response in the infected areas in murine model of S. pyogenes 
infection, mimicking the pathological findings of severe deep tissue infections in humans. 
 
1.3.5.4 Reduced neutrophil priming via cleavage of host chemokines by ScpC 
Another mechanism by which ScpC retards neutrophil infiltration is via cleavage of 
chemokines granulocyte chemotactic protein-2 (GCP-2) and growth related oncogene α 
(GRO α). GROα (CXCL1) and GCP-2 (CXCL6) are important inflammatory mediators, 
which act as potent neutrophil activating proteins as well as chemoattractants. Both GROα 
and GCP-2 are CXC chemokines with a conserved ELR sequence motif. GROα (CXCL1) 
shares 33-40% identity with IL-8. GROα is produced by a variety of cells such as monocytes, 
endothelial cells, fibroblasts, and synovial cells after stimulation with lipopolysaccharide, IL-
1, or tumor necrosis factor (TNFα) (Geiser et al., 1993). Although GROα and GCP-2 are 
powerful activators of neutrophils and inducers of chemotaxis, exocytosis and the respiratory 
burst in neutrophils, they are somewhat less potent than IL-8. GCP-2 has 5-10 fold lower 
specific activity than IL-8. Cleavage of GCP-2 and GROα by S. pyogenes markedly inhibited 
neutrophil priming as measured by cell surface expression of integrin CD11b by activated 
neutrophils. Neutrophils showed higher surface expression of CD11b in response to GCP-2 
and GROα pre-incubated with a scpC deletion mutant  as compared to WT M1T1 S. pyogenes 
strain (Sumby et al., 2008).  
 
1.3.5.5 Biological characteristics of ScpC 
A homologous sequence search for scpC indicates that it belongs to a family of subtilisin-like 
serine proteases and shares sequence similarity with other cell envelope proteinases from 
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lactic acid bacteria. The scpC gene encodes a 150 kDa protein which is composed of approx. 
1,673 amino acids. scpC shares 40% sequence identity with the scpA gene of S. pyogenes 
(encoding C5a peptidase that cleaves and inactivates human complement protein C5) and 
39% identity with cspA. CspA is a homolog of ScpC in group B streptococcus which protects 
bacteria from opsonophagocytic killing by neutrophils via deposition of fibrinogen cleaved 
products on the cell surface (Harris et al., 2003). ScpC is a putative multi-domain calcium-
dependent serine protease with a C-terminal Leu-Pro-X-Thr-Gly (LPXTG) motif to cross link 
with peptidoglycan layer on the surface of bacteria. ScpC has a predicted N-terminal pre-pro 
domain (PP) with signal peptide sequence which is required for the translocation of protein 
across the cell membrane, 3 subtilase domains (PR, A and B/H), cell wall spacer domain (W) 
and cell wall-anchor domain (AN) containing a membrane spanning region of 17 hydrophobic 
amino acids, a charged amino acid tail and a highly conserved sorting signal, LPXTG cell 
wall-anchoring motif (Figure 3).  The pre-pro-domain has a predicted cleavage site between 
Val123 and Asn124, for the cleavage during the protein maturation process. Three subtilase like 
domains are designated as PR-domain, A-domain and B-domain partly fused with the H 
(helical) domain (Hidalgo-Grass et al., 2006). 
 
 
C terminus
LPxTG
PP PR A B/H W AN
N terminus
 
 
Figure 3. Domain organization of ScpC. Abbreviations indicate: PP, pre-pro-domain containing signal peptide; 
PR, catalytic domain; A, A-domain which might serve as a domain required for dictating the substrate specificity 
of ScpC protease; B, stabilizing domain; H, helical domain; W, spacer domain; AN, cell wall-anchoring domain 
containing LPXTG sequence motif. Arrows indicate genes flanking the ScpC open reading frame (ORF). Left 
arrow indicates the gene for lactate oxidase and right side arrow indicates ORF of unknown function (Figure 
adapted from Hidalgo-Grass et al., 2006). 
 
The function of each domain was predicted based on the sequence homology of ScpC with 
other cell envelope proteases from lactic acid bacteria. The PR-domain is the predicted 
catalytic domain, containing a conserved catalytic triad of amino acid residues Asp-His-Ser, 
which exhibit a high degree of similarity with the catalytic subunits of a variety of serine 
proteases. The A-domain is most likely required for proteolytic activity and may dictate 
substrate specificity. The putative B-domain along with the H-domain might function as a 
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spacer and provide overall stability to protease. The W-domain is a cell wall-spanning domain 
which usually serves as a spacer to keep protease away from the cell surface and the cell wall-
anchor domain ‘AN’ carrying the LPXTG motif (Siezen, 1999). Recent study has suggested 
that S. pyogenes IL-8 degrading activity can be assigned to serine class of proteases as shown 
by the irreversible inhibition of IL-8 degrading activity of the S. pyogenes supernatant with 
the serine protease inhibitor pefabloc SC. Inhibition of IL-8 proteolytic activity by 
benzamidine and soybean trypsin inhibitor further suggested that ScpC might share structural 
and functional similarity with trypsin like serine protease (Hidalgo-Grass et al., 2004). 
  
1.3.5.6 Regulation of scpC expression  
To adapt to the various locations within its human host, S. pyogenes are able to respond to 
environmental changes by regulating the expression of virulence factors. The expression of 
virulence factors in S. pyogenes is regulated by many stand alone regulators and two 
component signal transduction regulatory systems. Two-component regulatory systems (TCS) 
are characterized by having a specific sensor protein located in the cell membrane and a 
partner response regulator protein. The sensor protein has a kinase activity, which 
autophosphorylates at a specific histidine residue on the cytoplasmic surface upon receiving a 
signal from the extracellular environment. This high energy phosphoryl group is then 
transferred to the partner response regulator, a DNA binding protein, which in turn induces a 
conformational change in the response regulator. This conformational change alters the 
binding affinity of the response regulator to a promoter region on the target gene thus 
regulating the transcription of a specific gene (Chang and Stewart, 1998). 
 
1.3.5.6.1  Regulation of scpC expression by sil  
Although the scpC locus is highly conserved among all S. pyogenes strains with available 
genome, ScpC protein expression differs widely among the S. pyogenes strains. Edwards et al. 
(2005) have reported that S. pyogenes strains display differential IL-8 degrading activity and 
the strains possessing IL-8 degrading phenotype gives higher ScpC expression in the S. 
pyogenes supernatant. The S. pyogenes strains isolated from blood have higher ability to 
degrade IL-8 in comparison to non-invasive throat isolates suggesting that scpC is 
differentially regulated and the upregulation of ScpC expression may lead to the invasiveness 
of the S. pyogenes strains. Hidalgo-Grass et al. (Hidalgo-Grass et al., 2002) demonstrated the 
role of the streptococcal invasion locus (sil) in regulating the invasive potential of the M14 S. 
pyogenes strain JS95. The sil locus contains silA/B encoding a TCS and silD/E encoding two 
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ABC transporters. In between silA/B and silD/E, two highly overlapping open reading frames 
silC and silCR are situated. The silCR gene encodes a 17 amino acid residue signalling 
peptide (CSP) which modulates the virulence of M14 S. pyogenes by regulating the 
expression of ScpC. silCR can not be translated in invasive M14 S. pyogenes strain JS95 due 
to the presence of a missense mutation in the start codon. The role of the SilCR signalling 
peptide in modulating S. pyogenes pathogenicity in a murine model of necrotizing fasciitis 
was observed by co-injecting S. pyogenes with SilCR peptide. Inoculation of mice with M14 
S. pyogenes strain JS95 alone was lethal and engendering necrotic tissue containing a large 
number of streptococci along with the absence of neutrophils and ultimately death of the 
animal. However, co-injection of M14 S. pyogenes with SilCR triggered the neutrophil influx 
into the infected area thus restricting bacterial proliferation and systemic bacterial spread 
(Hidalgo-Grass et al., 2004). SilCR negatively regulates scpC transcription by interacting with 
the two component system, SilA/B. The subcutaneous co-injection of SilCR and M14 S. 
pyogenes in mice downregulates transcription of scpC by 10 fold (Hidalgo-Grass et al., 2006). 
Transcription of silC and silCR, highly regulated by the SilCR peptide, makes a regulatory 
circuit that in turn regulates the invasive potential of S. pyogenes. SilCR autoregulates the 
transcription of silCR via the two component system silA/B, as shown by marked upregulation 
in the transcription of silD/E/CR by the WT JS95 strain when grown in the presence of SilCR. 
However, in JS95 silA mutant strain, SilCR was unable to induce the transcription of 
silD/E/CR. (Eran et al., 2007). The sil locus was found in 16% of the invasive S. pyogenes 
isolates of different emm types (Bidet et al., 2007) and 18% of S. pyogenes strains containing 
sil locus produced SilCR peptide. Although, the sil is absent in M1 and M3 serotype S. 
pyogenes, which are predominant serotypes associated with invasive S. pyogenes diseases, the 
impact of SilCR in modulating M14 S. pyogenes virulence indicates that it might play an 
important role in regulating the expression of ScpC in other serotypes. 
 
1.3.5.6.2  Regulation of S. pyogenes virulence by two component system covRS  
A two component regulatory system, covRS (also designated as csrRS) influences the 
transcription of 15% S. pyogenes genes including several virulence factors. It negatively 
regulates the expression of important virulence factors i.e. hylauronic acid capsule, SpeB, 
streptokinase, streptolysin S, and streptodornase. Inactivation of covRS results in increased 
production of these virulence factors thus enhancing S. pyogenes virulence in mouse models 
of invasive disease (Federle et al., 1999; Heath et al., 1999; Levin and Wessels, 1998). 
Recently, Sumby et al. (2006) suggested the role of covRS in a phenotypic switch from non-
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invasive to invasive phenotype by regulating the differential transcription of certain virulence 
factors. By studying the distinct trascriptome of invasive and pharyngeal isolates, it has been 
shown that a spontaneous generation of a single 7-bp insertion mutation in the gene encoding 
the sensor kinase component (covS) of the two component regulatory system covRS leads to 
the invasive phenotype of S. pyogenes. This mutation leads to a characteristic increase in the 
expression of various virulence factors including hyaluronic acid capsule, SpyCEP, Sic, Mac, 
streptococcal DNase D2, C5a peptidase and other exoproteins. A marked upregulation (>25 
fold) in the transcription of scpC (spyCEP) by invasive S. pyogenes isolates was observed in 
comparison to pharyngeal isolates, further supporting the contribution of ScpC to the outcome 
of invasive S. pyogenes disease. Additionally, the mutation in covRS leads to upregulation of 
ScpC protein expression as shown by enhanced concentration of secreted ScpC by covR/S 
mutant strain in comparison to WT S. pyogenes strain further indicates that scpC is negatively 
regulated by covRS (Sumby et al., 2008). 
 
1.4 S. pyogenes and the host innate immune response 
 
1.4.1 Neutrophils  
The migration of neutrophils from the bloodstream into infected tissue is the key feature of 
inflammation. Neutrophils, which are normally found in the bloodstream, migrate from 
circulating blood to the infected tissue in response to an inflammatory signal. The average 
lifespan of neutrophils is 12 h in blood and 1-2 days in tissue. To reach the infected tissues, 
neutrophils transmigrate across the endothelium and the basement membrane, a process 
known as diapedesis. Neutrophil extravasation is a multi-step process which includes 
tethering, rolling, activation, adhesion and subsequent migration of adherent cells through the 
intercellular spaces between the endothelial cells to the infected underlying tissue. This 
process involves a complex system of intracellular cell signaling and regulated interplay 
between various adhesion molecules on neutrophils and vascular endothelial cells to cause 
cells trafficking from the bloodstream into the tissue. The tethering and rolling of neutrophils 
along the endothelium is mediated by the transient interaction between selectins (L, E and P-
selectins; cells adhesion molecules) and their carbohydrate ligands (Lawrence et al., 1994; 
Ley and Tedder, 1995). The rolling of polymorphonuclear leukocytes (PMNs) on the 
endothelial cell surface facilitates their exposure to chemokines bound on  the endothelial cell 
surface via glycosaminoglycans (Rot et al., 1996). The chemokines trigger the arrest of rolling 
leukocytes expressing specific receptors by providing a signal through G-protein coupled 
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receptors that convert the low affinity selectin mediated interaction to high-affinity integrin 
mediated interaction with intercellular adhesion molecule (ICAM)-1 and vascular cell 
adhesion molecule (VCAM)-1 present on endothelial cells. To induce the integrin mediated 
neutrophil arrest, chemokines enhance the integrin avidity to endothelial cell ligands (Chan et 
al., 2001; Rainger et al., 1997). The leukocyte adhesion to endothelial cells subsequently 
transmits the signal to leukocytes to undergo cytoskeleton rearrangement that contributes to 
the outcome of transendothelial migration. 
 
1.4.2 Neutrophil killing mechanism 
After reaching the site of infection, neutrophils engulf the microbe by phagocytosis into a 
vacuole known as a phagosome. Once phagocytosed, the microbe is killed within the 
phagocyte via both, non-oxidative and oxidative mechanisms (Nathan, 2006). The non-
oxidative mechanism involves the discharge of granules containing antibacterial compounds 
into the phagosome. Neutrophil granules are categorised into primary (azurophilic granules), 
secondary (specific granules) and tertiary granules (gelatinase granules). The secondary and 
tertiary granules contain antimicrobial proteins such as lysozyme, lactoferrin, lipocalin, 
gelatinase and metalloproteases. Metalloproteases facilitate the migration of neutrophils into 
the tissue by degradation of extracellular matrix proteins (Borregaard and Cowland, 1997). 
The azurophilic granules contain small antimicrobial peptides, defensins, cathepsin G, 
proteases, elastase and myeloperoxidase (MPO) (Urban et al., 2006). The oxygen dependent 
mechanism kills the microbe via respiratory burst, in which reactive oxygen species including 
superoxide, singlet oxygen, ozone, hydrogen peroxide, hypohalous acids, chloramines and 
hydroxyl radicals are generated. The respiratory burst has been shown to be essential for the 
optimal killing of many bacterial species. It involves abrupt non-mitochondrial reduction of 
oxygen by NADPH-oxidase complex assembled in the phagosomal membrane to generate 
superoxide (O2-) (Babior et al., 1973; Segal and Abo, 1993).  
 
                                                   NADPH Oxidase 
                             NADPH +  2O2                      NADP+ + 2O2- + H+ 
 
Superoxide ions are converted to H2O2 by superoxide dismutase (SOD) which in turn, is 
consumed by MPO to form hypochlorous acid (HOCl). It has been shown that HOCl is the 
strong non-radical bactericidal oxidant produced by the neutrophils (Hampton et al., 1998). 
Subsequently, the phagocytosis of the microbe induces changes in PMN gene expression 
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leading to programmed cell death (apoptosis) of PMN which is essential to limit tissue 
damage and contributes to resolve the bacterial infection. Studies of Kobayashi et al. (2003) 
have shown that S. pyogenes can enhance its survival by altering the PMN apoptosis program 
as observed the enhanced, premature apoptosis of neutrophils incubated with WT S. pyogenes 
as compared to heat-killed S. pyogenes which had very low capacity for inducing PMN 
apoptosis.  
 
1.4.3 Neutrophil Extracellular Traps  
In addition to intracellular killing by neutrophils, activated neutrophils can release neutrophil 
extracellular traps (NETs), which are essential for extracellular killing of bacteria. NETs are 
composed of antimicrobial proteins and proteases of neutrophil granules along with DNA and 
histones as a major structural component. NETs are non-membranous traps which kill the 
microbe by delivering a high local concentration of antimicrobial molecules (Brinkmann et 
al., 2004). It has been shown that S. pyogenes circumvent neutrophil killing by degrading 
neutrophil extracellular traps (Figure 4). The S. pyogenes M1T1 clone is frequently associated 
with invasive diseases and expresses a phage encoded DNase streptodornase 1 (Sda1). Sda1 
enables S. pyogenes to survive extracellular killing by degrading the DNA framework of 
NETs as evidenced by dose-dependent degradation of NETs by WT M1T1 in comparison to 
M1T1 ∆Sda1 mutant, where significant quantities of NETs were observed upon co-incubation 
(Buchanan et al., 2006). Additionally, it has been reported that degradation of IL-8 by ScpC 
can lead to reduced IL-8 mediated NET production which may aid the bacteria to escape the 
extracellular killing by neutrophils thus enhancing bacterial survival and spread (Sumby et al., 
2008). 
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Figure 4. Degradation of NETs by S. pyogenes. NETs consisting of DNA backbone, histones and granules. S. 
pyogenes expresses DNases that degrade the DNA-backbone of NETs. Image modified from Wartha et al. 
(2007). 
 
1.4.4 Interleukin-8  
IL-8, also known as neutrophil chemotactic factor-1, is a major host-derived chemokine 
which acts as an activator and chemoattractant of neutrophils during the host inflammatory 
response (Bickel, 1993). IL-8 is produced by a variety of cell types during infection, including 
monocytes, T lymphocytes, neutrophils, fibroblasts, epithelial cells and endothelial cells, upon 
activation by other pro-inflammatory mediators and cytokines. IL-8 also mediates respiratory 
burst, granule release, and enhances cellular adhesion of neutrophils to the endothelial cell 
surface. The activity of IL-8 is mediated through its binding to specific GTP-coupled, seven-
helix transmembrane chemokine receptors, CXCRl and CXCR2 on neutrophils. IL-8 is a 
member of the subclass of CXC chemokines which contains a specific motif of amino acid 
sequence Glutamic acid-Leucine-Arginine (ELR) immediately before the first conserved 
cysteine near the N-terminus. Chemokine members of the CXC branch of the family have 
four invariant cysteines, the first two of which are separated by one non-cysteine amino acid 
residue designated as X (Strieter et al., 2002). IL-8 is a non-glycosylated protein of 72 amino 
acids with a molecular mass of 8.4 kDa, which is produced by the processing of a precursor 
protein of 99 amino acids.  
 
1.4.4.1  Transendothelial migration of neutrophils 
During inflammation, circulating leukocytes migrate across the endothelial barrier to reach 
the site of microbial infection/ tissue injury. IL-8 is a major neutrophil chemoattractant which 
induces the migration of neutrophils across the inflammed endothelium (Smith et al., 1991). 
Endothelial cells produce IL-8 constitutively, and show markedly increased IL-8 production 
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in response to inflammatory signals such as TNF- α and IL-1 (Strieter et al., 1989). To cause 
the transendothelial migration of leukocytes, tissue derived IL-8 and endothelial cell derived 
IL-8 is transported to the luminal surface of the endothelial cells (Rot et al., 1996). IL-8 gets 
immobilized on the luminal side of the endothelial cell surface via highly charged amino acids 
present at the C-terminus. The IL-8 C-terminal alpha helix mediates transient anchoring of IL-
8 on endothelial cells via binding with heparin sulphate glycosaminoglycans present on the 
endothelial surface. Therefore, an intact C-terminus of IL-8 is necessary for both the 
transcytosis across the endothelial cells and subsequent binding on the endothelial apical cell 
surface (Middleton et al., 1997; Webb et al., 1993; Witt and Lander, 1994). Binding of IL-8 
on the endothelial cell surface creates a haptotactic chemokine gradient of IL-8 which then 
triggers the recruitment of leukocyte subsets expressing specific receptors into the area of 
microbial invasion (Rot, 1992; Rot et al., 1993). The presentation of IL-8 anchored on the 
apical surface of endothelial cells to circulating neutrophils expressing the chemokine 
receptors CXC1and CXC2 is responsible for the neutrophil arrest and promigratory activity of 
IL-8 (Skelton et al., 1999). In vivo, due to the continuous flow of blood, soluble chemokines 
would be washed away and soluble chemokine gradient would rarely persist in the blood 
stream. Huber et al. (1991) have shown that endothelial cells produce a 77 amino acid variant 
of IL-8 when stimulated with proinflammatory mediators like cytokines or lipopolysaccharide 
(LPS). The endogenous IL-8 synthesized by stimulated endothelial cells induces neutrophil 
attachment and migration across the endothelial monolayer. Various other studies have 
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also shown that chemoattractants bound to the 
surface of endothelial cells are responsible for 
inducing the transmigration of neutrophils. In 
contrast, the soluble IL-8 added externally to the 
cell culture inhibited adhesion and 
transmigration of neutrophils (Rot, 1992). 
Apically bound chemokines on activated human 
umbilical vein endothelial cells (HUVEC) 
augmented T cell arrest and subsequent 
migration through the endothelial cell barrier to 
the site of inflammation in the absence of 
soluble chemotactic gradients across the 
endothelial barrier (Cinamon et al., 2001; 
Middleton et al., 1997). In contrast, another 
study has reported that TNF-α stimulated 
endothelial cells produced two chemokines 
GRO-α, and MCP-1. GRO-α immobilized on 
the endothelium mediates monocyte adhesion  
and arrest to the endothelium under shear flow while a soluble MCP-1 gradient mediates the 
transendothelial migration of monocytes (Weber et al., 1999). 
 
1.5 Intracellular invasion by S. pyogenes  
 
S. pyogenes, once considered as an extracellular pathogen, can efficiently invade and survive 
within a variety of host cells (Hagman et al., 1999; LaPenta et al., 1994). S. pyogenes triggers 
its own uptake by non-phagocytic host cells during its initial encounter with the host. 
Although the pathogenic significance of the invasion of S. pyogenes into non-phagocytic host 
cells is not clearly understood, it is possible that an intracellular state may provide a protective 
niche to bacteria by providing protection from antibiotic therapy and host defence 
mechanisms that enables S. pyogenes to persist in the host and invade deeper tissues. 
Antibiotic treatment with penicillin and clindamycin can efficiently eradicate extracellular S. 
pyogenes, however it is unable to kill intracellularly residing bacteria, which might be the 
major cause of antibiotic treatment failure for streptococcal infections. Brandt et al. (2001) 
have shown that 80% of pharyngitis patients had relapse of infection with the same S. 
Figure 5. Model showing the binding of IL-8 on 
the endothelial cell surface via 
glycosaminoglycans and the presentation of 
immobilized IL-8 to the CXCR-1 receptor on a 
passing neutrophil (Skelton et al., 1999). 
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pyogenes strains which were originally isolated, even after vigorous penicillin treatment. The 
intracellular presence of viable S. pyogenes in pharyngeal epithelial cells collected from 
patients with tonsillitis and the tonsils of asymptomatic S. pyogenes carriers suggests that 
intracellular S. pyogenes constitute a reservoir of bacteria capable of causing recurrent S. 
pyogenes infections (Osterlund and Engstrand, 1997; Osterlund et al., 1997). S. pyogenes can 
also reside intracellularly in host phagocytic cells like macrophages, monocytes and 
neutrophils.  Intracellular viable streptococci were isolated from macrophages in skin biopsies 
of patients with severe invasive S. pyogenes soft tissue infection. In vitro invasion of S. 
pyogenes into macrophages showed that the intracellular viable S. pyogenes were able to 
replicate extracellularly after the removal of antibiotics. Also, intracellular S. pyogenes were 
frequently isolated from newly involved non-inflamed tissue suggesting that internalization of 
S. pyogenes by host cell may lead to the invasion of the deeper tissues (Thulin et al., 2006). 
Invasion of host cells is a multi-factorial process involving the interaction of specific cell 
surface exposed virulence factors of S. pyogenes with host components. S. pyogenes enhances 
intracellular survival via various strategies to evade lysosomal killing, which serves as an 
important intracellular innate defense function. Lysosomes are the terminal compartments in 
the cellular endocytic pathway which kill and degrade the phagocytosed microbe upon fusion 
with the phagosome. Lysosomes have an acidified lumen with pH 4.5, maintained by the 
proton pump activity of the vacuolar ATPase, and digestive enzymes including proteases, 
lipases, lysozyme and nucleases that work optimally at acidic pH (Mellman et al., 1986). To 
enhance intracellular survival, S. pyogenes are able to inhibit the fusion of phagosome with 
lysosome, escape from phagosome into the cytoplasm and enhance survival inside the phago-
lysosomes. M1 serotype S. pyogenes expressing surface-associated M or M-like proteins can 
survive and replicate inside the neutrophils via specifically inhibiting the fusion of azurophilic 
granules with S. pyogenes containing phagosomes (Staali et al., 2006; Staali et al., 2003). 
Also, S. pyogenes are able to combat the oxidative stress by upregulating the expression of 
genes such as such as alkylhydroperoxidase (ahpC), alkylhydroperoxidase reductase (nox1) 
and glutathione peroxidase (bsaA) which encode proteins that detoxify reactive oxygen 
species and other free radicals in neutrophils (Voyich et al., 2003).  
 
1.5.1 Virulence factors involved in the invasion of S. pyogenes into  
host cells 
The S. pyogenes surface protein Sfb1 (also known as PrtF1) is an essential factor for 
adherence to and invasion into human epithelial (HEp2) cells. Epidemiology studies have 
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shown that the sfb1 gene is present in 50-70% of S. pyogenes isolates (Neeman et al., 1998; 
Talay et al., 1992). Sfb1 binds the extracellular matrix protein fibronectin (Fn) with high 
affinity. Pre-incubation of Sfb1-carrying streptococci with soluble Fn efficiently promoted 
bacterial adherence to epithelial cells which is indicative of the role of Sfb1 in the 
colonization process during infection (Valentin-Weigand et al., 1994). The binding of Sfb1 to 
Fn is a prerequisite for adhesion to and invasion into non-phagocytic host cells. Fn acts as a 
bridge between Sfb1 present on the S. pyogenes cell surface and the α5β integrin receptor on 
HEp2 cells. Molinari et al. (1997) have demonstrated that the presence of Sfb1 on the S. 
pyogenes surface is sufficient to trigger invasion into HEp2 cells as shown by efficient 
internalization of Sfb1 coated latex beads by epithelial cells. Sfb1 mediates adherence to 
epithelial cells via its C-terminal fibronectin-binding repeat region which is a prerequisite for 
the subsequent invasion process. The lack of the fibronectin-binding domains impairs the 
adhesion and internalization of recombinant Sfb1 protein by epithelial cells. The SfbI spacer 
domain also triggers the invasion of streptococci into the eukaryotic cells. Two distinct N-
terminal regions of fibronectin co-operatively interact with the two C-terminal fibronectin 
binding domains of Sfb1, a process that subsequently triggers the invasion of S. pyogenes into 
epithelial cells (Talay et al., 2000). 
Rohde et al. (2003) have shown that S. pyogenes follows distinct pathways for invasion into 
host cells depending upon the expression of specific virulence proteins. Sfb1 expressing S. 
pyogenes strains follow a caveolae-mediated endocytic pathway to gain entry into epithelial 
as well as endothelial cells. Sfb1 expressing S. pyogenes strains trigger the formation of large 
membrane invaginations in the host cells via fibronectin-mediated interaction with the cellular 
integrin α5β1. Sfb1 expressing S. pyogenes induce integrin clustering at the site of entry which 
results in recruitment of host cell caveolae towards the cytoplasmic membrane. Recruitment 
of caveolae subsequently leads to streptococcal uptake into distinct compartments called as 
caveosomes. S. pyogenes thereby evades the fusion with lysosomes and bypasses the classical 
endocytic pathway of eukaryotic cells. Incubation of epithelial cells with purified recombinant 
Sfb1 protein was sufficient to trigger the uptake process by formation of membrane 
invaginations in the host cell as shown by clustering and uptake of Sfb1 coated gold particles. 
In contrast, Sfb1 negative M1 S. pyogenes uses a distinct pathway to invade host cells. 
Binding of Sfb1-negative S. pyogenes to host cell microvilli triggers cytoskeletal 
rearrangements that induce the formation of membrane protrusions by epithelial cells to 
engulf the microbe (Rohde et al., 2003).  
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M-protein has also been shown to participate in the interaction with eukaryotic cells. Invasion 
of S. pyogenes into epithelial cells was triggered by binding of M1 protein to the extracellular 
matrix proteins fibronectin or laminin. Inactivation of the emm1 gene reduced the binding of 
S. pyogenes by 88% indicating that interaction of M1 protein with Fn is a prerequisite to 
mediate adherence and internalization of M1 serotype S. pyogenes into A549 cells. Also, the 
invasion of epithelial cells by a highly virulent M1 clone was dependent upon exposure of 
bacteria to fibronectin or synthetic peptide containing RGD amino acid sequence (Cue and 
Cleary, 1998). The role of M6 protein in invasion of S. pyogenes into human epithelial cells 
was confirmed by Fluckiger et al. (1998). The M+ strain invaded a human pharyngeal cell line 
at a significantly higher rate than isogenic M- strains of S. pyogenes. Another report has 
shown that both M protein and SfbI contribute significantly to the invasion of epithelial cells 
and require the activation of the integrin-linked kinase signaling pathway (Wang et al., 
2006a). The expression of heterologous Sfb1 in the S. pyogenes strain of M1 serotype 
significantly enhanced the potential of S. pyogenes to invade epithelial cells and resistance to 
phagocytosis suggesting the significant contribution of Sfb1 in enhancing the virulence of S. 
pyogenes (Hyland et al., 2007). LaPenta et al. (1994) have reported that streptococcal 
pyrogenic exotoxin A (SpeA) might contribute to the invasion process of S. pyogenes into 
host cells as evidenced by the higher frequency of invasion of M1 strain containing speA gene 
into epithelial cells in comparison to a speA negative M1 strain.  
Nakagawa et al. (2004) have reported that SLO mediates the escape of intracellular S. 
pyogenes from endosomes into the cytoplasm. This has been shown by the lack of extrication 
of the SLO mutant strain from the endosomes in comparison to WT S. pyogenes. S. pyogenes 
present in the cytoplasm were shown to induce autophagic machinery and become enveloped 
by an autophagosome-like compartment which leads to intracellular killing of bacteria upon 
fusion of autophagosome with lysosomes. In contrast to this, it has been reported that SLO 
reduces both internalization of S. pyogenes into epithelial cells and intracellular killing by the 
lysosomes as shown by enhanced internalization of SLO deficient S. pyogenes into the cells 
via lysosomes with subsequent killing within the lysosomes. The SLO producing WT S. 
pyogenes however retards trafficking to lysosomes and thus may prolong the survival of 
bacteria by resisting intracellular lysosomal killing (Hakansson et al., 2005).  
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1.6 Objectives of the study 
 
To understand the basic molecular mechanism of S. pyogenes pathogenesis that leads to the 
outcome of highly invasive human infections, it is essential to study the S. pyogenes virulence 
factors that contribute to enhance the virulence by evading the innate immune response of the 
host towards infection. The S. pyogenes serine protease ScpC is a novel virulence factor 
which impairs the recruitment of neutrophils at the site of infection by inactivating the host 
CXC chemokine IL-8, thereby enhancing the survival of S. pyogenes in the host. Studies have 
indicated that ScpC-mediated reduced local inflammatory response towards S. pyogenes 
infection significantly contributes to the enhanced virulence of S. pyogenes in a mouse model 
of soft tissue infection. Despite the important role of ScpC in enhancing S. pyogenes 
virulence, the biological characteristics of ScpC are undetermined and little is known about its 
biochemical properties. Thus, the first objective of this study was: 
 
a) To recombinantly express and characterize ScpC to further understand the 
contribution of ScpC in S. pyogenes pathogenesis of invasive soft tissue infections. 
 
Invasive deep tissue S. pyogenes infections are characterized by the accumulation of 
neutrophils in blood capillaries. However, neutrophils fail to transmigrate across the 
endothelium to the site of infection containing massive bacteria load. Vascular endothelial 
cells line the interior surface of blood vessels and act as a barrier between the blood and 
underlying tissue. The endothelium plays a central role in the inflammation process by 
secreting cytokines and regulating  the transmigration of neutrophils via conveying signals 
from the inflammed tissue to the circulating neutrophils, to cause diapedesis. In non-
inflammed tissue, endothelial cells control vessel wall permeability and quiesce circulating 
neutrophils. Recent studies have indicated the potential role of ScpC in retarding the 
transendothelial migration of neutrophils into the infection tissue. Based on these findings, it 
was hypothesized that breaching an endothelial barrier or interfering with endothelial cell 
function might in part contribute to the enhanced virulence of S. pyogenes during severe 
invasive soft tissue infections. Therefore, the second objective of this study was: 
 
b) To study the role of ScpC in the interaction of S.  pyogenes with human vascular 
endothelial cells. 
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2 Materials and Methods 
 
2.1 S. pyogenes strains      
  
Strain                            Phenotype Serotype 
A475 Invasive isolate   M3 
JS95 Muscle tissue isolate   M14 (Hidalgo-Grass et al., 2004) 
KTL3    Blood isolate                       M1 
A416   Invasive isolate   M12 
A471 Invasive isolate M18 
 
 
2.2 E. coli strains     
 
Strain Genotype Reference 
M15 [pREP4] NaIS, StrS, RifS, Thi–, lac–, ara+, 
gal+, mtl–, F–, recA+, uvr+, lon+ 
Qiagen, 1994 
DH5α supE44, ∆(lac)U169 Φ80∆(lacZ) 
M15, hsdR17, recA1, endA1, 
gyrA46, thi-1, relA1 
Sambrook et al., 1989 
SG13009 Lac- ara gal Mtl- F- recA+ uvr+ Qiagen, 1994 
  
                                                                                                   
2.3 Vectors  
 
Vector           Selection marker                Reference 
pQE-60 Ampicillin (100 µg/ml)  Qiagen, 2003 
pGEX-6P-1 Ampicillin (100 µg/ml)   Amersham, 2006 
pJRS233 Spectinomycin (80 µg/ml) (Perez-Casal et al., 
1993) 
 
 
2.4 Antibiotics 
 
Antibiotic   Concentration Company 
Ampicillin           100 µg/ml Applichem 
Gentamicin 100 µg/ml Sigma 
Kanamycin 25 µg/ml and 250 µg/ml* Applichem 
Penicillin G 5 µg/ml Sigma 
Spectinomycin 80 µg/ml Sigma 
 
* For S. pyogenes 
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2.5 Chemical Reagents 
 
Name Company 
2,2'-azino-bis(3-ethylbenzthiazoline-6-
sulphonic acid) (ABTS )  
Roche 
Acetic Acid                Merck 
Acetonitrile (HPLC-grade)   J.T. Baker 
Agarose                                Roth 
Antarctic phosphatase New England Biolabs 
Ammoniumpersulfate (APS)            Roth 
Ammoniumsulfate                                             J.T. Baker 
N-propyl-gallate  Sigma 
Bacto Agar          Difco 
Bacto Peptone        Difco 
Bacto Tryptone  Difco 
Bacto Yeast Extract     Difco 
2-mercaptoethanol Sigma 
Bovine serum albumine (BSA)                         Applichem 
Bradford reagent Bio-Rad 
Bromphenolblue Merck 
Calcium chloride (CaCl2)      Merck 
Chloroform    Baker 
Citric acid Roth 
D-Glucose  Merck 
Dipotassium hydrogen phosphate (K2HPO4) Merck 
Disodium hydrogen phosphate (Na2HPO4) Merck 
dNTP mix     Fermentas 
Dithiothreitol (DTT) Applichem 
Ethanol   J. T. Baker 
Ethidiumbromide ICN-Biomedicals 
Ethylene diaminetetraacetic acid (EDTA)  Applichem 
Ferric nitrate (FeNO3)       Fluka 
Ferric sulfate (FeSO4)                                        Merck 
Fetal calf serum (FCS) PAP 
Fibrinogen (human)                  Calbiochem 
Formaldehyde Fluka 
Formamide Roth 
Gelatin Sigma 
Glycerol Fluka 
Glycine Roth 
Glycogen   Roche 
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Glutathione sepharose Amersham 
Glutathione (reduced) Sigma 
L-Glutamine PAN Biotech 
High fidelity polymerase Roche 
Hoechst Molecular probes 
Hydrochloric acid (HCl)                                    Fluka 
Hydrogen peroxide Applichem 
Imidazole Applichem 
Isopropyl β-D-1-thiogalactopyranoside  
 (IPTG)                 
Applichem 
Lysozyme Sigma 
Magnesiumchloride (MgCl2)                             Merck 
Methanol Baker 
Mowiol                  Fluka 
Mutanolysin Fluka 
Neopeptone     Difco 
Ni-NTA sepharose Qiagen 
Papain Sigma 
Phenol    Applichem 
Phenol/Chloroform/Isoamylalcohol      Applichem 
PMSF Applichem 
Prolong Gold-antifade                                       Invitrogen 
Pefabloc Fluka 
Ponceau S   Applichem 
Potassium dihydrogenphosphate (KH2PO4)      Roth 
Prescission protease GE-healthcare 
Proteinase K Fluka 
Protein A sepharose Pharmacia 
Restriction enzymes                                           New England Biolabs /Fermentas 
Saponin Fluka 
Sheep blood, defibrinated    Oxoid 
Silver Nitrate Merck 
Skim milk                                                          Difco 
Sodium acetate (NaCH3COO)      Merck  
Sodium carbonate (NaHCO3)                            Merck 
Sodium Chloride (NaCl)        Roth 
Sodium dihydrogenphosphate (NaH2PO4)        Roth 
Sodium hydroxide (NaOH)                                Merck 
Sodiumdodecylsulfate (SDS)                             Roth 
Extravidin-HRP Molecular Probes 
Sucrose   Fluka 
Sulfosalicylic acid  Merck 
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T4 DNA ligase  New England Biolabs        
Taq-polymerase Qiagen 
TEMED   Roth 
Trifluoroacetic acid Applichem 
Tris  (Trizma base)        Sigma 
Trypan Blue                                                      Sigma 
Trypsin Sigma/Gibco 
Tryptic Soy Broth                                              Beckton Dickinson 
Todd-Hewitt Broth  Beckton Dickinson 
Urea     J.T. Baker 
X-Gal (5-Bromo-4-Chloro-3-indolyl-ß-D-
galactopyranosid)                          
Applichem 
Trypsin-EDTA PAN Biotech 
Coomassie Blue R-250 Serva 
Triton X-100 Sigma 
Human Interleukin -8                           R&D 
Dimetheylsulfoxide (DMSO) (CH3)2SO Applichem 
Latex polystyrene beads (1µm & 3µm)             Sigma 
Tween 20                                                           Roth 
Acrylamid-Bisacrylamid (Rotiphorese Gel 
30)        
Roth 
 
The chemicals which are not listed were either purchased from Sigma/Roche or referred to in 
the text. 
 
 
2.6 Primers 
 
Name                         Sequence 5’          3’ 
scpC-PR fwd BspHI                GCTAATTCATGACTGATGCGACTCAA 
scpC-B/H rev  BamHI TTCATTGGATCCGGTATTCACCTTTG 
scpC-PR rev   BamHI   CCGCTGGATCCAGCTCCGTCAATATT 
scpC-A rev BamHI CGGATCCTTGTGGTAGGTGATCTCCT 
scpC-A fwd TCATGACAGGAAAAGACAACTATGGC 
scpC-A fwd BamHI                     CGGGATCCTATGTGACAGGAAAAGAC         
scpC-A rev EcoRI                   CCGGAATTCTCATGTTTGTGGTAGGTGATC
scpC B/H rev EcoRI                 CGGGAATTCTCAGGTATTCACCTTTGTGTT 
scpC-PR2 fwd CTAATTCATGAAGGCACCGAAAGAAACT
pQE fwd TTGTGAGCGGATAACAA 
pQE rev GTTCTGAGGTCATTACTGG 
pQE fwd promoter Seq CCCGAAAAGTGCCACCTG 
pGEX fwd GGGCTGGCAAGCCACGTTTGGTG 
pGEX rev CCGGGAGCTGCATGTGTCAGAGG 
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2.7 Antibodies  
 
Antibodies Conjugated with Source/Company 
Anti-human IL-8, monoclonal, 
hybridoma           
-- R&D 
Goat anti-human IL-8 IgG, polyclonal -- R&D 
Goat anti-mouse IgG                            HRP Sigma 
Goat anti-rabbit IgG      Alexa Fluor® 488             Molecular Probes 
Goat anti-rabbit IgG   Alexa Fluor® 568             Molecular Probes 
Goat anti-rabbit IgG HRP Dianova 
Mouse anti-human Integrin β 1 -- Chemicon 
Mouse anti-human LAMP-1, clone 
H4A3, monoclonal  
-- Beckton Dickinson 
Mouse anti-human IL-8, monoclonal Biotin   Abcam 
Rabbit  IgG                    -- Sigma 
Rabbit anti- S. pyogenes, polyclonal     
                                                 
-- Talay et al. 
Rabbit anti-goat IgG HRP Dianova 
Rabbit anti-mouse IgG                       Alexa Fluor® 568      Molecular Probes 
Rabbit anti-ScpC antibody, polyclonal --    (this study) 
Anti-EEA1, monoclonal -- Beckton Dickinson 
 
 
2.8 Cultivation of bacteria 
 
2.8.1 Cultivation of S. pyogenes  
S. pyogenes strains were grown overnight in either Todd-Hewitt broth supplemented with 
yeast extract (THY) at 37°C or in Tryptic Soy broth (TSB) under a humidified environment 
containing 5% CO2. Antibiotics were added to the medium when required, and used as a 
selection marker for S. pyogenes mutant strains. To grow streptococci on solid media, bacteria 
were grown overnight at 37°C either on THY plates, which were made by supplementing 7 g 
of agar per liter of THY media. For plate culturing, S. pyogenes was grown on Columbia 
Blood Agar plates containing 5 % sheep blood (oxoid). 
 
THY broth        
30 g Todd-Hewitt Broth 
10 g Yeast Extract 
Dissolved in one liter of ddH2O 
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Autoclaved for 15 min at 121°C 
TSB   
34.5 g Tryptic Soy Broth 
Dissolved in one liter of ddH2O 
Autoclaved for 15 min at 121°C 
 
2.8.2 Cultivation of E. coli  
E. coli strains were grown in Luria Bertani (LB) media at 30°C or 37°C, while shaking. For 
the cultivation of E. coli M15 [pREP4] [pQE-60 scpC], ampicillin (100 µg/ml) and 
kanamycin (25 µg/ml) were added to LB media, as a selection marker. E. coli DH5α 
transformed with pGEX-6P-1 derivative were grown in LB media supplemented ampicillin 
(100 µg/ml). For plate culturing, LB agar plates were made by adding 7 g of agar per one litre 
of LB media.  
 
LB media 
10 g Bacto Tryptone 
5 g Bacto Yeast Extract 
10 g NaCl 
Dissolved in one liter of ddH2O, pH adjusted to 7.4 with NaOH. 
Autoclaved for 15 min at 121°C 
 
For long-term storage, S. pyogenes strains and E. coli strains were grown overnight in 
appropriate media and stationary phase bacteria were mixed with sterile glycerol in the ratio 
of 3:1 to give final concentration of 20% glycerol. The glycerol stocks were stored at -80°C in 
cyrotubes (Biozyme). 
 
2.9 DNA isolation and quantification  
 
2.9.1 Isolation of genomic DNA from S. pyogenes 
S. pyogenes strains were grown overnight in THY media at 37oC and the DNA was isolated 
using the DNeasy DNA Isolation Kit (Qiagen) according to manufacturer’s instructions. 
InstaGeneTM Matrix (BioRad) was used alternatively for isolating the DNA for PCR analysis 
to check the presence of a gene in S. pyogenes strains. The colonies were gently scraped from 
the surface of agar plates and resuspended in 1 ml of dH2O. The suspension was pelleted by 
centrifugation at 10,000 x g, for 1 min and the pellet was resuspended in 100 µl of InstaGene 
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matrix and incubated at 56°C for 20 min. The mixture was subsequently incubated at 100°C 
for 8 min. After vortexing for 10 sec, the sample was centrifuged at 10,000 x g for 3 min and 
the supernatant was used as template in PCR reactions.  
 
2.9.2 Quantification of DNA 
The DNA concentration was estimated by loading the equal volume of DNA sample and 
Gene Ruler DNA Ladder Mix (Fermentas) onto a 1% agarose gel. The amount of DNA was 
estimated in comparison to the DNA ladder according to manufacturer’s instructions. 
Alternatively, the absorbance of DNA containing solution was measured using an UV-
spectrophotometer and the concentration of DNA was calculated according to formula given 
below: 
 
 
2.10  Polymerase chain reaction (PCR) 
 
The DNA fragments were amplified by PCR using Taq polymerase and specific 
oligonucleotides complementary to the 5’ end and the 3’ end of the DNA fragment. The PCR 
for amplification of the gene of interest was carried out in three repetitive steps including 
denaturation, annealing and extension, using a thermocycler (Biometra). For all the cloning 
steps, the proof reading polymerase (Expand high fidelity PCR system) was used for the 
amplification of gene of interest, according to the manufacturer’s recommendations. To verify 
the amplification of a gene fragment, samples were analysed by agarose gel electrophoresis as 
described in section 2.11 and the gel was visualized under UV light by using an UV 
transilluminator.  
 
The following reagents were used for PCR reaction: 
DNA (template)        10 – 100 ng 
dNTPs (each 50 µM dNTP) 200 µM                                    
Primers 0.2 µM                 
MgCl2 (Qiagen) 250 µM                
10 × Taq-Reaction buffer (Qiagen)  5 µl 
Taq Polymerase (Qiagen)  0.5 µl              
 
1 O.D. (260nm) = 50 mg DNA/ml 
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Added double distilled H2O to make final volume of 50 µl. 
 
 PCR procedure for amplification of gene:  
Step 1: 5 min 96°C 
Step 2: 40 sec 96°C (denaturation) 
Step 3: 40 sec 58°C (annealing) 
Step 4:  variable time 72°C (extension) 
Step 2 - 4: repeated 29X 
Step 5: 4 min 72°C  
 
The length of the primers was chosen between 25-30 bp for the specific annealing of 
oligonucleotides with the gene of interest.  The annealing of primers with template depends 
upon the melting temperature (Tm) of the oligonucleotides. The GC content of the sequence 
gives an indication of Tm of the primers. The Tm of primers was between 55-65°C. If the 
melting temperature of primers is too high, it can interfere with the function of Taq 
polymerase which has optimum activity at 75-80oC. The Taq polymerase polymerizes 
approximately a thousand nucleotides per minute, therefore, duration of the extension step 
was chosen depending upon the size of the DNA fragment.  
 
2.11  Agarose gel electrophoresis 
 
DNA fragments were analysed by agarose gel electrophoresis by using agarose gels made by 
dissolving 1-2 % of agarose (w/v) in TAE buffer. The size of PCR products was determined 
by comparison with a GeneRulerTM DNA Ladder Mix (Fermentas). The DNA samples was 
mixed with DNA loading dye (1:5) and loaded on an agarose gel. The gels were allowed to 
run at 80-120 V in TAE buffer for 45 min in a Minigel or Maxigel chamber (HorizonTM58). 
After electrophoresis, agarose gels were stained with ethidium bromide (1 µg/ml ethidium 
bromide in distilled H2O), DNA was visualized under UV light at 254 nm using an UV 
transilluminator (Herolab) and the image of the gel was captured using a Herolab Enhanced 
Analysis System.  
 
1 × TAE         
40 mM Tris HCl (pH 7.9) 
5 mM Sodium acetate 
1 mM EDTA 
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5 × DNA Loading Dye         
0.25 % Bromphenolblue (w/v) 
0.25 % Xylencyanol (w/v) 
30 % Glycerol (v/v) 
 
2.12  Molecular cloning techniques 
 
2.12.1  Digestion of DNA with restriction endonucleases  
The DNA fragments (PCR amplicons or plasmids) were digested at specific sites using 
restriction endonucleases. Restriction endonucleases recognize specific regions with 
palindromic sequence and cut DNA at a specific site within this region, creating two single 
stranded complementary cut ends. For restriction digestion, DNA was incubated with 
restriction enzymes in an appropriate buffer according to the manufacturer’s 
recommendations, and the reaction mixture was incubated at 37°C for 3-4 h. After the 
digestion of DNA with restriction enzymes, the enzymes were heat inactivated according to 
the manufacturer’s recommendation. Alternatively, fragments were separated on a 1% 
agarose gel and the DNA band of the appropriate size was excised from the gel and DNA was 
eluted from agarose gel using the QIAquick Gel Extraction Kit (Qiagen). Alternatively, the 
reaction product was purified using the PCR Purification Kit (Qiagen) according to the 
manufacturer’s recommendations. 
 
2.12.2  Dephosphorylation of vector 
To avoid religation of the vector, the 5’ phosphate group of extended ends was 
dephosphorylated using antarctic phosphatase. For dephosphorylation, antarctic phosphatase 
reaction buffer (10X) was added in 1/10 volume to 1 µg of DNA (pre-digested with restriction 
endonuclease) along with 1µl (5 U) of antarctic phosphatase. The reaction mixture was 
incubated for 15 min at 37°C and the enzyme was inactivated by incubating at 65°C for 5 
min. 
 
2.12.3  Ligation of DNA fragments 
The vectors and PCR amplicons digested with compatible restriction enzymes were mixed 
and the base pairing between overhangs generated by restriction digestion was further 
strengthened by covalently linking the 3’-hydroxyl group and 5’-phosphate group of the 
extended ends, using T4 DNA Ligase. 5-10 U of T4 DNA ligase was added to the reaction 
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mixture containing vector and insert DNA, mixed in a proportion dependent upon the size of 
vector and insert, to give a total reaction volume of 10 µl. The reaction mixture was incubated 
overnight at 16°C.  
 
2.12.4  DNA precipitation 
In order to increase the concentration of DNA in sample, DNA was precipitated by mixing the 
DNA containing sample with 1/10th volume of 3 M sodium acetate (pH 4.6) and 2.5 fold 
volume of 98% ethanol. The reaction mixture was incubated overnight at -20°C, or 
alternatively at -80°C for 1 hour, centrifuged at 13,000 × g, 10 min at 4°C and the pellet was 
washed twice with 70% ethanol. The pellet containing precipitated DNA was air dried for 10-
15 min and dissolved in TE buffer or distilled H2O.  
 
2.12.5  Preparation of chemically competent E. coli cells  
The competent E. coli cells were prepared by a method as described by Dagert et al. (1979) 
with some modifications. A glycerol stock of the respective E. coli strain was thawed and 
added to 15 ml of LB broth and bacteria were allowed to grow overnight at 37°C while 
shaking at 120 rpm. The next day, the culture was diluted in the ratio of 1:15 in fresh LB 
broth and the absorbance of the culture was measured at 600 nm. Bacterial cells were grown 
to mid exponential phase (A600nm 0.3-0.4) at 37°C, the culture was centrifuged at 5000 rpm for 
10 min at 4°C and bacteria incubated for 10 min in 25 ml of 100 mM MgCl2. After pelleting 
bacteria as described before, the cells were resuspended and incubated in 25 ml of 50 mM 
CaCl2 at 4°C for 30 min. After centrifugation at 5000 rpm for 10 min, the pellet was 
resuspended in 5 ml of 50 mM CaCl2 and glycerin solution, aliquoted, immediately frozen in 
liquid nitrogen and stored at -80°C.  
 
2.12.6  Transformation of E. coli cells  
For transformation, 100 µl of competent cells were thawed on ice and mixed with 10-20 ng of 
plasmid DNA or 5µl of ligation mixture and incubated on ice for 30 min to allow the binding 
of DNA to the cell wall. The cells were then heat shocked at 42°C for 90 sec in a waterbath 
and 1 ml of pre-warmed LB medium was added to the mixture. The cells were then incubated 
at 37°C for 1 h, while shaking at 120 rpm. The 100-500 µl of cell suspension was plated onto 
LB agar plates overlayed with the appropriate antibiotics and incubated overnight at 37°C. 
Resulting colonies were screened by using colony PCR (see section 2.12.7). The positive 
clones were inoculated in fresh pre-warmed LB medium containing appropriate antibiotics 
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and grown overnight at 37°C. The overnight culture of transformants was mixed with glycerol 
as described before and maintained as a glycerol stock at -80°C. In addition, the plasmid 
DNA was isolated using the Qiagen Plasmid Mini or Midi Preparation Kit according to the 
manufacturer’s instructions and stored at -20oC.   
 
2.12.7  Colony PCR  
The E. coli transformants were analysed by colony PCR using primers specific for the gene of 
interest. For this, single bacterial colonies were picked using a sterile toothpick and 
resuspended in 13 µl of double distilled water. The bacterial cells were lysed by incubating at 
96°C for 10 min. The PCR reaction was filled up with components as mentioned in 2.10, to 
give a final volume of 20 µl and amplified using a PCR program described in 2.10. The PCR 
products were analysed by agarose gel electrophoresis. 
 
2.12.8  Colony Hybridization 
The colonies were also characterized by colony hybridization, in order to select the positive 
clones. A nylon membrane (BioRad) was cut to the size of a petri dish and the circular 
membrane was overlayed on the surface of an agar plate. Three marks were spotted on the 
membrane and plate for orientation. Using a forcep and needle, the nylon membrane was 
carefully peeled from the agar surface and placed colony side up, onto a puddle of denaturing 
solution for 30 min. The membrane was then transferred to puddle of neutralizing solution for 
the next 30 min and briefly washed in 2 X SSC supplemented with 0.1% SDS. The membrane 
was dried and the DNA was cross-linked using a Stratalinker1800 (Stratagene) and hybridized 
with a DIG-labeled DNA probe. Hybridized DNA was detected as described by Sambrook et 
al. (1989). 
 
2.12.9  DNA sequencing 
The amount of DNA in the solution (purified PCR products or plasmid DNA) was calculated 
as described in 2.9.2. Approximately 100 ng of DNA, along with specific primers was 
prepared for sequencing. The DNA sequencing was conducted in the Department of Genome 
Analysis, Helmholtz Centre for Infection Research. The analysis of sequence data was 
performed using Chromas 1.44 and DNAMAN. The Oligonucleotides were ordered at MWG 
Biotech and diluted with distilled water to a concentration of 100 pM/µl. 
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2.13   Recombinant protein expression in Escherichia coli 
 
2.13.1  Construction of plasmids for cloning and overexpression of protein 
For expression of recombinant ScpC (rScpC) with 6xHistidine as an affinity tag, scpC 
encompassing 642-5018 nucleotides (accession no. DQ192030), excluding pre-pro domain 
and cell wall-anchoring domain (full-length scpC) was amplified with PCR using DNA of S. 
pyogenes invasive strain A416. The proof-reading polymerase (Expand High Fidelity PCR 
system) was used according to the manufacturer’s instructions. The oligonucleotides (scpC-
PR fwd BspHI and scpC-B/H rev BamHI) were designed with restriction sites, in order to 
amplify and incorporate the restriction site into 1458 aa fragment corresponding to 106-1564 
amino acid of ScpC (ABA33824.1). The amplicon was then digested with restriction enzymes 
BspHI and BamHI as described in 2.12.1. The digested fragment was ligated into pQE-60 
vector pre-digested with restriction enzyme NcoI (compatible with BspH1) and BamHI using 
T4 DNA ligase (Qiagen).  
The pQE-60 derivative containing scpC was then transformed into the competent E. coli 
strain M15 containing repressor plasmid pREP4 as described in 2.12.6. pQE-60 contains β-
lactamase gene (bla) as a selection marker which confers resistance to ampicillin at 
concentration of 100 µg/ml and pREP4 confers resistance to kanamycin at concentration of 25 
µg/ml. Therefore, the positive clones, M15 [pREP4] [pQE60-scpC] were selected on LB agar 
plates containing ampicillin (100 µg/ml) and kanamycin (25 µg/ml). The presence of the 
insert gene (scpC) was checked by colony PCR using primers specific for scpC. Expression of 
ScpC by positive clones was checked on a small scale by running the samples on SDS-PAGE 
gel after incubating the 10 ml of E. coli cell culture with IPTG.  
 
2.13.2  Heterologous expression and purification of recombinant protein 
The transformants selected were grown overnight in LB medium containing ampicillin (100 
µg/ml) and kanamycin (25 µg/ml). The overnight cultures were mixed with glycerol to give a 
final concentration of 20% glycerol and stored at -80oC in cryotubes. The 5 ml of overnight 
cultures were added to 1 litre of LB broth supplemented with the appropriate antibiotics and 
incubated at 37oC until an absorbance (A600nm) was reached at 0.3. The expression of 
recombinant protein encoded by pQE-60 is rapidly induced by the addition of isopropyl-β−D-
thiogalactoside (IPTG). IPTG binds to the lac repressor protein rendering it incapable of 
binding the operator region.  Once repressor protein is inactivated, E. coli RNA polymerase 
binds to promoter region and transcribes the insert sequences present downstream to the T5 
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promoter region which is then translated into rScpC. The E. coli cells grown to mid-
exponential phase were then incubated with 2 mM IPTG for 4 h at 37°C to induce expression 
of recombinant protein and then harvested by centrifugation at 6000 × g for 15 min at 4°C. 
The pellet was resuspended in 10 ml of lysis buffer containing 1 mM PMSF. The E. coli cells 
were lysed using a French Press (SLM Aminco, SLM Instruments, 1000 bar). The cell debris 
were removed by centrifugation at 10,000 × g for 20 min at 4°C and the clear lysate was 
obtained. Four millilitres of 50% Nickel–nitrilotriacetic acid (Ni–NTA) resin slurry was 
added to the bacterial cell lysate and incubated for 1 h at 4°C while rotating, to allow the 
protein to bind to the resin. This resin with immobilized protein was then packed into a 
column. After the column was washed with wash buffer containing 0.02 M imidazole, the 
recombinant protein was eluted with 0.25 M imidazole (elution buffer). 6xHis tagged 
recombinant protein was purified from bacterial cell lysate using Ni-NTA agarose under 
native conditions, according to the manufacturer’s instructions. The protein purification was 
performed with either batch or column method. Fractions containing the protein were pooled, 
dialysed against PBS overnight and stored at -20°C. All purified protein fractions were 
analysed by SDS-PAGE and protein concentration was determined using a Bradford assay 
and/or by using the UV spectrophotometer as described below in section 2.14.4. 
 
PBS (10X) 
160 g NaCl 
4 g KCl 
15.2 g Na2HPO4 
4 g KH2PO4 
Added to 1.8 l of distilled H2O 
pH was adjusted to 7.4 with NaOH 
Lysis buffer 
6.9 g NaH2PO4. H2O 
17.54 g NaCl 
0.68 g imidazole 
Added to 1 l distilled H2O,  pH was adjusted to 8.0 using NaOH 
Wash buffer 
6.9 g NaH2PO4. H2O 
17.54 g NaCl 
1.36 g imidazole 
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Added to 1 l distilled H2O , pH was adjusted to 8.0 using NaOH 
Elution buffer 
6.9 g NaH2PO4. H2O 
17.54 g NaCl 
17.00 g imidazole 
Added to 1 l distilled H2O , pH was adjusted to 8.0 using NaOH 
 
pREP‐4 pQE‐60
3.4kb
IPTG 
(1mM)
6xHis tagged 
recombiant ScpC
Selection marker 
ampicillin (100 mg/ml) 
and kamamycin (25 
mg/ml)
P T5 Lac O scpCRBSLac O Stop codon
pQE‐60
3.4kb
6xHis
E. coli    M15
pQE‐60
3.4kb
pREP‐4
Transformation
 
Figure 6. Schematic overview of cloning and recombinant expression of ScpC. Full-length scpC was 
expressed using pQE-60 expression vector. Expression in pQE-60 is under the control of T5 promoter and 
operator element. For the expression of rScpC, pQE-60 derivative containing scpC was transformed into 
competent E. coli strain M15 containing pREP4 repression plasmid. 
 
2.13.3  Recombinant expression of fusion proteins encompassing 
subfragments of ScpC  
Recombinant expression and purification of a fusion proteins encompassing the N-terminal 
PR-domain of ScpC, spanning 106-689 aa (EC-PR, accession no. ABA33824.1), and a fusion 
protein encompassing the PR along with the A-domain, spanning 106-1126 aa (EC-PR+A) 
were performed as described above in section 2.13.2.  
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2.13.4  Cloning, expression and purification of fusion proteins with GST tag 
The C-terminal domains of ScpC, the A-domain spanning 690-1127 aa (EC-A, accession no. 
ABA33824.1) and the A-domain along with the B/H-domain, spanning 690-1560 aa (EC-
A+B/H), were expressed as recombinant fusion proteins tagged with glutathione S-transferase 
(GST). The DNA fragments were amplified with primers (scpC-A fwd BamHI, scpC-B/H rev 
EcoRI and scpC-A rev EcoRI) designed to incorporate restriction site and stop codon and 
cloned into pGEX-6P-1 as described in 2.13.1. The E. coli strain DH5α was transformed with 
pGEX-6P-1 derivative containing insert. The transformants were selected on LB agar plates 
containing ampicillin (100 µg/ml). The positive clones were grown overnight in LB medium 
containing ampicillin (100 µg/ml). The next day, 5 ml of overnight grown culture was added 
to fresh 1 liter of LB medium and incubated at 37oC in a shaking incubator (120 rpm) and 
bacteria was grown to A600 0.3. Afterwards, the expression of recombinant protein was 
induced by addition of 2 mM IPTG for 4 h at 37°C and the culture was centrifuged at 6000 × 
g for 15 min at 4°C. The pellet was resuspended in 10 ml of PBS buffer containing 1 mM 
PMSF (serine protease inhibitor) and lysozyme (1mg/ml). The cells were lysed using a French 
Press (SLM Aminco, SLM Instruments, 1000 bar) and cell debris was removed by 
centrifugation at 10,000 × g for 20 min at 4°C. The clear lysate was transferred to a falcon 
tube, incubated with glutathione sepharose, and protein was eluted under mild non-denaturing 
conditions according to manufacturer’s instructions. The positive clones were stored as 
glycerol stocks at -80oC. The plasmid DNA was isolated from 2 ml of overnight culture and 
sequence of the insert was verified by sequencing. 
  
Elution buffer  
50 mM Tris-HCl 
10 mM reduced glutathione 
pH was adjusted to 8.0 
Prescission cleavage buffer 
50mM Tis-HCl 
150mM NaCl 
1mM EDTA 
1mM DTT 
pH was adjusted to 7.5 
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2.14   Protein analysis  
 
2.14.1  SDS-PAGE 
In sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), migration of 
protein is determined by the molecular weight of the polypeptide (Laemmli et al., 1970). SDS 
is an anionic detergent which denaturates proteins by wrapping the hydrophobic tail around 
the polypeptide backbone. For almost all proteins, SDS binds at a ratio of approximately 1.4 g 
SDS per gram of protein, thus conferring a net negative charge to the polypeptide in 
proportion to its length. SDS also disrupts hydrogen bonds and unfolds the protein molecules 
thus minimizing differences in molecular form by eliminating the tertiary and secondary 
structures. The proteins can be totally unfolded by using a reducing agent such as β-
mercaptoethanol, which cleaves the disulfide bonds between cysteine residues. 
For SDS-PAGE analysis of the protein samples, resolving gels containing 8%-17.5% 
acrylamide were prepared. A stacking gel containing 5% acrylamide was used for all the 
SDS-PAGE gels. The protein samples were mixed with sample loading buffer in a ratio of 2:1 
and boiled for 5 min. The samples were loaded on gel and electrophoresed using Mini-Protean 
3 cell (BioRad) by applying 150 V (constant voltage). A PageRulerTM Prestained Protein 
Ladder (Fermentas) was loaded as a standard for determining the size of protein in 
comparison to the ladder mix. Following electrophoresis, the gel was either stained with 
Coomassie Brilliant Blue R-250 or silver nitrate (2.16.1) or used for western blot analysis as 
describedin section 2.14.2. 
 
SDS-Loading buffer 
0.2 M Tris-Cl (pH 6.8) 
β -Mercaptoethanol 
3 % SDS 
30 % Glycerol 
0.2 % Bromphenolblue 
Resolving Gel 
10 – 15 % Acrylamide/Bisacrylamide (30:0.8) 
0.37 M Tris/HCl (pH 8.8) 
0.1 % SDS 
0.5 µl/ml TEMED 
0.5 mg/ml APS 
Materials and Methods    40 
Stacking Gel 
5 % Acrylamide/Bisacrylamide (30:0.8) 
0.125 M Tris HCl pH 8.8 
0.1 % SDS 
0.5 µl/ml TEMED 
0.5 mg/ml APS 
5 × Running buffer 
30 g Tris 
144 g Glycine 
10 g SDS 
pH adjusted to 8.6 
Added to 2 l of dH2O 
 
2.14.2  Western blotting 
For western blot analysis, proteins were separated by SDS-PAGE and electrotransferred to a 
nitrocellulose membrane (BioRad) in blotting buffer at 35 V for 2 h at 4°C using a Mini 
Trans-Blot cell (BioRad). Following this, protein transfer was confirmed by staining the 
nitrocellulose membrane with Ponceau as described in section 2.16.3. After washing the 
membrane with PBST (PBS supplemented with 0.05% Tween 20), the membrane was 
incubated overnight with blocking buffer (5% skim milk dissolved in PBST) at 4oC to block 
the non-specific binding sites on the membrane. To check the expression of recombinant full-
length ScpC and fusion protein constructs of ScpC subfragments, the membrane was probed 
with rabbit polyclonal anti-ScpC IgG, diluted in 1:1000 ratio in PBST, for 1 h at RT. The 
membrane was washed twice with PBST and incubated with anti-rabbit IgG (diluted 1:2000 
in PBST) conjugated with horseradish peroxidase (HRP) for 1 h. The blot was washed three 
times with PBST for 15 min, and immunoreactive protein was detected by using the ECL 
Western Blotting Detection Kit (Amersham). 
 
Transfer Buffer 
50 mM Tris-Base 
40 mM Glycine 
20 % Methanol (v/v) 
Added to ddH2O 
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Blocking Buffer  
5 % (w/v) Skim milk or 3 % BSA 
Dissolved in PBST 
 
2.14.3  Dot blot 
The interaction of recombinant protein with the ligand was analysed by dot blotting. For this, 
samples containing 2-4 µg of recombinant protein were applied directly onto nitrocellulose 
membrane and the membrane was dried for short time at room temperature. To differentiate 
between nonspecific and positive signals, both 2-4 µg of purified GST and 2 µl of a cell 
extract of the host strain without plasmid was applied to the membrane. Non-specific protein 
binding was inhibited by incubating the membrane in blocking buffer (5% skim milk 
dissolved in PBST) for 1 h at RT, membrane was probed and immunodetection was 
performed as mentioned in section 2.14.2. 
 
2.14.4  Determination of protein concentration 
The concentration of purified proteins was determined by a method described by Bradford et 
al. (1976). For this, 40 µl of Bradford solution (BioRad) was added to 10 µl of a protein 
solution in a microtiter plate, and double distilled water was added to give a total volume of 
200 µl. The absorption at 595 nm was measured by using an ELISA-Reader (Tecan Sunrise) 
without any prior incubation. The standard curve was plotted by using BSA as a standard. The 
absorbance of known concentrations of BSA was measured at 595 nm and the amount of 
protein in the solution was estimated by comparing with the standard. Alternatively, the 
concentration of protein in solution was determined by using an UV-spectrophotometer. The 
spectrophotometer (UV deuterium lamp) was turned on 15 min before measuring the 
absorbance of the sample. The absorbance of the protein solution was measured at 280 nm in 
a quartz cuvette. To eliminate absorbance due to possible nucleic acid contamination, 
absorbance of the solution was also measured at 260 nm. The buffer solution was used as 
reference and the concentration of protein in solution was determined using a formula given 
below: 
       Concentration (mg/ml) = (1.55 x A280) – (0.76 x A260)     (Waddell, 1956) 
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2.14.5  Peptide sequencing       
NH2-terminal amino acid sequence of the purified recombinant protein was determined by 
Edman degradation. Briefly, about 10 µg of purified protein was resolved by SDS-PAGE and 
electrotransferred onto a polyvinylidine fluoride membrane (Bio-Rad) preactivated in 100% 
methanol, at 20 V for 2 h at 4oC. The protein was visualized by staining with 0.1% coomassie 
in 50% methanol. The band of interest was excised from the membrane and destained in 50% 
methanol and finally washed in double distilled H2O. The amino acid sequence of the sample 
was identified by Edman degradation performed using an Applied Biosystems 494 protein 
sequencer at the Department of Biophysical Analysis, Helmholtz Centre for Infection 
Research, Braunschweig. 
 
2.15  Generation of anti-ScpC polyclonal antibodies and purification of 
IgG 
 
To raise specific antibodies against recombinant full-length ScpC, 500 µg of purified 
recombinant ScpC was sent to Pineda Antikorper-service (Berlin) for rabbit immunization. 
Rabbit were immunized four times with 100 µg of recombinant ScpC per dose at one week 
interval and serum was collected 2 weeks after the final immunization. For purification of 
anti-ScpC IgG antibodies from serum, a column was packed with protein-A speharose CL-4B 
and equilibrated with 0.1 M potassium phosphate buffer (pH 7.0). Following the equilibration 
step, 2 ml of rabbit immune serum was applied to a column. Afterwards, the column was 
washed with PBS and bound IgG were eluted using 0.1 M glycine/HCl (pH 3.0). The elutant 
was neutralized by adding 50 µl of Tris-HCl (pH 8.0) to 1 ml elutant and the IgG fractions 
were analysed by SDS-PAGE.  The IgG containing fractions were pooled, dialysed against 
PBS for 16 h and stored at -20°C. The concentration of purified IgG was measured using an 
UV-spectrophotometer (Pharmacia Ultrospec III) as described in section 2.14.4. 
                                              
Elution buffer 
                                                  0.1 M Glycin (pH 3.0) 
Neutralizing buffer 
                                                  1.5 M Tris-HCl (pH 8.8) 
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2.16   Staining methods   
                  
2.16.1  Sliver staining 
Silver staining is the most sensitive method for the permanent visible staining of proteins in 
polyacrylamide gels with protein detection limit in the nanogram range. It is 30-50 fold more 
sensitive than Coomassie Brilliant Blue R-250 dye. To determine IL-8 degradation, 10 µl of 
culture supernatant of bacterial strains was co-incubated with equal volume of human IL-8 
(5µg/ml) overnight at 37oC and electrophoresed on SDS-PAGE gel (17.5%). For silver 
staining, the gel was impregnated with soluble silver ions and developed by treating with 
formaldehyde, which reduces silver ions to form an insoluble brown precipitate of metallic 
silver. Staining of gel was performed using the Silver Stain Plus kit (BioRad). The procedure 
was followed according to manufacturer’s recommendations. 
 
2.16.2  Coomassie staining 
 To visualize proteins on the SDS-PAGE gel, the gel was stained for 2-3 h in Coomassie 
Brilliant Blue R-250 staining solution. The gel was then washed with water and incubated in 
destainer solution for 2-3 h or alternatively kept overnight in destainer. Gels were scanned 
using a HP DeskScan II 6100C/T and anlysed using GIMP 2.6.1. 
 
Coomassie stain solution 
                                     0.25 % (v/v) Coomassie Brilliant Blue R-250  
                                     50 % (v/v) Methanol 
                                     10 % (v/v) Acetic acid 
                                     Added to distilled water 
Destainer  
20 % (v/v) Methanol 
7 % (v/v) Acetic acid 
Added to distilled water 
 
2.16.3  Ponceau staining 
To confirm the successful transfer of proteins from SDS-PAGE gel onto a nitrocellulose 
membrane during western blotting, the membrane was stained with Ponceau S stain for 1-2 
min. The staining of the membrane with Ponceau S allows the reversible staining of proteins 
on a nitrocellulose membrane. The membrane was then rinsed with dH2O and the bands were 
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examined. Afterwards, the membrane was washed several times with PBST until the bands 
were not visible and probed for western blot analysis as described in section 2.14.2.  
 
Ponceau stain solution 
                                                          0.2 % (v/v) Ponceau S 
                                                          3 % (v/v) Trichloroacetic acid 
                                                          3 % (v/v) Sulfosalicylic acid 
 
2.17   Immunolabeling methods and Electron microscopy  
 
2.17.1  Immunolabeling of cell surface-bound ScpC 
To characterize the surface localization of ScpC, S. pyogenes strains were grown overnight in 
THY medium. The overnight cultures were diluted in 1:15 ratio in fresh THY medium and the 
absorbance was measured at 600 nm. The S. pyogenes strains were grown at 37oC to mid 
exponential phase (A600nm 0.3-0.4). For labeling, 2-3 ml of early-exponential phase S. 
pyogenes cell culture was centrifuged at 4000 rpm for 10 min and the pellet was washed two 
times with PBS. The bacterial cells were incubated with rabbit anti-ScpC polyclonal antibody 
diluted 1:100 in PBS supplemented with 10% fetal calf serum for 1 h at room temperature, 
while shaking at 70 rpm. The cell suspension was centrifuged at 4000 rpm for 10 min and the 
pellet was washed twice with PBS to remove unbound antibody. The pellet was resuspended 
in goat anti-rabbit Alexa Fluor® 488 conjugated secondary antibody, diluted 1:200 in PBS 
supplemented with 10 % fetal calf serum, for 1 h in the dark at room temperature. As a 
negative control, the anti-ScpC antibody was omitted in one series of experiments. The 
suspension was centrifuged at 4000 rpm for 10 min. The bacterial cells were then washed two 
times with PBS and the pellet was resuspended in 50 µl of PBS.  10 µl of each suspension 
was placed onto a slide and fixed with 10 µl of Mowiol and analyzed by fluorescence 
microscopy using a Zeiss Axiophot microscope and images were captured using Zeiss 
AxioCam HRc 14-bit color CCD camera. 
To check the reassociation of ScpC to the surface of S. pyogenes, S. pyogenes strains were 
grown overnight in THY medium. The antibiotics were added to the medium in appropriate 
concentration. The next day, strains were sub-cultured as described above and grown to early 
exponential phase (A600 0.3-0.4). The S. pyogenes cultures were centrifuged at 4000 rpm for 
10 min. The supernatant of WT JS95 was transferred to a 15 ml falcon tube and sterile 
filtered. The pellet of JS95 ∆scpC/∆scpA and A475 ∆scpC mutant were incubated with the 
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supernatant of WT JS95 for 1 h at 37oC. After the incubation period, the bacterial cells were 
washed twice with PBS, probed with anti-ScpC antibody and anti-rabbit Alexa Fluor® 488  
conjugated secondary antibody, mounted on glass slides and analysed by fluorescence 
microscopy as described above.  
 
2.17.2 Immunogold labeling to identify cell surface-associated ScpC  
For immunogold labeling of surface-bound ScpC, S. pyogenes strains were grown overnight 
in THY medium. The next morning, each strain was subcultured by diluting in 1:100 ratio in 
fresh THY medium and grown to mid exponential phase (A600 0.3-0.4), samples were fixed 
with 1% formaldehyde for 1 h on ice and washed three times with cacodylate buffer 
containing 10 mM glycine for quenching free aldehyde groups. One millilitre of the bacterial 
suspension was centrifuged and pellet was resuspended in 180 µl PBS. To this solution, 20 µl 
of protein A purified anti-ScpC IgG (3.5 mg/ml) were added and incubated for 1 h at 30°C. 
After centrifuging the bacterial suspension at 4500 xg, bacterial cells were washed three times 
with PBS and resuspended in 190 µl of PBS. The suspension was then incubated with 10 µl of 
colloidal protein A coated gold  particles (15 nm) solution (British BioCell) for 30 min at 
30°C. The bacterial suspension was centrifuged at 4500 xg for 10 min at room temperature. 
The cells were washed three times with PBS and fixed with 2% glutaraldehyde for 10 min at 
room temperature. The fixed cells (25 µl) were dropped onto the coverslips and allowed to 
attach for 10 min at RT and transferred to a 24 well plate containing 800 µl of a fixing 
solution. The ∆scpC deletion mutant of M3 S. pyogenes strain A475 was constructed in our 
laboratory by Dr. Dorothea Zahner (2002; Helmholtz Centre for Infection Research, 
Braunschweig). 
 
2.17.3 Field-emission scanning electron microscopy (FESEM) 
For FESEM analysis, the coverslips were washed twice with TE buffer and dehydrated on ice 
by incubation in a raising series of acetone (10, 30, 50, 70, 90, 100%) with each step for 15 
min. The samples were warmed to RT and critical-point dried using liquid CO2 (CPD030, 
Balzers). For detection of gold-particles, the coverslips were then fixed on aluminium-plates 
and covered with a thin layer of coal (MED020, Balzers). The samples were analyzed with a 
Zeiss field emission scanning electron microscope (DSM982 Gemini) at 5 kV using the 
Everhart-Thornley SE detector and the inlens secondary electron (SE) detector in a 50:50 
ratio. 
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Cacodylate Buffer 
100 mM Cacodylate (pH 6.9) 
90 mM Sucrose 
10 mM MgCl2 
10 mM CaCl2 
Fixative  
2% (w/v) Glutaraldehyde 
5% (w/v) Formaldehyde 
in Cacodylate Buffer 
TE buffer  
10 mM Tris 
2 mM EDTA, pH 6.9 
 
2.18   Enzyme-linked immunosorbent assay (ELISA)  
 
S. pyogenes strains were grown overnight in THY medium. The next day, the culture was 
diluted in 1:15 ratio in fresh pre-warmed THY medium and grown to mid-exponential phase 
by incubating at 37°C. Antibiotics were added to the medium for growing the A475 ∆scpC 
(spectinomycin, 80 µg/ml), JS95 ∆scpC/∆scpA (kanamycin, 250 µg/ml and spectinomycin, 50 
µg/ml), JS95 ∆scpA (spectinomycin, 50 µg/ml) mutant strains. The bacterial culture was 
centrifuged at 4500 rpm for 10 min and the pellet was washed twice with PBS to remove the 
remaining yeast extract. The pellet was then resuspended in Dulbecco’s Modified Essential 
Medium (DMEM; PAA Laboratories) supplemented with 0.1% fetal calf serum and incubated 
overnight at 37°C. For growing ∆scpC mutant strains, the appropriate antibiotics were added 
to DMEM. On the next day, the culture was centrifuged at 4500 rpm for 8 min and the 
supernatant was transferred to a 15 ml falcon tube and filtered using a filter with 0.2 µm pore 
size. The supernatant was diluted in a 1:1 ratio in PBS and 10 ng of IL-8 was added to give a 
final volume of 100 µl.  For testing the activity of recombinant proteins, approximately 5-20 
µg of recombinant protein was added to 10 ng of recombinant IL-8, and PBS was added to 
give a final volume of 100 µl. The reaction mixture was incubated for 16-18 h at 37°C. The 
amount of residual interleukin-8 was measured by ELISA using human IL-8 Quantikine 
ELISA kit (R&D) in accordance with the manufacturer’s instructions. The absorption was 
measured at 450 nm by using ELISA-Reader (Tecan Sunrise). 
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For inhibition assay, culture supernatant of S. pyogenes and rScpC was incubated with 
affinity-purified anti-ScpC IgG (50 µg/ml) for 1 h at RT and then co-incubated with 
recombinant IL-8 at 37°C for 16 h. The residual IL-8 was measured by ELISA as described 
above. The scpC deletion mutant of M14 serotype S. pyogenes invasive strain JS95 (JS95 
∆scpC/∆scpA) was kindly provided by Prof. Emanuel Hanski (The Hebrew University-
Hadassah Medical School, Jerusalem, Israel). 
 
2.19   Ligand overlay assay 
 
For ligand overlay assay, recombinant fusion proteins (10 µg of each protein) encompassing 
full-length ScpC, N-terminal domains of ScpC (EC-PR, EC-PR+A), C-terminal domains of 
ScpC (EC-A+B/H) and cell lysate of E. coli M15 containing pQE-60 derivative with the A-
domain insert were separated on a SDS-PAGE gel and transferred to a nitrocellulose 
membrane (see section 2.14.2). Alternatively, for the dot blot analysis, 5 µg of each 
recombinant protein was directly loaded on the nitrocellulose membrane and the membrane 
was dried briefly. Purified recombinant GST (5 µg) was used as a negative control. 10 µg of 
IL-8 was radiolabeled with 125I using the chloramine-T method as described by Hunter and 
Greenwood (1962). The membrane was blocked for 30 min with 5% skim milk in PBS at RT 
and incubated with 6 µg [125I] IL-8 dissolved in 15 ml of PBST  (4x105 c.p.m./ml) for 1 h 
while rotating at room temperature. After extensive washing (5-7 times with PBST), the 
interaction of immobilized recombinant protein with radiolabeled IL-8 was detected by 
exposing an X-ray film (Kodak BioMax XAR) overnight to the membrane and the X-ray film 
was developed next day.  
 
2.20   Flow cytometry 
 
For the detection of ScpC on the surface of S. pyogenes strain JS95, bacteria were grown 
overnight in THY medium. The next day, culture was diluted 1:15 in THY medium and 
bacteria were incubated at 37oC. Bacterial cells were collected at different growth phases 
(mid-exponential phase; A600nm 0.4 and late exponential phase; A600nm 0.85) by centrifugation 
at 4000 rpm for 8 min and washed twice with PBS. The cells were then incubated for 1 h with 
rabbit polyclonal anti-ScpC antibody (1:100 in PBS supplemented with 10% FCS) and anti-
rabbit fluor® 488 conjugated antibody. The fluorescence intensity of each sample was 
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measured using a FACS calibur cytometer (Becton & Dickinson) and data were analyzed with 
the Cellquest software. 
 
2.21   Peptide analysis 
 
2.21.1  Synthesis of chromogenic substrate 
The synthesis of para-nitroanilide peptides were performed as described previously by 
Abbenante et al. (2001).  A chromogenic substrate with the peptide sequence, Ac-K-E-N-W-
V-Q-pNA and a control peptide Ac-N-E-K-Q-V-W-pNA were synthesized. Briefly, 2 g 
chlorotrityl-chloride resin was treated with phenylene diamine (2 mM) and diisopropylethyl 
amine (2 mM) in DMF at room temperature for 24 h. After washing with dimethylformamide 
(DMF) and dichloromethane (DCM) the resin was dried and 515 mg of the dry material was 
treated with Fmoc-Gln (Trt)-OH (800 µM), 2-(1H-benzotriazol-1-yl)-1,1,3,3-
tetramethyluroniumtetrafluoroborate (TBTU, 800 µM) and di-isopropylethyl amine (1.6 mM) 
in DMF for 2 h at RT. After washing the resin with DMF, the Fmoc group was cleaved by 10 
min treatment with 20% piperidine in DMF. The remaining amino acids of the peptide 
sequence were coupled in the same way as described above. After the final acetylation, the 
resin was washed with DMF and DCM. The dry resin was treated for 5 h repeatedly with 2% 
trifluoro acetic acid in DCM. The filtrate was collected and dried by evaporation. The residue 
was taken up in 110 ml acetonitrile and 100 ml H2O were added. After the addition of Oxone 
(2 g, 3 mM), the mixture was incubated for 18 h at RT, while shaking. After filtering off the 
Oxone, the solvents were evaporated and the crude product was purified by preparative high 
performance liquid chromatography (HPLC) and characterized by analytical HPLC and 
matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS).  
 
2.21.2  Synthesis of 16-mer peptide 
The solid-phase synthesis of the peptide (Ac-52DPKENWVQRVVEKFLK67-amide) was 
carried using a Pioneer Automatic Peptide Synthesizer (Applied Biosystems) employing 
Fmoc chemistry with TBTU activation as described by Reid and Simpson et al. (1992) with 
some modifications. Side chains were protected and peptide was synthesized using coupling 
time of 1 h. The peptide was cleaved from the resin and deprotected by 3 h treatment with 
TFA containing 3% triisobutylsilane and 2% water (10 ml/g resin). The resin was removed by 
filtration and washed several times with acetic acid. The combined filtrate and washings were 
dried by evaporation. The crude peptides were dissolved in water/acetonitrile in 1:1 ratio and 
passed over 6 ml octadecyl disposable extraction columns. After rinsing the columns with 
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acetonitrile, most of the acetonitrile of the combined eluents was evaporated. After 
precipitation with t-butyl methylether, samples were centrifuged. The samples were 
lyophilized and the resulting crude peptide was purified by preparative HPLC (RP-18) with a 
water/acetonitrile gradient containing 0.1% trifluoroacetic acid (TFA).  
 
2.21.3  Analysis of substrate specificity of protease  
The enzymatic activity of both rScpC (15-20 µg) and S. pyogenes culture supernatant against 
synthetic chromogenic substrate was assayed in a microtitre plate by measuring the release of 
para-nitroaniline from para-nitroanilide derived peptide via measuring the absorbance changes 
at 405 nm at various time intervals. The enzymatic activity of rScpC against the peptide 
substrates was tested at substrate concentrations of 0.5-1 mM by incubating for 10 min-1 h at 
different temperatures (25oC, 30 oC, 37 oC) in 0.1 M PBS buffer (pH 7.0) or Tris-HCl buffer 
with or without the presence of 2-5 mM Ca2+. 
For analysing the activity of rScpC against the 16-mer synthetic peptide substrate, peptide 
(0.1 mM) was incubated with rScpC (20 µg) for overnight at 37°C in PBS. Each digest was 
separated by reversed-phase HPLC using a linear gradient from 0 to 30% acetonitrile in 
0.1%TFA and average molecular mass of peptide fragments was determined by MALDI-MS. 
The synthesis of peptides was kindly performed by Dr. Werner Tegge (Dept. of Chemical 
Biology, Helmholtz Centre for Infection Research, Braunschweig). 
 
2.22  Cell culture methods 
 
2.22.1  Cultivation of human endothelial cells 
Primary human umbilical vein endothelial cells (HUVEC; PromoCell) were aliquoted and 
cryopreserved in liquid nitrogen. Endothelial cell growth medium 2 (EGM 2, PromoCell) was 
mixed with supplement mix (PromoCell) and penicillin/streptomycin. The pre-warmed 
medium (12 ml) was added to gelatin coated petri dishes with a 10 cm diameter. The cells 
were thawed on ice, resuspended in 200 µl of medium and added to the cell culture dish 
containing pre-warmed medium. HUVEC were cultivated for 2-3 days at 37oC in humidified 
environment under 5% CO2 conditions in an incubator (Forma Scientific), until cells formed a 
confluent monolayer. All the cell culture experiments with HUVEC were performed with 
cells at 2nd-4th passage. The cells were grown to confluency and sub-cultured at an interval of 
2-3 days. The monolayer was washed with 5 ml of wash buffer (HEPES BSS buffer) and the 
cells were incubated with 3 ml of trypsin EDTA buffer (PromoCell) to detach them from the 
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surface of the cell culture plate followed by the addition of 7 ml of pre-warmed fresh medium. 
The cells were resuspended, transferred to a falcon tube and centrifuged at 900 xg for 10 
minutes. The supernatant was discarded and the pellet was resuspended in EGM 2 
supplemented with growth factors and penicillin/streptomycin. 0.5-1 ml of cell suspension 
was added to cell culture dishes (10 cm diameter) containing 12 ml of pre-warmed medium 
and incubated at 37oC in a humidified environment containing 5% CO2. For microscopy 
studies, glass cover slips with a diameter of 12 mm (Nunc) were sterilized in a covered dish at 
180oC in a dry autoclave. To enhance the attachment of HUVEC, sterile coverslips were 
coated with 0.1% gelatin dissolved in double distilled water. For this purpose, 200 µl of 
gelatin solution was added to each well and incubated for 15 min at RT and then removed 
prior to the addition of cells into each well. 
 
2.22.2  In vitro infection assay of HUVEC with S. pyogenes 
To study the interaction of S. pyogenes or rScpC with HUVEC, the monolayer was washed 
with 5 ml of washing buffer (HEPES BSS buffer). The monolayer was incubated with 3 ml of 
trypsin EDTA buffer and resuspended in 7 ml of pre-warmed fresh medium. The cell 
suspension was centrifuged at 900 xg for 10 minutes. The supernatant was removed and cells 
were diluted in EGM 2 supplemented with growth factors and penicillin/streptomycin to give 
a final concentration of approx. 1 x 105 cells/ml. 500 µl of cell suspension was seeded into a 
24 well cell culture plate to give a semiconfluent monolayer after 24 h. On the day of 
infection, cells were washed twice with endothelial cell basal medium without antibiotics and 
500 µl of fresh medium was added into each well and kept at 37oC in humidified environment 
containing 5 % CO2 in an incubator before infecting the cells with S. pyogenes. 
 
2.22.2.1  Preparation of inoculum and infection assay 
Bacteria were grown overnight by gently scraping the colonies from the surface of blood agar 
plates with an inoculation loop or by inoculating with 50 µl of glycerol stock in THY or TSB 
medium. The following day, an overnight culture was diluted 1:15 in fresh medium and 
grown to A600 0.3-0.4 (early exponential growth phase). The culture was centrifuged at 4000 
xg for 10 min at RT and bacteria were then washed twice with PBS. The pellet was diluted in 
PBS to achieve 10% transmission at 600 nm, which corresponds to approximately 5x108 
bacteria/ml. The bacterial suspension was further diluted in 1:100 ratio in EGM 2 
supplemented with 2% fetal calf serum (FCS). 250 µl of this cell suspension was added to 
each well containing a semi-confluent monolayer of HUVEC, giving a multiplicity of 
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infection (MOI) 16:1. At 30 min post-infection, HUVEC were washed to remove extracellular 
bacteria and incubated for additional 30 min and 90 min. Following incubation, the cells were 
washed three times in EGM 2 basal medium and fixed either in 4% paraformaldehyde for 
fluorescence microscopy or in a fixative containing 5% formaldehyde and 2% glutaraldyhde 
in cacodylate buffer for electron microscopy. The cells were immuno-stained for 
immunofluorescence microscopic analysis as described in section 2.24. Images were captured 
using Zeiss AxioCam HRc 14-bit color CCD camera and Zeiss AxioVision 4.7 software and 
processed for contrast and brightness by GIMP 2.6.1 
 
2.22.3  Interaction of recombinant protein coated latex beads with HUVEC 
HUVEC were cultivated in EGM 2 supplemented with FCS, growth factors and 
penicillin/streptomycin (2.22.1). The cells were seeded into 24 well or 4 well plates 
containing sterile glass coverslips as described in section 2.22.2. The cells were grown to a 
semi-confluent monolayer on 12 mm diameter coverslips. For coating the latex beads with 
recombinant protein, approximately 107 polystyrene latex beads (3 µm and 1 µm diameter; 
Sigma) were washed three times in PBS and then coated overnight with 100 µg/ml of the 
recombinant full-length ScpC (EC-ScpC) and fusion protein constructs encompassing several 
domains of ScpC (EC-PR+A, and E-PR, EC-A+B/H) in PBS at 4°C. Affinity-purified 
recombinant GST was used for coating beads and served as a negative control. The 
recombinant protein coated beads were washed with PBS by centrifugation at 2500 rpm for 5 
min. Beads were then washed twice in PBS and once in EGM 2 supplemented with 2% FCS 
as described above and the pellet was resuspended in 2-4 ml of EGM 2 supplemented with 
2% FCS.  250 µl of the bead suspension was co-incubated with cells for 30 min, 1 h, 2 h and 3 
h at 37°C under humidified environment containing 5% CO2. After the incubation period, 
cells were washed several times with EGM 2 basal medium to remove unbound beads, fixed 
either in 4% paraformaldehyde dissolved in PBS (USB) and analysed under the light 
microscope. 
 For transmission electron microscopy, HUVEC were cultivated in a 6 cm cell culture dish, 1 
ml of protein coated latex beads (3 µm; approx. 108 beads) were co-incubated with the cells 
for 2 h at 37°C under humidifiedenvironment containing 5% CO2 and subsequently washed 
three times with EGM 2 basal medium. The cells were then fixed with 5% formaldehyde and 
2% glutaraldehyde in cacodylate buffer for electron microscopic analysis. For inhibition 
assay, the ScpC coated beads were pre-incubated with EGM 2 supplemented with 10% rabbit 
anti-ScpC IgG for 1 h at room temperature. 
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The coupling efficiency of recombinant protein with latex beads was checked by washing 
protein coated beads with PBS and then mixing in 1:1 ratio with SDS-PAGE loading buffer. 
Samples were boiled for 5 min at 95oC and separated via SDS-PAGE. The activity of rScpC 
adsorbed to the surface of latex beads was checked by monitoring the IL-8 degradation by 
rScpC pre-coated on latex beads using human IL-8 Quantikine ELISA kit according to 
manufacturer’s instructions. To study the uptake of recombinant protein without prior coating 
on latex beads, rScpC at concentration of 1-100 µg/ml was incubated with semi-confluent 
monolayer of HUVEC for a predetermined time period (1 h, 2 h and 3 h), cells were washed 
and then fixed in 4% paraformaldehyde. Cell bound ScpC coated latex beads and rScpC were 
visualized using rabbit polyclonal anti-ScpC IgG and anti-rabbit Alexa fluoro® 488 
conjugated IgG and analysed under fluorescence microscope as describedin section 2.24. 
 
2.22.4  Transmission electron microscopy              
Cells were fixed in 5% formaldehyde and 2% glutaraldehyde in cacodylate buffer and washed 
once with cacodylate buffer. Cells were then osmificated with 1% aqueous osmium for 1 h at 
room temperature and washed again. The pellets were embedded in 2% water agar and cut 
into small cubes. Samples were dehydrated with a graded series of acetone (10%, 20%, 50%) 
for 30 min on ice, followed by contrasting with 2% uranyl acetate in 70% acetone for 
overnight at 4° C. Samples were then further dehydrated with 90% and 100% acetone. 
Samples were infiltrated with the epoxy resin by applying 1 part 100% acetone and 1 part 
epoxy resin and incubated overnight, then 1 part 100% acetone and 2 parts epoxy resin for 8 h 
(Spurr, 1969). Pure resin was then added next day and incubated overnight. The samples were 
then placed into resin filled gelatine capsules and polymerized for 8 h at 75°C. Ultrathin 
sections were cut with a diamond knife, affixed to formvar-coated copper grids (300 mesh) 
and counterstained with 2% aqeuous uranyl acetate and lead citrate. After air-drying, samples 
were examined in a Zeiss transmission electron microscope (TEM910) at 80 kV acceleration 
voltage. The electron microscopic analysis and the preparation of the samples were kindly 
performed by Dr. Manfred Rohde (Helmholtz Centre for Infection Research, Braunschweig). 
 
2.22.5  Antibiotic protection assay for the quantification of adherent and 
intracellular S. pyogenes   
The number of viable intracellular streptococci were determined by an antibiotic protection 
assay as previously described by Valentin-Weigand et al. (1996). HUVEC were grown to 
confluency in 24 well cell culture plates as described in section 2.22.2. For the infection 
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assay, cells were washed once with EGM 2 basal medium, and 500 µl of EGM 2 
supplemented with 2% fetal calf serum was added into each well. S. pyogenes strains were 
grown overnight in TSB at 37oC in a 5% CO2 incubator. The overnight culture was 
centrifuged at 4000 rpm for 8 min and the inoculum was prepared as described in 2.22.2.1.   
The bacteria were diluted in a 1:100 ratio in the EGM 2 supplemented with 2% FCS to give 
approximately 5x106 bacteria/ ml. To calculate the exact colonies forming units (cfu) of the 
initial inoculum, serial dilutions of the inoculum were plated on blood agar plates. The 
confluent HUVEC monolayer was co-incubated with 250 µl of bacterial suspension for 2 h at 
37°C under humidified conditions containing 5% CO2. HUVEC were then washed twice with 
EGM 2 basal medium. Then, 500 µl of EGM 2 + 2 % FCS containing 100 µg/ml gentamicin 
and 5 µg/ml penicillin was added to each well and incubated for an additional 2 h at 37°C in a 
5% CO2  incubator to kill the extracellular bacteria. The cells were washed three times with 
EGM 2 basal medium and then 100 µl trypsin-EDTA solution was added into each well. After 
5 min, 400 µl of 0.025% Triton X-100 (v/v) in PBS was added and serial dilutions of the cell 
lysate were plated in triplicate on blood agar plates and incubated for 24 h at 37°C. The next 
day, colony forming units were counted and intracellular bacteria were calculated compared 
to initial inoculum added into each well and expressed as percent invasion of bacteria into 
HUVEC.  
The total number of adherent and invasive bacteria was determined by infecting the HUVEC 
monolayers with same amount of inoculum as described for the infection assay. The cells 
were lysed at 2 h post-infection in a same way as described above without pre-treatment of 
the cells with antibiotics. Accordingly, the serial dilutions of cell lysate were plated on blood 
agar plates in triplicate and incubated at 37°C for 24 h and colonies were counted the next 
day. The adherent bacteria were calculated by subtracting the number of invasive bacteria 
from the total number of cfu. The results were expressed as percent adherence of bacteria. 
Experiments were performed in triplicate and repeated three times. 
 
2.23   In vitro assay with A549 lung epithelial cells 
 
2.23.1 Cultivation of A549 lung epithelial cells 
 
The A549 human lung epithelial cells were cultivated in DMEM supplemented with 10% 
FCS, 5 mM glutamine, penicillin (100 units/ml), and streptomycin (100 µg/ml) at 37oC in 
humidified environment under 5% CO2 conditions. The cells were cultivated to confluency 
and sub-cultured at an interval of 2-3 days. For sub-culturing, cells were washed once with 
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pre-warmed DMEM, incubated with 0.25% trypsin 1 mM Na-EDTA (trypsin-EDTA; PAN 
Biotech GmbH) to detach cells from the surface of the cell culture plate and 1 ml of cell 
suspension was then added to a new cell culture plate containing 15 ml of DMEM 
supplemented with antibiotics. Cells were cultivated at 37°C under humidified environment 
containing 5% CO2 for 2-3 days. Cells were sub-cultured at an interval of 2-3 days. For latex 
beads assay, the cells were counted using a hemocytometer, diluted in antibiotic free DMEM 
supplemented with 10% FCS and glutamine (approximately 1.5 x 105 cells /ml) and seeded 
into a 24 well cell culture plate to give a semi-confluent layer of epithelial cells after 24 h.  
 
2.23.2  Latex beads assay under acidic pH environmental conditions  
The A549 lung epithelial cells were cultivated and seeded into 24 well cell culture plate as 
described above in section 2.23. On the next day, the cells were washed twice with DMEM 
supplemented with 1% FCS and 25 mM HEPES and incubated at 37°C under humidified 
environment containing 5% CO2. Latex polystyrene beads were coated with rScpC as 
described above in section 2.22.3. To establish low pH environment conditions during the 
interaction of ScpC coated beads with host cells, the ScpC coated beads were centrifuged and 
the pellet was resuspended in DMEM + 1 % FCS diluted in 1:1 ratio in citric phosphate buffer 
(pH 5.5) to give final pH of 6.3. Subsequently, 250 µl of suspension was added to each well 
and incubated for 2 h at 37°C in 5% CO2 incubator. After the incubation period, cells were 
washed 3-4 times with PBS to remove unbound beads and fixed in 5% formaldehyde and 2% 
glutaraldehyde in cacodylate buffer, processed and analysed by scanning electron microscopy 
as described in section 2.17.3. 
 
2.24  Double-immunofluorescence staining and  fluorescence 
microscopy 
 
2.24.1  Immunostaining to determine intracellular and extracellular  
bacteria 
To distinguish intracellular bacteria from extracellularly located bacteria, infected cells were 
differentially stained with fluorophore-conjugated antibodies. The infected cells stored in 4% 
paraformaldehyde solution were washed twice with 500 µl of PBS. Non-specific binding sites 
were blocked by incubating the cells with 200 µl PBS supplemented with 10 % FCS for 1 h at 
room temperature (RT). Cells were incubated with rabbit anti-S. pyogenes polyclonal 
antibody (1:100 in PBS + 10% FCS) for 45 min at RT and washed two times with PBS. Then, 
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the secondary antibody, goat anti-rabbit Alexa fluor® 488 conjugated IgG (diluted 1:200 in 
PBS supplemented with 10 % FCS) was added and incubated for 45 min at RT. After the 
incubation period, cells were washed twice with PBS, permeabilized by addition of 0.1 % 
Triton X-100 in PBS for 5 min and washed two times with PBS. Intracellularly located 
bacteria were labeled by incubating the cells with the anti-S. pyogenes antibody for 45 min at 
RT, followed by incubation with goat anti-rabbit Alexa fluor® 568 conjugated IgG (diluted 
1:300 in PBS + 10% FCS) for 45 min at RT. Hoechst (Molecular probes) was used to stain 
the nuclei of cells. Cells were incubated for 10 min with Hoechst (Molecular probes) diluted 
1:5000 in PBS + 10% FCS and washed three times with PBS. The coverslips were mounted 
onto glass slides using prolong-gold antifade or Mowiol supplemented with N-propyl-gallate 
diluted in a ratio of 2:1 and sealed with nail polish. The samples were analysed using a 
fluorescence microscope (Zeiss Axiophot) as describedin 2.24.3. 
 
2.24.2  Immunostaining for late endosomal/lysosomal compartments 
To test the presence of S. pyogenes in a late endosomal/lysosomal compartment, monoclonal 
antibodies against human lysosomal-associated membrane protein 1 (LAMP-1) were used for 
staining. Following infection, cells were fixed in 4% paraformaldehyde diluted in PBS. The 
cells were washed twice with PBS and blocked with 10% FCS in PBS for 1 h at room 
temperature. After the incubation period, cells were washed twice with PBS, permeabilized by 
addition of 0.1 % Triton X-100 in PBS for 5 min and washed two times with PBS.  The cells 
then incubated with rabbit anti-S. pyogenes antiserum/anti-ScpC IgG, diluted in 1:100 ratio in 
blocking buffer, for 45 min at room temperature. The secondary antibody, anti-rabbit Alexa 
fluor® 488 conjugated antibody were used to label S. pyogenes or rScpC coated latex beads. 
Then, LAMP-1 positive compartments were visualized by incubating the cells with mouse 
monoclonal anti-LAMP-1 antibodies (diluted 1:50 in blocking buffer) for 1 h at room 
temperature in a humid chamber. The cells were then incubated with anti-mouse Alexa fluor® 
568 conjugated antibody for 45 min at RT. The coverslips were mounted on glass slides as 
described above in section 2.24.1 and examined by fluorescence microscopy. 
 
Mowiol 
20 g Mowiol 
80 ml PBS, pH 7.3 
40 ml glycerol 
Centrifuged for 1 h at 20000 × g 
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Added 0.01M Sodiumazide to supernatant 
N-propyl-gallate 
0.1 M N-Propyl-Gallate 
Dissolved in glycerol: PBS (1:9) 
 
2.24.3  Fluorescence microscopy 
For fluorescence microscopic analysis, the sample of interest was labeled with a fluorophore-
conjugated antibody. The basic principle of a fluorescence microscope involves illuminating 
the sample with the light of specific wavelength, which is absorbed by the fluorophores and 
causes the sample to emit a longer wavelength light which is in the visible range of light 
spectrum. The components of a fluorescence microscope used include the mercury-vapor lamp 
as light source, the excitation filter, the dichroic mirror, and the emission filter. The filters and the 
dichroic mirror are specifically chosen to match the spectral excitation and emission 
characteristics of the fluorophore as described below in table 2. The epifluorescence 
microscope (Zeiss Axiophot) was used in this study. In epifluorescence microscopy, the light 
of a specific wavelength is passed through the objective and then onto the specimen instead of 
passing it first through the specimen. The fluorescence in the specimen gives rise to emitted 
light which is focused to the detector by the same objective that is used for the excitation. A 
filter between the objective and the detector filters out the excitation light from fluorescent 
light and only reflected excitatory light reaches the objective together with the emitted light.  
This method therefore gives an improved signal to noise ratio. The images were captured 
using a Zeiss AxioCam HRc 14-bit color CCD camera and Zeiss AxioVision 4.7 software. 
 
Table 2 
Filter       Excitation wavelength  Emission wavelength Fluorochrome 
Nr. 01               365 nm 397 nm                          Hoechst 
Nr. 10             450-490 nm                      515-565 nm                   Alexa Fluor® 488 
Nr. 15               546-512 nm 590 nm   Alexa Fluor® 568 
 
2.25   Statistical Analysis 
 
The data were compared by unpaired Student’s t-test using GraphPad Prism 5 and the P-value 
<0.05 was considered significant. 
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3 Results 
 
3.1 Recombinant expression and characterization of ScpC  
 
3.1.1 ScpC cleaves chemoattractant interleukin-8 
In order to investigate whether ScpC per se is responsible for the IL-8 degrading protease 
activity displayed by M3 serotype S. pyogenes, a ∆scpC single gene mutant of M3 serotype S. 
pyogenes invasive strain A475 was analysed for its ability to degrade IL-8 in comparison to 
wildtype (WT) A475 in vitro. For this, a cytokine ELISA was performed for quantitative 
determination of IL-8 in the culture supernatant of WT A475 and its isogenic ∆scpC mutant 
after co-incubating the supernatant with recombinant IL-8 (100 ng/ml). Our data showed a 
significant (P<0.001) reduction in the amount of IL-8 after co-incubation with the culture 
supernatant of WT A475 in comparison to IL-8 co-incubated with growth medium alone, 
indicating that IL-8 is degraded by the A475 culture supernatant. However, in contrast, when 
recombinant IL-8 was co-incubated with the supernatant of its isogenic ∆scpC mutant strain, 
there was no reduction in the amount of IL-8, confirming that the genetic deletion of scpC 
gene results in the elimination of IL-8 proteolytic activity (Figure 7A). The in vitro 
degradation of IL-8 by S. pyogenes A475 and the complete lack of IL-8 degrading ability of 
its isogenic ∆scpC mutant were further shown by SDS-PAGE analysis (Figure 7B). Thus, by 
using a scpC single gene deletion mutant of M3 serotype S. pyogenes invasive isolate A475, 
this study showed that ScpC is responsible for the IL-8 proteolytic activity of M3 S. pyogenes. 
This finding is in accordance with the previous reports on the role of ScpC in IL-8 
degradation by M14 and M1 serotype S. pyogenes (Hidalgo-Grass et al., 2006; Zinkernagel et 
al., 2008). 
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Figure 7. IL-8 degrading ability of wildtype M3 serotype S. pyogenes strain A475 and its isogenic ∆scpC 
mutant. A) The degradation of IL-8 by M3 serotype S. pyogenes strain A475 and the lack of IL-8 proteolytic 
activity of its isogenic ∆scpC mutant is shown by cytokine ELISA. The data represent mean ± standard deviation 
of three independent experiments. Error bars represent standard deviation. The data were compared by utilizing 
an unpaired Student’s t-test and a P-value <0.05 was considered significant. B) Silver stained SDS-PAGE gel 
showing the cleavage of IL-8 into a smaller peptide fragment after co-incubation with the M3 S. pyogenes 
supernatant. The A475 ∆scpC mutant strain lacks the IL-8 proteolytic activity as shown by the presence of a 
band of approximately 8 kDa, corresponding to intact IL-8. High level ScpC expressing M14 S. pyogenes strain 
JS95 was taken as a positive control.  
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3.1.2 Recombinant expression and purification of biologically active ScpC 
 
3.1.2.1  Cloning, heterologous expression and purification of recombinant ScpC 
S. pyogenes strains isolated from patients with invasive disease were anlysed for the presence 
of the scpC gene via polymerase chain reaction (PCR). The scpC gene was found to be 
present among all S. pyogenes strains tested (Figure 8). Multiple sequence alignment of the 
scpC from all available S. pyogenes genomes indicated >98% sequence similarity. Previous 
studies have shown IL-8 degrading activity of partially purified ScpC (SpyCEP) from the 
culture supernatant of S. pyogenes strain H292 (Edwards et al., 2005). To further characterize 
the ScpC protease and to study the role of ScpC in S. pyogenes pathogenesis of invasive 
diseases, we recombinantly expressed ScpC in Escherichia coli (E. coli). The scpC open 
reading frame encodes a 1458 amino acid protein with an approximate molecular mass of 150 
kDa. For recombinant expression of ScpC, the full-length scpC excluding regions encoding 
pre-pro domain and cell wall-anchoring domain was amplified from the S. pyogenes invasive 
isolate A416 by PCR using primers which incorporated the appropriate restriction sites at 5’ 
and 3’ end of the full-length scpC (see section 2.13.1). The sequence of the scpC gene in the 
vector was verified by DNA sequencing. 
The scpC was heterologously expressed in E. coli strain M15 containing plasmid pREP4 
using a pQE-60 expression vector. pQE-60 expresses the recombinant ScpC with a 
6xHistidine (6xHis) affinity tag placed at the C-terminus of the protein. In pQE-60, 
expression of recombinant protein is induced by the addition of an analogue of lactose, 
isopropyl-β-D-thiogalactose (IPTG). Therefore, the E. coli cells transformed with pQE-60 
derivative containing scpC were induced with IPTG for 4 h. The recombinantly expressed 
ScpC was purified from the bacterial cell lysate by using immobilized metal affinity 
chromatography and the protein was eluted under native conditions as described in section 
2.13.2. Recombinant ScpC tagged with 6xHis was purified from the bacterial lysate via 
binding to Nickel-nitrilotriacetic acid (Ni-NTA) agarose (see section 2.13.2). The western 
immunoblotting using horseradish peroxidase-conjugated Ni-NTA, which is used for the 
direct detection of 6xHis tagged protein, recognized the band with a molecular weight of 
approximately 150 kDa in the cell lysate of E. coli transformants (Figure 9A), indicating the 
expression of full-length 6xHis tagged ScpC. The size of the purified recombinant ScpC 
protein, as estimated by SDS-PAGE, was 120-150 kDa, which is close to its expected 
molecular mass (Figure 9B). 
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Figure 8. PCR analysis for screening of the scpC gene in different M serotype S. pyogenes strains. 
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Figure 9. Cloning and recombinant expression of ScpC A) E. coli cells transformed with pQE60 derivative 
harboring the scpC gene were incubated with IPTG for 4 h. E. coli cells collected before and after induction with 
IPTG were lysed and separated on SDS-PAGE gel. Protein was transferred to a nitrocellulose membrane and 
detected using Ni-NTA conjugate. B) SDS-PAGE analysis of the E. coli cell lysate showing the expression of 
recombinant protein with molecular weight of approximately 120-150 kDa. Lane 1-6 refers to the fractions 
collected after purification of recombinant protein from bacterial crude extracts using Ni-NTA agarose. 
 
3.1.2.2 NH2-terminal amino acid sequencing of recombinant protein 
Edman degradation sequencing procedure was followed for determining the N-terminal amino 
acid sequence of purified recombinant ScpC. When separated on SDS-PAGE gel, the 
recombinant protein showed two bands which corresponded to molecular weights of 
approximately 150 kDa and 120 kDa (Figure 9B). The protein was then electrotransferred 
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onto PVDF membrane for 2 h and stained. Both, the upper and lower band was excised 
individually from the membrane and sequenced. Followed by the Edman degradation 
chemistry, amino acids were analysed by high performanceliquid chromatography (HPLC). 
The first ten NH2-terminal amino acid residues of 120 kDa band were identified as indicated 
below. The sequence alignment of amino acids residues deduced by Edman degradation with 
the ScpC peptide sequence from NCBI protein data bank (accession number ABA33824.1) 
corresponded to the 245-255 amino acid residues of ScpC (Figure 10). The amino acid 
sequence of 150 kDa band could not be determined due to low protein concentration. 
 
 
                                              MRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAH    200 
                                              ........................................       
                                   
               NYVENSDNIKENQFEDFDEDWENFEFDAEAEPKAIKKHKI    240 
               ........................................       
  
       ScpC    YRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHG    280 
 
       rScpC   ....STQAPKETVI..........................     
                                        
 
Figure 10. Amino terminal amino acid sequence of recombinant ScpC. The multiple sequence alignment of 
the first ten amino acid residues of rScpC identified by edman degradation with the peptide sequence of ScpC of 
S. pyogenes strain JS95. 
   
 
3.1.2.3 Proteolytic activity of purified recombinant ScpC 
The proteolytic activity of purified recombinant ScpC was examined by monitoring its IL-8 
degrading ability. To determine the IL-8 proteolytic activity of purified rScpC, rScpC and its 
serial dilutions were incubated with recombinant IL-8 for 16 h at 37oC and residual IL-8 was 
measured with cytokine ELISA. Incubation of purified rScpC with IL-8 showed significant 
reduction in the amount of IL-8 in comparison to IL-8 incubated with PBS, indicating that 
rScpC is functionally active. Incubation of 3.0 µg of rScpC with recombinant IL-8 (100 
ng/ml) cleaved almost 99% of IL-8. IL-8 proteolytic activity could also be detected at lower 
recombinant protein concentration, with reduction in the amount of rScpC to 0.003 µg  
showed efficient degradation of IL-8 (Figure 11A). Western immuno-blotting further 
confirmed the retained IL-8 proteolytic activity of rScpC as shown by the loss of the 8 kDa 
band corresponding to IL-8 after co-incubation with purified rScpC as well as with the culture 
supernatant of invasive M14 serotype S. pyogenes strain JS95. In contrast, co-incubation of 
IL-8 with supernatant of scpC mutant of JS95 (JS95 ∆scpC/∆scpA; kindly provided by Prof. 
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Emanuel Hanski, The Hebrew University-Hadassah Medical School, Jerusalem, Israel) 
retained a band of approximately 8 kDa, corresponding to intact IL-8 (Figure 11B). 
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Figure 11. Cleavage of IL-8 by recombinant ScpC. A) The purified rScpC and its diluted fractions 
significantly degraded IL-8 when co-incubated with recombinant IL-8 for 16 h at 37oC in comparison to A475 
∆scpC mutant, which lacks the IL-8 proteolytic activity, indicating that rScpC is enzymatically active. The 
culture supernatant of WT A475 efficiently degraded IL-8, which served as a positive control. B) The 8 kDa 
band corresponding to IL-8 disappeared when co-incubated with rScpC or with WT S. pyogenes JS95 for 16 h, 
due to the degradation of IL-8. The JS95 ∆scpC/∆scpA double mutant did not possess IL-8 proteolytic activity as 
the 8 kDa band was retained on western immunoblot. The JS95 ∆scpA mutant strain served as a control. 
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3.1.3 Raising polyclonal antibodies against ScpC and purification of 
specific IgG 
The immunogenicity of ScpC in humans and mice was identified by Lei et al. (2000). 
Rodriguez-Ortega et al. (2006) have suggested a potential role of specific antibodies against a 
putative cell envelope protease Spy0416, a homologue of ScpC in M23 S. pyogenes, in host-
pathogen interaction based on the observed protective effect of ScpC specific antibodies 
against S. pyogenes infections. Therefore, to investigate the contribution of ScpC specific 
antibodies in combating S. pyogenes infection, polyclonal antibodies against the purified 
recombinant ScpC protein were raised in a rabbit. The rabbit anti-ScpC serum showed 
immuno-reactivity with rScpC on the dot blot (Figure 12) as well as on western blot. 
Antiserum did not cross react with recombinant GST or S. pyogenes M1 protein, which was 
taken as negative control. Also, rabbit pre-immunization sera did not cross react with rScpC 
or S. pyogenes culture supernatant. The immunoglobulin Gs (IgG) were isolated from 
antiserum by affinity chromatography using protein A agarose. F(ab’)2  fragment of  anti-
ScpC IgG was generated by papain digestion and separated from Fc fragment. Purified IgG 
could detect as low as 0.001 µg of rScpC at dilutions ranging from 1:100 to 1:5000. 
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Figure 12. Recombinant ScpC is highly immunogenic in rabbit. The purified rScpC and its serial dilutions 
were incubated with antiserum containing specific antibodies against rScpC. Recombinant ScpC was recognized 
by anti-ScpC antiserum as shown by the dot-blot analysis. 
 
3.1.4 Bacterial growth in liquid culture 
The growth behavior of WT M3 serotype S. pyogenes strain A475 and its isogenic ∆scpC 
mutant strain was compared in vitro, to check if the inactivation of scpC gene has affected the 
metabolic growth rate of the mutant strain in comparison to parental strain. The WT A475 and 
 
Recombinant          
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isogenic ∆scpC mutant showed equivalent logarithmic growth in Tryptic Soy Broth (TSB) 
when grown at 37oC in 5% CO2 incubator. The generation time of WT parental strain A475 
and isogenic ∆scpC mutant strain was about 45 min in exponential phase (Figure 13). 
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Figure 13. Growth curve of S. pyogenes A475 and isogenic ∆scpC mutant strain. Strains were grown in TSB 
medium and optical density was measured at 600 nm at 30 min time interval. 
 
3.1.5 Localization and reassociation of ScpC on the S. pyogenes cell surface 
 
3.1.5.1 Localization of ScpC on the cell surface of S. pyogenes  
ScpC shows homology with various extracellular cell wall-anchored proteins of Gram-
positive bacteria including C5a peptidase of S. pyogenes, CspA of S. agalactiae, cell envelope 
protease PrtP of non-pathogenic Lactococcus lactis and PrtS of Streptococcus thermophilus 
(Harris et al., 2003; Fernandez-Espla et al., 2000; Siezen et al., 1999). These surface-anchored 
proteins usually have a conserved C-terminal sorting signal with a LPXTG motif which is 
required for sortase-mediated cleavage and subsequent covalent cross linking of the protein 
on the cell surface. Based on the predicted LPXTG motif containing C-terminal sequence of 
ScpC, which is required for the cell wall-anchoring, we investigated whether ScpC is located 
on the cell surface of S. pyogenes. For this, IL-8 proteolytic activity was determined in the S. 
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pyogenes culture supernatant as well as in the pellet containing bacterial cells grown to mid-
exponential phase. Among the S. pyogenes strains (M1 serotype KTL3, M3 serotype A475 
and M14 serotype JS95) tested, IL-8 proteolytic activity was detected both as cell-associated 
(pellet fraction) and secreted form (supernatant fraction). Among these strains, M1 serotype S. 
pyogenes strain KTL3 showed significantly higher cell-associated IL-8 proteolytic activity in 
comparison to the presence of proteolytic activity in bacterial growth medium (Figure 14) 
indicating that a major fraction of ScpC is cell-associated. 
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Figure 14. ScpC protease is secreted as well as cell surface-anchored. The culture supernatant and the 
bacterial cells of S. pyogenes strains M3 serotype A475, M1 serotype KTL3, and M14 serotype JS95 were 
collected after pelleting the exponential phase culture medium. The culture supernatant and bacterial cells were 
incubated with recombinant IL-8 for 16 h at 37oC. To examine the presence of the IL-8 degrading proteolytic 
activity, the amount of IL-8 was determined by using a cytokine ELISA. The IL-8 proteolytic activity was 
detected in the culture supernatant as well being associated with S. pyogenes cells.  
 
To examine the cell surface localization of ScpC, S. pyogenes strains of serotype M1, M3, 
M14 and M18 were immunolabeled with the affinity-purified rabbit polyclonal anti-ScpC IgG  
and anti-rabbit Alexa fluor® 488 conjugated secondary antibody and then analyzed by 
immunofluorescence microscopy. A strong fluorescence signal was observed co-localizing 
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with S. pyogenes incubated with anti-ScpC IgG, indicating that ScpC is a cell surface-
anchored protein (Figure 15). Immunostaining of whole cells of WT S. pyogenes M14 JS95 
and M3 A475 with rabbit polyclonal anti-ScpC IgG also revealed the presence of ScpC on the 
cell surface (Figure 18 A&D). In contrast, the respective isogenic ∆scpC mutant strains 
showed no fluorescence signal indicating that fluorescence emission by the WT S. pyogenes 
strains is due to the specific interaction of anti-ScpC antibody with the surface-bound ScpC 
(Figure 18 B&E). 
  
 
                           
  
  
 
Figure 15. Localization of ScpC on the cell surface of M18 S. pyogenes. Whole cells of highly encapsulated 
M18 serotype S. pyogenes were immunolabeled with anti-ScpC IgG. The anti-rabbit Alexa fluor® 488 
conjugated secondary antibody was used to detect the bound IgG.                            
 
Surface localization of ScpC was further confirmed by field emission scanning electron 
microscopy (FESEM). Whole cells of streptococci were immunolabeled with polyclonal anti-
ScpC IgG. Bound IgG were visualized by incubating with protein A-coated gold particles and 
analysed by scanning electron microscopy. Confirming the results of immunofluorescence 
microscopic analysis, the gold particles were associated with the surface of M14 S. pyogenes 
strain JS95 (Figure 16A) as well as with the surface of M3 S. pyogenes strain A475 (Figure 
16C), but not with the respective isogenic ∆scpC mutant strains (Figure 16 B&D). Together, 
these results strongly indicate that ScpC is localized on the cell surface of S. pyogenes. 
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Figure 16. FESEM analysis of the localization of ScpC on the S. pyogenes cell surface. WT S. pyogenes 
JS95, A475 and the respective isogenic ∆scpC mutant strains were immuno-gold labeled with specific antibodies 
raised against ScpC and protein A-gold particles. FESEM depicts the presence of gold particles on the cell 
surface of JS95 and A475 indicating that ScpC is located on the cell surface (A&C).  In contrast, gold particles 
did not associate with the surface of JS95 ∆scpC/∆scpA and A475 ∆scpC  mutant strains indicating the lack of 
surface expression of ScpC (B&D). Arrows indicates the association of gold particles to the surface of S. 
pyogenes. Bar corresponds to 0.5 µm (C) and 1 µm (A-B-D). 
 
The observation that the fluorescence signal intensity emitted by S. pyogenes varies among 
the S. pyogenes serotypes tested (M1, M3, M14, M18) indicated the differential surface 
expression levels of ScpC by these strains. S. pyogenes strain JS95 emitted a stronger 
fluorescence signal in comparison to A475, indicating the higher level of surface expression 
of ScpC by JS95 (Figure 18 A&D). M18 serotype S. pyogenes A471, a high capsule 
producing strain emitted an intense fluorescence signal, pointing towards a high level 
expression of ScpC on the cell surface (Figure 15). In contrast, M1 S. pyogenes strain A270 
showed much less surface expression level of ScpC (data now shown). To determine the 
surface expression of ScpC by JS95, a flow cytometer was used to collect 10,000 events for 
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each strain. A higher level of surface expression of ScpC by JS95 during the early exponential 
phase of the growth was observed, however very little fluorescence signal was detected in the 
late exponential phase or stationary phase (Figure 17).  Previous studies have also described 
that the expression of ScpC is highly upregulated in S. pyogenes invasive isolates in 
comparison to pharyngeal isolates, indicating the differential regulation of ScpC expression 
(Sumby et al., 2006).  Thus, the present data further confirmed that the expression of ScpC is 
highly regulated in S. pyogenes strains and may explain the difference in the ability of S. 
pyogenes strains to evade the immune response and to cause invasive diseases. 
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Figure 17.  Surface expression of ScpC is growth phase dependent. S. pyogenes JS95 were grown to mid-
exponential phase (A600nm 0.4) and late-exponential phase (A600nm 0.85). After washing the bacterial cells with 
PBS, cells were labeled with rabbit polyclonal anti-ScpC antibody and anti-rabbit Alexa fluor® 488 conjugated 
secondary antibody. Samples were analysed by using a flow cytometer. Data shows change in mean fluorescence 
intensity between JS95 in late exponential phase and JS95 in mid exponential phase.  
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JS95 in mid exponential phase 
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3.1.5.2 Reassociation of ScpC with the S. pyogenes cell surface 
Various cell surface-anchored glycolytic proteins including surface dehydrogenase (SDH) and 
surface enolase (SEN) have been shown to be essential for the overall virulence of S. 
pyogenes (Boel et al., 2005). These proteins interact with extracellular matrix proteins and 
described to be localized on the surface by reassociation (Chhatwal, 2002).  On the basis of 
the observed cell surface localization of ScpC in previous results, we anticipated that ScpC 
might reassociate to the cell surface of S. pyogenes. As demonstrated before, ScpC proteolytic 
activity can also be detected in the culture supernatant of S. pyogenes (Figure 14), suggesting 
that ScpC is secreted into the extracellular environment. Therefore, we next tested whether 
secreted ScpC can subsequently be displayed on the cell surface of S. pyogenes via 
reassociation. To examine this, we incubated the JS95 ∆scpC/∆scpA and A475 ∆scpC 
bacterial cells with the culture supernatant of WT JS95 grown to mid-exponential phase for 1 
h. The WT JS95 showed high IL-8 proteolytic activity in the supernatant as well as high level 
of expression of ScpC on the cell surface in early to mid-exponential phase of growth (Figure 
14). Interestingly, when respective isogenic ∆scpC mutant strains, pre-incubated with 
supernatant of the WT JS95, were subsequently immunolabeled with rabbit polyclonal anti-
ScpC IgG and secondary fluorophore-conjugated antibody, a strong fluorescence signal was 
emitted by bacterial cells of ∆scpC mutant strains (Figure 18 C&F). The JS95 ∆scpC and 
A475 ∆scpC mutant strains, without prior incubation with the supernatant of WT JS95, did 
not emit any fluorescence signal when immunostained with anti-ScpC IgG and fluorophore-
conjugated secondary antibody (Figure 18 B2&E2). As a control, WT parental strains and 
isogenic ∆scpC mutant strains incubated only with anti-rabbit fluorophore-conjugated 
antibody gave no background signal. This data indicated that ScpC could reassociate with the 
surface of mutant strains when these bacteria were incubated with the supernatant of WT 
strain as a natural source of ScpC. 
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Figure 18. Surface localization and reassociation of ScpC. S. pyogenes strains were incubated with anti-
ScpC IgG for 1 h at RT. The anti-rabbit Alexa fluor® 488 conjugated antibody was used to visualize the cell 
bound IgG. Surface expression of ScpC was indicated by the fluorescence signal emitted by WT JS95 and 
A475 strains (A&D). In contrast, no signal was shown by the respective isogenic ∆scpC mutant strains 
(B2&E2). The phase contrast images (B1&E1) of respective isogenic ∆scpC mutant indicate that despite the 
presence of bacteria, no fluorescence signal was emitted (B2&E2). For testing reassociation, the cells of JS95 
∆scpC and A475 ∆scpC mutant were incubated with the supernatant of WT JS95 growth medium for 2 h. The 
bacterial cells were washed twice in PBS, stained as described above and analysed under the fluorescence 
microscope. The mutant strains showed enhanced fluorescence signal intensity indicating the reassociation of 
secreted ScpC on the cell surface (C&F). 
 
Consistently, immuno-FESEM revealed the reassociation of ScpC with the cell surface of 
JS95 ∆scpC (Figure 19C) and A475 ∆scpC mutant (Figure 19E) when incubated with the 
culture supernatant of ScpC expressing WT JS95. Very low or almost no surface expression 
of ScpC was observed on the JS95 ∆scpC mutant (Figure 19B) and A475 ∆scpC mutant 
(Figure 19D) incubated with growth medium alone, which served as control. The low 
background label of gold particles on cell surface of A475 ∆scpC mutant might not be due to 
the ScpC expression since this strain was unable to degrade IL-8 (see section 3.1.1, Figure 7). 
However, this mutant still produces a small N-terminal fragment of ScpC, which might 
explain its weak interaction with anti-ScpC IgG. These results indicate that ScpC can 
reassociate with the cell surface of S. pyogenes after being secreted into the extracellular 
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environment and suggests that ScpC is able to reassociate either with the surface of a 
producing strain via binding-back or with the surface of other bacteria present in the local area 
 of infection.  
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Figure 19. Reassociation of ScpC with the S. pyogenes cell surface: High level surface expression of ScpC 
was observed on WT JS95 (A). The bacterial cells of JS95 ∆scpC and A475 ∆scpC mutant strain were incubated 
with the supernatant of WT JS95 culture medium for 2 h and washed with PBS. The cells were immuno-gold 
labeled by using anti-ScpC antibody and protein A-coated gold particles.  FESEM analysis shows reassociation 
of secreted ScpC with the cell surface of JS95 ∆scpC mutant strain and A475 ∆scpC mutant strain (C&E). The 
JS95 ∆scpC mutant did not show localization of gold particles on the surface (B) and very low background 
labeling in case of A475 ∆scpC mutant was observed (D). Each bar corresponds to 0.5 µm. 
   
3.1.6 Cloning, overexpression and purification of subfragments of ScpC  
A homologous sequence search identified that scpC shares sequence similarity with the cell 
wall-anchored subtilisin-like serine proteases containing a highly conserved Asp-His-Ser 
catalytic triad. ScpC is highly similar to the extracellular cell envelope-associated protease, 
lactocepin of Lactococcus lactis. In Lactococcus, lactocepin is required for the degradation of 
casein to make essential amino acids and other peptides. In S. pyogenes, its homologue ScpC 
plays an essential role in evading innate acute inflammatory immune response. Multiple-
sequence alignment of the ScpC amino acid sequence with other extracellular cell envelope 
proteinases indicated that ScpC has a multi-domain structure with similar domain 
organization as that of other subtilisin-like serine proteases (Hidalgo-Grass et al., 2006). As 
 
Results    72 
described in section 1.3.5.5, ScpC has a predicted N-terminal pre-pro domain (PP) with signal 
peptide sequence, PR-domain, A-domain, B-domain which is partly fused with the H-domain 
(B/H), cell wall spacer domain (W) and a cell wall-anchor domain (AN) containing a highly 
conserved LPXTG motif (Figure 20). The PR-domain is a putative catalytic domain 
containing the conserved catalytic triad of amino acid residues, Asp151-His279-Ser617.  
Each individual domain of proteases often can exist and function independently from the rest 
of the peptide chain. Therefore, to delineate the minimal functional domain of ScpC required 
for the IL-8 proteolytic activity, we recombinantly expressed several domains of ScpC in E. 
coli (Figure 21, Table 3.1). The recombinant fusion protein constructs encompassing the N-
terminal putative catalytic PR-domain (designated as EC-PR) and PR along with the A-
domain of ScpC (designated as EC-PR+A), were expressed using the pQE-60 expression 
vector with 6xHis as an affinity tag as described in section 2.13.3. The constructs spanning 
the C-terminal domains including the A-domain along with the B/H-domain (designated as 
EC- A+B/H) as well as the A-domain alone (designated as EC-A) were expressed as fusion 
proteins with Glutathione-S-transferase (GST) tag using the pGEX 6P-1 plasmid expression 
vector. The GST fusion proteins were purified by affinity chromatography (see section 
2.13.4), followed by the cleavage of GST from the recombinant protein using a site specific 
prescission protease. Recombinant expression of the A-domain of ScpC (EC-A) formed 
insoluble protein aggregates in the form of inclusion bodies, which were observed in the pellet 
of the E. coli cell lysate. In spite of several attempts to solublize the recombinant protein from 
inclusion bodies, we were unable to purify the soluble recombinant EC-A. 
 
Table 3.1.  Recombinant fusion protein constructs of ScpC. 
 
Protein 
fragments 
Insert Expression 
Plasmid 
Host strain Affinity tag 
EC-ScpC 
 
106-1564 aa pQE-60 M15 [pREP4] 6xHis 
EC-PR+A 
 
106-1126 aa pQE-60 M15 [pREP4] 6xHis 
EC-PR 
 
106-689 aa pQE-60 M15 [pREP4] 6xHis 
EC-A+B/H 
 
690-1560 aa pGEX-6P-1        DH5α          
                           
GST 
EC-A 
 
690-1127 aa pGEX-6P-1 DH5α    GST 
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    Figure 20. Schematic representation of the domain organization of ScpC. 
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Figure 21. SDS-PAGE analysis showing the bands corresponding to purified recombinant fusion proteins 
spanning distinct domains of ScpC. Lane 1-5: 1. EC-ScpC, 2. EC-PR+A, 3. EC-PR 4. EC-A+B/H, 5. Cell 
lysate of E.coli containing pQE-60 derivative showing expression of A-domain. 
 
3.1.7  Identification of the minimal essential domain required for the 
proteolytic activity of ScpC 
The minimal domain required for the proteolytic activity of ScpC was evaluated in vitro by 
monitoring the IL-8 degradation by recombinant fusion protein constructs spanning distinct 
domains of ScpC. For this, recombinant protein constructs of ScpC were incubated with IL-8 
for 16 h and the amount of IL-8 was determined by ELISA. By determining residual IL-8, 
results indicated that the EC-PR, a putative catalytic domain with serine protease activity, was 
incapable of degrading IL-8 independently. However, a significant degradation of IL-8 by 
EC-PR+A was observed.  In contrast, the recombinant EC-A+B/H encompassing C-terminal 
domains was unable to degrade IL-8 (Figure 22 A&B). These results indicate that the PR-
domain and the flanking A-domain are essential for the proteolytic cleavage of IL-8 and 
deletion of the C-terminal domains does not affect the proteolytic activity of ScpC protease. 
The role of the A-domain in defining substrate specificity of a cell envelope serine proteinase 
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PrtP of Lactococcus lactis has been shown by Siezen et al. (1993). The protein engineering 
studies of PrtP showed that two adjacent residues Arg and Lys (747-748) lying in the A-
domain are involved in determining the cleavage specificity of PrtP towards caseins and other 
peptide substrates indicating the potential role of A-domain in defining substrate specificity of 
the protease. Thus, the observation that the recombinant protein EC-PR+A encompassing the 
PR-domain along with the A-domain efficiently degrades IL-8, while EC-PR itself could not 
show proteolytic activity against IL-8, suggests that the A-domain may play a role in 
regulating the proteolytic activity of ScpC by dictating substrate specificity.  
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Figure 22. Localization of the domain required for the proteolytic activity of ScpC. A)  Histogram 
representing the IL-8 degrading ability of purified recombinant full-length ScpC and recombinant protein 
constructs spanning distinct domains of ScpC. The amount of IL-8 was determined after incubation of 
recombinantly expressed fusion protein or PBS (control) with recombinant IL-8 for 16 h. The supernatant of A475 
was taken as a positive control. B) The domain organization of full-length ScpC and schematic representation of 
the domains of ScpC expressed as recombinant fusion proteins. The IL-8 protease activity and the IL-8 binding 
ability of fusion protein constructs of ScpC are indicated on the right hand side of the schematic overview of the 
ScpC domain organization. 
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3.1.8  Characterization of the IL-8 binding domain of ScpC    
The next aim was to identify the minimal ligand binding domain of ScpC. Full-length ScpC 
and recombinant proteins encompassing distinct domains of ScpC were analysed for the 
binding of radiolabeled IL-8. By using [125I] IL-8 in the ligand-binding assay, the results 
indicated that the full-length ScpC (EC-ScpC) in native form showed strong affinity for IL-8 
(Figure 23). In contrast, recombinant protein EC-PR+A and EC-PR did not show affinity for 
IL-8. EC-A+B/H encompassing C-terminal domains showed weak interaction with IL-8, 
suggesting that full-length ScpC might be required for the interaction with IL-8. Recombinant 
GST, used as a control, did not show interaction with radiolabeld IL-8. When recombinant 
full-length ScpC and protein constructs encompassing distinct domains of ScpC were 
separated on SDS-PAGE gel under denaturing conditions, full-length ScpC lost the ability to 
interact with IL-8 (data not shown).  
    
 
                        
 
1                   2                  3                    4
 
                                   
 
 
Figure 23. Binding of IL-8 with recombinant ScpC.  5µg of each recombinant protein spanning subfragments 
of ScpC were loaded on a nitrocellulose membrane and the membrane was probed with radiolabeled [125I] IL-8 
(4x105 c.p.m./ml) for 30 min and autoradiographed overnight. Lane 1. Purified recombinant EC-ScpC, Lane 2. 
EC-PR+A, Lane 3. EC-PR, Lane 4. EC-A+B/H 
 
3.1.9 Substrate specificity of streptococcal chemokine protease C 
For the purpose of identifying an inhibitor for ScpC protease, it was aimed to develop a high 
throughput assay for measuring the enzymatic activity of ScpC. As mentioned before, ScpC 
belongs to a family of subtilisin-like serine protease which specifically inactivates IL-8 by a 
single proteolytic cleavage event (Edwards et al., 2005). It cleaves IL-8 on its C-terminus, at a 
peptide bond between glutamine and arginine, releasing 13 amino acids of the C-terminus 
(Figure 24, see section 1.3.5.1).  
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            Figure 24. Amino acid sequence of IL-8. Arrow indicates the cleavage site of ScpC. 
 
 
Using the natural substrate, IL-8, is costly and requires a complicated assay (ELISA) which is 
not suitable for testing a large library of inhibitors. ScpC proteolytic activity has been reported 
to be inhibited by serine protease inhibitors like Pefabloc, benzamidine and soyabean trypsin 
inhibitor (Hidalgo-Grass et al., 2004). Based on these findings, it was suggested that ScpC 
might have a trypsin like activity. Therefore, a panel of commercially available substrates 
used for assaying trypsin activity, such as Bz-Arg-pNA and Z-Gly-Pro-Arg-pNA, were tested 
against ScpC. Recombinant ScpC did not cleave these trypsin substrates. Therefore, a 
chromogenic substrate analogue of the site of cleavage of human IL-8 by ScpC was 
synthesized. Since proteases which belong to this family do not recognize the sequence at the 
C-terminal to the bond to be hydrolyzed, therefore the C-terminal to the site of cleavage of IL-
8 was replaced by a chromogenic leaving group. Thus, a synthetic chromogenic peptide 
derivative comprising six amino acid residues corresponding to the amino acids present 
upstream to the site of cleavage of IL-8, with p-nitroanilide (pNA) present at the C-terminus 
and glutamine at the P1 positions to the cleavage site (Ac-KENWVQ-pNA) was synthesized 
and examined for the cleavage by ScpC. Since the amino acid sequence of the substrate 
around the cleavage site can be a major determining factor for many proteases, a synthetic 
peptide substrate containing 16 amino acid residues corresponding to eight amino acid 
residues of IL-8 flanking on the either side of peptide bond to be cleaved by ScpC (Ac-
52DPKENWVQRVVEKFLK67-amid) was synthesized. The substrates were separated and 
purified by high performance liquid chromatography (HPLC) and molecular mass was 
determined by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS). 
The hydrolysing activity of ScpC against 16-mer synthetic substrate was determined after 
incubating the substrate for 16-18 h with rScpC as well as with the supernatant of S. pyogenes 
JS95 culture medium, by HPLC and MALDI-MS. These substrates were unable to be cleaved 
by rScpC and by culture supernatant of S. pyogenes, under the conditions tested (Figure 25). 
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These results suggest that cleavage of IL-8 by ScpC may depend upon the presence of specific 
amino acid residues at the cleavage site as well as on the overall three dimentional (3D) 
structural conformation of IL-8. 
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Figure 25.  Mass of synthetic 16-mer peptide containing IL-8 clevage site before (A) and after 
incubation with recombinant ScpC for 16 h at 37oC. The reaction products were separated and purified 
by HPLC and the peptide fragments were analysed by MALDI-MS. 
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3.2 Role of ScpC in the invasion process of M3 S. pyogenes into 
human endothelial cells  
 
3.2.1 Internalization of recombinant ScpC coated latex beads by primary 
human umbilical vein endothelial cells (HUVEC) 
The endothelial expression of cytokines plays an important role in regulating the 
inflammatory and immunological response towards infection. Modulating the cytokine 
production by endothelial cells can contribute significantly to the progression or clearance of 
the microbial infection via regulating the inflammatory response. Human endothelial cells 
produce IL-8 constitutively and IL-8 secretion by these cells is induced upon stimulation with 
proinflammatory cytokines like tumor necrosis factor alpha, IL-1, LPS (Chen and Manning, 
1996). Studies have shown that endothelial cells become major producers of IL-8 during 
bacterial infection in leukopenic cancer patients, with a disease condition where lack of 
leukocytes was observed (Oude Nijhuis et al., 2003). Also, the airway epithelial cells are 
capable of releasing inflammatory mediators including IL-1, TNFα, IL-8 and IL-6. The 
expression and release of IL-8 by A549 lung epithelial cells has been shown to be induced by 
serine proteinases like trypsin and thrombin (Wang et al., 2006b). These findings prompted us 
to investigate the in vitro interaction of ScpC with HUVEC and A549 lung epithelial cells. 
The HUVEC primary cell cultures between the second and fifth passage were used for 
investigating the interaction with ScpC coated polystyrene latex beads. For this, inert latex 
polystyrene beads (3 µm and 1 µm diameter) were coated with purified recombinant full-
length ScpC (ScpC-beads) and incubated with host cells in growth medium containing fetal 
calf serum for 2 h at 37oC under neutral pH environmental conditions. The cells were rinsed 
thrice with endothelial cell growth medium (EGM 2 basal medium) and fixed. Samples were 
then processed for analysis by scanning electron microscopy and immunofluorescence 
microscopy. ScpC-beads adhered to and were efficiently internalized by HUVEC (Figure 26 
A-E), whereas no internalization of bovine serum albumin (BSA) or glutathione S-transferase 
(GST) coated beads was detected. Internalization of ScpC-beads by HUVEC occurred only by 
a subpopulation of early passage cells, with some cells showing pronounced uptake of ScpC-
beads (Figure 27) indicating that cell specific factors/receptors might play an important role in 
mediating the interaction of ScpC-beads with HUVEC. In contrast, when interaction of ScpC-
beads was tested with A549 lung epithelial cells under neutral pH conditions, the ScpC-beads 
did not adhere to nor invaded A549 cells. Conclusively, this data shows that ScpC triggers the 
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uptake of latex beads by primary endothelial cells indicating the potential role of ScpC as an 
adhesin and invasin which can promote the invasion of S. pyogenes into endothelial cells. 
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Figure 26a. Electron microscopic images showing the adherence to and internalization of recombinant 
ScpC coated latex beads by HUVEC. HUVEC were co-incubated with ScpC-beads for 2 h, fixed and 
processed for scanning electron microscopy (A&B) and transmission electron microscopy (C&D). Arrows 
indicate adherent and internalized ScpC-beads (A). C&D) Transmission electron microscopy of ultrathin images 
showing intracellular ScpC-beads. Arrows delineate the intracellular ScpC-beads. 
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Figure 26b. Microscopic images showing the adherence to and internalization of recombinant ScpC coated 
latex beads by HUVEC. E) Internalization of ScpC-beads by HUVEC is shown by immunofluorescene 
microscopy. HUVEC were co-incubated with ScpC-beads (1 µm diameter) in a ratio of approximately 100:1 for 
2 h. Immunostaining was performed to distinguish extracellular beads from intracellular beads. Cells were 
incubated for 1 h with rabbit polyclonal anti-ScpC IgG and then with anti-rabbit fluoro® 488 conjugated 
antibody. Cells were permeablised with triton-X for 5 min and then incubated again with anti-ScpC IgG. The 
anti-rabbit fluoro® 568 conjugated antibody was then used as secondary antibody. Intracellular latex beads 
appear red and extracellular beads are labeled green.  
 
3.2.2 Co-localization of ScpC with LAMP-1 
Lysosomes are membrane bound compartments of the cells which have traditionally been 
considered as terminal degradative compartments. Various studies have shown that S. 
pyogenes can successfully escape the intracellular lysosomal killing via various mechanisms 
including inhibition of the fusion of phagosome with lysosomes, escape from phagosome into 
the cytoplasm and by enhancing survival inside the phagolysosome (Medina et al., 2003; 
Staali et al., 2006). To identify the intracellular fate of internalized beads, we tested if ScpC-
beads follow the classical cellular endocytic pathway. For this, we examined the intracellular 
trafficking of ScpC-beads by immunostaining the intracellular compartments with an antibody 
against lysosomal-associated membrane protein 1 (LAMP-1), a well known marker for late 
Intra/extracellular 
beads 
  Extracellular 
        beads 
 Overlay 
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endosomes/lysosomes and examined the co-localization of ScpC-beads with these cellular 
compartments. The immunofluorescence microscopic analysis revealed the presence of 
internalized ScpC-beads in LAMP-1 positive compartments within the cells after incubation 
of ScpC-beads with HUVEC for 2 h (Figure 27). This shows that the internalized ScpC-beads 
eventually fused with the lysosomes, thus indicating that ScpC can trigger the internalization 
process and subsequent targeting of ScpC carriers to the lysosomes in the endothelial cells. 
           
     
     
 
 
Figure 27. Co-localization of ScpC-beads with LAMP-1 positive compartments. HUVEC were incubated 
with ScpC-beads for 2 h. After the incubation period, cells were rinsed with EGM 2 basal medium and fixed. 
Beads were immunolabeled with rabbit polyclonal anti-ScpC antibody. Anti-rabbit Alexa fluor® 488 conjugated 
antibody was used to visualize the beads (green). To stain lysosomes, treated cells were immunolabeled with 
mouse monoclonal antibody against lysosome associated membrane protein 1 (LAMP-1). Arrows indicate 
intracellular ScpC-beads residing in the LAMP-1 positive compartments. Then, an anti-mouse fluorphore 
conjugated antibody was used to detect lysosomal compartments (red). Each bar represents 10 µm. 
 
3.2.3 Role of N-terminal PR domain in the internalization of latex beads by 
HUVEC 
In addition to the above described experiments, purified recombinant ScpC subfragments, as 
described in section 3.1.6.1, were evaluated for their interaction with HUVEC. For this 
purpose, the latex beads were coated overnight at 4oC with purified recombinant fusion 
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proteins spanning distinct ScpC domains. The recombinant protein coated beads were then 
incubated with HUVEC for 2 h. After the incubation period cells were rinsed with EGM 2 
basal medium to remove the unbound beads and immunostained for fluorescence microscopic 
analysis. Latex beads coated with recombinant protein EC-PR, containing putative catalytic 
domain, were efficiently internalized by HUVEC and subsequently co-localized with LAMP-
1 positive compartments (Figure 28B), whereas beads coated with EC-A+B/H rarely adhered 
to or invaded HUVEC. The latex beads coated with GST protein, which was taken as a 
control, did not adhere to or internalized by the endothelial cells (Figure 28C). The 
internalization of EC-PR coated beads by HUVEC was comparable to the uptake of full-
length ScpC coated beads (Figure 28 A) indicating that the N-terminal PR-domain of ScpC is 
sufficient to trigger the cellular uptake and subsequent fusion of latex beads with lysosomes. 
Thus, by identifying the domain involved in the invasion mediating activity of ScpC it was 
possible to narrow down the sequence essential for the invasion associated function of this 
large surface protein. 
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Figure 28. The N-terminal PR-domain is sufficient to trigger the uptake of latex beads and their fusion 
with lysosomes. Latex beads were coated overnight at 4oC with purified recombinant full-length ScpC and 
recombinant fusion proteins encompassing subfragments of ScpC. Recombinant protein coated beads were 
incubated with HUVEC for 2 h at 37oC and fixed. HUVEC incubated with protein coated beads were immuno-
stained using anti-ScpC antibody and anti-rabbit Alexa fluor® 488 (green) conjugated secondary antibody. The 
lysosomes were stained by using mouse monoclonal antibody against LAMP-1. LAMP-1 positive compartments 
were visualized by using anti-mouse Alexa fluor® 568 (red) antibody. Intracellular beads fused with lysosomes 
were counted for each fusion protein construct. Glutathione S-tranferase (GST) was purified and used as a 
negative control. Data is based on the analysis of 60 cells for each fusion protein construct. B) The primary 
culture HUVEC were incubated with EC-PR-beads and stained with similar procedure as described above. C) 
Control beads coated with GST did not adhere to nor internalized by HUVEC.  
C 
 
B 
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3.2.4 Interaction of purified recombinant ScpC with HUVEC 
The next aim was to analyse whether cultured endothelial cells can internalize purified rScpC 
without prior coating on the latex beads. For this, HUVEC were incubated with purified 
rScpC (20 µg/ml) for 2 h at 37oC in a humidified environment containing 5% CO2. After the 
incubation period, cells were rinsed three times to remove unbound rScpC and fixed. 
Consistent with the data showing the adherence and uptake of ScpC-beads by HUVEC, 
purified rScpC bound to HUVEC. The binding of rScpC with endothelial cells occurred in a 
wide concentration range (10-100 µg/ml) and was highest at 2 h post-incubation (Figure 29). 
A preliminary analysis of in vitro interaction of ScpC with HUVEC indicates that ScpC 
triggers cellular responses including disruption of membrane and intercellular junctions of 
endothelial cells. 
 
     
 
Figure 29. Interaction of recombinant ScpC with HUVEC. HUVEC were incubated with purified rScpC for 2 
h at 37oC. Cells were then washed three times with EGM 2 to remove unbound rScpC. The cells were fixed and 
stained for immuno-fluorescence microscopic analysis with rabbit polyclonal anti-ScpC IgG. An anti-rabbit 
Alexa fluor® 488 (green) conjugated antibody was used to visualize the interaction of rScpC with HUVEC. 
Enlarged area indicates the association of rScpC with the endothelial cell edges. Bar represent 10µm. 
 
3.2.5 Acidic pH triggers the interaction of ScpC with host cells 
It has been previously shown that exocytosis of lysosomes is triggered in the cells in response 
to the membrane damage in order to reseal the damaged areas on the membrane as a plasma 
membrane repair mechanism (Gerasimenko et al., 2001; Reddy et al., 2001; Wessels et al., 
1991). Therefore, the acidic pH (pH 6.3) environmental condition for host cells was tested in 
order to mimic the microenvironment of an in vivo infection, where host cells may encounter 
acidic conditions during S. pyogenes infections due to enhanced lysosomal exocytosis caused 
by secreted or cell bound proteins of S. pyogenes. For this, ScpC-beads were incubated with 
A549 lung epithelial cells in acidified environment (pH 6.3) at 37oC. Under acidified 
ScpC        B  
 
      A Control 
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extracellular conditions, ScpC-beads strongly adhered to A549 cells at 2 h post-incubation but 
were not internalized (Figure 30).  
 
20µm 20µm
 
 
Figure 30. Adherence of ScpC-beads to A549 lung epithelial cells. ScpC-beads were incubated with A549 
lung epithelial cells for 2 h in DMEM and citric phosphate buffer to provide extracellular pH of 6.3. After 2 h of 
incubation with ScpC-beads, A549 cells were fixed and processed for scanning electron microscopy. ScpC-beads 
efficiently adhered to A549 cells under low pH conditions.                  
 
It is noteworthy that ScpC-beads did not adhere to nor internalized by primary HUVEC at 6th 
passage and later. This might be due to the loss of the specific receptors by HUVEC which 
were involved in the interaction with ScpC. This data further suggests that cell specific 
factors/receptors are involved in the process of internalization of ScpC-beads by HUVEC. 
However, when HUVEC at 6th passage were incubated with ScpC-beads under acidic pH (pH 
6.3) environment conditions, ScpC-beads efficiently attached to and internalized by cells 
indicating that low pH environmental conditions triggers the adherence to and internalization 
of ScpC-beads by endothelial cells (Figure 31). These data suggest that acidic pH 
extracellular environmental conditions might have an impact on the ScpC-mediated invasion 
of S. pyogenes into host cells.  
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Figure 31. Acidic pH triggers the adherence of ScpC-beads to HUVEC. HUVEC at 6th passage were 
incubated with rScpC coated latex beads for 2 h under neutral (A) or acidic pH environment (B). ScpC-beads 
showed adherence to HUVEC when exposed to low pH (pH 6.3). Whereas under neutral pH, ScpC-beads did 
not adhere nor internalized by HUVEC. Bar corresponds to 5 µm.            
3.2.6 Effect of specific antibodies raised against ScpC on its functional 
activity 
 
3.2.6.1  Neutralizing effect of anti-ScpC antibody towards the internalization of 
ScpC coated polystyrene latex beads by HUVEC 
Rodriguez-Ortega et al. (2006) have shown that immunization with ScpC had a protective 
effect against S. pyogenes infection after mucosal challenge in a murine model of infection. 
Another report has shown that the human serum collected from patients with S. pyogenes 
infections contain antibody titer against ScpC, thus indicating the immunogenicity of ScpC in 
humans (Lei et al., 2000). Based on these reports, we next investigated the effect of specific 
antibodies induced against rScpC on the internalization of ScpC-beads by HUVEC. The 
ScpC-beads were pretreated with rabbit polyclonal anti-ScpC IgG for 1 h at room temperature 
before the co-incubation with HUVEC. Treatment of ScpC-beads with anti-ScpC antibodies 
almost completely abolished the attachment to and internalization of ScpC-beads by HUVEC. 
Non-immune rabbit IgG, taken as negative control, did not affect the adherence to or 
internalization of ScpC-beads by HUVEC (Figure 32). This indicated that the internalization 
of ScpC-beads by HUVEC is due to the specific interaction between ScpC and endothelial 
cells and not because of a non-specific association of latex beads with HUVEC. These results 
suggest that antibodies induced against ScpC may show an inhibitory effect on the invasion of 
S. pyogenes into endothelial cells via blocking the invasion mediating activity of ScpC. 
      A     B  
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Figure 32. Inhibition of invasion of ScpC coated latex beads into HUVEC by anti-ScpC antibodies. The 
ScpC-beads were incubated with rabbit polyclonal anti-ScpC antibodies for 1 h and then co-incubated with 
HUVEC for 2 h. Pre-incubation of ScpC-beads with anti-ScpC IgG completely abolished the adherence to and 
invasion of ScpC-beads into HUVEC. Non-immune rabbit IgG served as a control. Each dot represents the total 
number of ScpC-beads associated with or internalized by one cell. Horizontal bars represent mean. 
 
3.2.6.2 Effect of anti-ScpC antibody on the proteolytic activity of ScpC 
We next investigated if ScpC specific IgG have a neutralizing effect towards the IL-8 
proteolytic activity of ScpC. The culture supernatant of S. pyogenes strain A475 and its 
isogenic ∆scpC mutant was pretreated with rabbit polyclonal anti-ScpC IgG and then co-
incubated with IL-8. The effect of anti-ScpC IgG on the IL-8 proteolytic activity of purified 
rScpC was determined as well, by incubating rScpC with anti-ScpC IgG for 1 h prior to co-
incubation with IL-8. The amount of residual IL-8 was measured by cytokine ELISA. In 
contrast to the blocking effect of anti-ScpC IgG on ScpC-mediated uptake of latex beads by 
endothelial cells, the pre-incubation of rScpC with anti-ScpC IgG had no effect on its 
proteolytic activity. Also, the IL-8 proteolytic activity of culture supernatant of A475 and its 
isogenic ∆scpC mutant remained unaltered after co-incubation with anti-ScpC IgG (Figure 
33). Taken together, these results show that anti-ScpC antibody can specifically block the 
ScpC-mediated invasion of latex beads into endothelial cells without altering its proteolytic 
activity. Therefore, it may be anticipated that antibodies raised against ScpC might have a 
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protective role against S. pyogenes infection via inhibiting the ScpC-mediated interaction of S. 
pyogenes with endothelial cells. Additionally, the specificity of antibody for neutralizing the 
invasion mediating activity but not the proteolytic activity of ScpC suggests that different 
epitopes are involved in these two distinct functions of ScpC.       
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Figure 33. Effect of anti-ScpC antibody on the IL-8 proteolytic activity of ScpC. The culture supernatant of 
S. pyogenes strain A475 and its isogenic ∆scpC mutant were incubated with rabbit polyclonal anti-ScpC IgG or 
with preimmune rabbit IgG for 1 h, prior to the incubation with IL-8 to determine the IL-8 proteolytic acitivty 
of ScpC as decribed above. To test if the specific antibodies raised against ScpC can block the proteolytic 
activity of rScpC, the purified rScpC was pre-incubated with anti-ScpC IgG and then incubated with IL-8 to 
determine the proteolytic activity of ScpC. Each bar represents mean of optical density ±SD. 
 
3.3 In vitro invasion of S. pyogenes into human umbilical vein 
endothelial cells 
  
3.3.1 ScpC affects invasion and transcytosis of M3 S. pyogenes through 
HUVEC 
 
Previous studies have shown that M3 S. pyogenes can efficiently adhere to and invade primary 
human endothelial cells. M3 S. pyogenes invades endothelial cells via inducing the generation of 
host cell membrane protrusions around the streptococci that extend to engulf the bacteria, a 
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process which requires the reorganization of the actin cytoskeleton. Following the internalization 
into HUVEC, M3 S. pyogenes were observed to be localized within phagosomes which 
subsequently fused with lysosomes (Talay et al., unpublished; N. Peterman, Diploma thesis, 
2003). Based on the in vitro interaction of ScpC with HUVEC, we examined if ScpC has a direct 
role in mediating the invasion of S. pyogenes into primary human endothelial cells. For this, the 
invasion of WT A475 and its isogenic ∆scpC mutant into a cultured semi-confluent monolayer 
of HUVEC was compared. The cells were incubated with bacteria for 30 min at a multiplicity of 
infection (MOI) of 16:1. After the incubation period, cells were rinsed with EGM 2 basal 
medium and fixed. For studying the invasion mechanism of S. pyogenes into HUVEC at later 
time points, cells were rinsed two times with endothelial cell basal medium at 30 min post-
infection to eliminate extracellular bacteria, and incubated further for 30 min and 90 min in 
EGM 2 supplemented with 2% fetal calf serum. Immunostaining was performed to distinguish 
intracellular and extracellular bacteria. Analysing the invasion of WT A475 and its isogenic 
∆scpC mutant into HUVEC at early time points (30 min post-infection), showed a significant 
reduction in the invasion of  ∆scpC mutant in comparison to WT A475 (Figure 34). These data 
further corroborate the previous results showing the ability of recombinant ScpC to trigger the 
invasion of latex beads into HUVEC. Thus, these results indicate the significant contribution of 
ScpC in mediating the invasion of M3 S. pyogenes into HUVEC. 
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Figure 34.  Invasion of WT S. pyogenes A475 and its isogenic ∆scpC mutant into HUVEC. A) Cells were 
infected for 30 min with bacteria to cell ratio of 16:1 at 37oC in a humidified atmosphere containing 5% CO2 and 
fixed. For studying invasion at later time points, cells were rinsed two times with EGM 2 basal medium at 30 min 
post-infection to remove extracellular bacteria and incubated further for 90 min in EGM 2 + 2% fetal calf serum. 
Cells were immunostained to distinguish intracellular bacteria from extracellular bacteria in order to compare the 
invasion of WT A475 and its isogenic ∆scpC mutant into HUVEC. Intracellular bacteria were counted for each cell. 
Representative data is based on the analysis of 25-30 cells for each experiment. B&C). Microscopic images 
showing the invasion of WT A475 and its isogenic ∆scpC mutant strain into HUVEC at 30 min post-infection. 
Intracellular bacteria appear red and extracellular appear yellow. 
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However, at later time points (2 h post-infection), significantly (P=0.014) higher numbers of 
intracellular A475 ∆scpC mutant bacteria were observed in comparison to WT A475 (Figure 
34A). The number of intracellular WT A475 decreased at 2 h post-infection whereas, 
A475∆scpC were present in large aggregates (Figure 35) inside a subpopulation of HUVEC at 
2 h post-infection.  Previous studies of Talay et al. (unpublished) indicated that intracellular 
M3 S. pyogenes can promote its subsequent transcytosis through cultured human endothelial 
cells (HUVEC) via exocytosis of lysosomes as shown by the presence of LAMP-1 on the 
surface of HUVEC, closely associated with S. pyogenes. Based on these findings, the present 
data indicate that A475∆scpC mutant lacks the ability to escape from endothelial cells which 
results in its intracellular accumulation, suggesting that ScpC might play an important role in 
mediating the transcytosis of S. pyogenes across HUVEC. 
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Figure 35. Intracellular accumulation of A475 ∆scpC mutant at 2 h post-infection. Cells were infected with 
A475 (A&B) and isogenic ∆scpC mutant (C&D) for 30 min with bacteria to cell ratio of 16:1 and rinsed two 
times with endothelial cell growth medium to remove extracellular bacteria. Cells were then incubated further 
for 90 min in EGM 2 supplemented with 2% fetal calf serum at 37oC. The infected cells were immunostained to 
distinguish intracellular and extracellular bacteria as described in materials and methods. Intracellular bacteria 
are shown in red and extracellular in green. Each bar indicates 5 µm. 
 
3.3.2 Invasion and intracellular survival of scpC mutant S. pyogenes 
An antibiotic protection assay was conducted to determine the capability of S. pyogenes A475 
and its isogenic ∆scpC mutant to invade endothelial cells. HUVEC were infected for 2 h at 
MOI of 10:1 in the presence of serum. For the quantification of intracellular bacteria, cells 
were further treated with gentamicin (100 µg/ml) and penicillin (5 µg/ml) for 2 h to kill the 
extracellular adherent bacteria (see section 2.22.5). The monolayer of cells was lysed with 
triton X-100 and cell lysate was plated on blood agar plates. The intracellular viable S. 
pyogenes were quantified by counting colony forming units. In this case, significant reduction 
(P=0.002) in the intracellular invasion of A475 ∆scpC mutant was observed in comparison to 
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C 
        Phase Extracellular/ 
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WT parental strain  at 2 h post-infection (Figure 36; Table 3.2). It is likely that the reduction 
in the invasion is due to the reduced survival of the mutant strain instead of the difference in 
invasion efficiency since previous results indicated significantly higher number of 
intracellular ∆scpC mutant bacteria in comparison to WT A475 at 2 h post-infection. The 
reduced intracellular survival of ∆scpC mutant in comparison to WT A475 can be explained 
on the basis of intracellular killing of bacteria by bactericidal activity of lysosomes due to the 
lack of the ability of ∆scpC mutant to escape the lysosomal killing, in contrast to WT A475 
which is able to escape endothelial cells via exocytosis. Another possibility is that the 
enhanced endothelial cell membrane injury by the A475 ∆scpC mutant in subpopulation of 
cells might have caused the leakage of antibiotics into the cells, thus killing the intracellular 
residing ∆scpC mutant bacteria. Alternatively, the accumulation of A475 ∆scpC mutant inside 
the cells might have caused the enhanced endothelial cell death which correlates with the 
previous reports showing the endothelial cell death following the intracellular invasion by S. 
aureus (Menzies and Kourteva, 1998). 
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Figure 36. Quantitative analysis of adherence to and invasion of WT A475 and isogenic ∆scpC mutant into 
HUVEC. The cells were infected for 2 h in humidified environment containing 5% CO2. For the quantification 
of intracellular bacteria, the cells were additionally treated with antibiotics for another 2 h to kill extracellular 
bacteria. The cells were then lysed with triton-X 100 and intracellular bacteria were plated on blood agar plates. 
The colony forming units (cfu) released by cells were counted on the next day and the percentage of invasion 
was calculated in comparison to the initial inoculum of bacteria. Data is representative of three experiments with 
each experiment performed in triplicates.                
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Table 3.2. Number of viable intracellular bacteria per well after infecting HUVEC monolayer 
for 2 h 
 
 
       
S. pyogenes cfu/well SD 
WT A475 1.51x104 ± 0.3482 
A475 ∆scpC 1.34x103 ± 2.0450 
 
 
 
 
3.3.3 Characterization of the invasion process of M3 S. pyogenes A475 and 
its isogenic scpC mutant 
Based on the observed difference in the invasion of WT A475 and its isogenic ∆scpC mutant 
into HUVEC, the invasion process of WT and mutant strain was further characterized. To test 
whether intracellular bacteria reside in the phagosomal compartment, we aimed to identify the 
intracellular compartment in which WT A475 and its isogenic ∆scpC mutant resides. HUVEC 
were infected with bacteria to cell ratio of 16:1. After an incubation period of 30 min, cells 
were washed twice with EGM 2 basal medium to remove extracellular bacteria and then 
incubated further in EGM 2 supplemented with 2 % FCS at 37oC. After a pre-determined 
incubation period (30 min, 90 min and 120 min) cells were washed three times with EGM 2 
basal medium and fixed. Bacterial cells were labeled with rabbit polyclonal anti-S. pyogenes 
antibody and host cell lysosomal compartments were identified by immuno-staining with 
monoclonal antibodies against LAMP-1. Immunofluorescence microscopic analysis revealed 
that following invasion into HUVEC, WT A475 was found in a phagosome-like compartment 
and most of bacteria co-localized with LAMP-1 at 1 h post-infection indicating that S. 
pyogenes containing vacuoles fused with late endosomes/lysosomes. At 2 h post infection, 
WT bacteria were identified in LAMP-1 positive compartments, however very less 
intracellular bacteria could be detected at this time point of infection. At 1 h post-infection, 
the ∆scpC mutant showed co-localization with LAMP-1 indicating that the mutant strain also 
resides in late endosomes/lysosomes. In contrast to the invasion by WT A475 which showed 
few numbers of bacteria co-localized with LAMP-1 at 2 h post-infection (Figure 37A), large 
aggregates of A475 ∆scpC mutant showed co-localization with LAMP-1 positive 
compartments (Figure 37B). This finding shows correlation with our previous results showing 
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the reduced survival of A475 ∆scpC mutant in endothelial cells in comparison to WT parental 
strain by antibiotic protection assay. Based on these observations, it can only be speculated 
that the A475 ∆scpC mutant might have been partially killed in the lysosomes due to the lack 
of ability to escape from endothelial cells. However, further studies are required to fully 
understand the mechanism of ScpC-mediated invasion and transcytosis of S. pyogenes across 
endothelial cells. Taken together, these results indicate that ScpC plays an important role in 
the invasion process of M3 S. pyogenes into endothelial cells which might significantly 
contribute to enhance the virulence of S. pyogenes, enabling them to cause invasive diseases. 
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Figure 37.  WT A475 and isogenic ∆scpC mutant reside in late endosomes/lysosomes. Cells were infected 
with WT A475 (A) and its isogenic ∆scpC mutant (B) for 2 h at 37oC with bacteria to cell ratio of 16:1. Infected 
cells were incubated with mouse monoclonal antibody against LAMP-1 for 1 h. To visualize the lysosomes, 
infected cells were then incubated with anti-mouse Alexa fluor® 568 (red) conjugated antibody. S. pyogenes 
were visualized by use of a polyclonal rabbit antiserum specific against S. pyogenes and with anti-rabbit Alexa 
fluor® 488 (green) conjugated secondary antibody. Enlarged area shows the co-localization of WT A475 with 
LAMP-1. Arrows delineate the co-localization of WT A475 and isogenic ∆scpC mutant with late 
endosomal/lysosomal marker LAMP-1. Each bar represents 5 µm. 
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4 Discussion  
  
S. pyogenes is a highly specific human pathogen which can cause diseases ranging from 
minor infections to life threatening invasive deep tissue infections. S. pyogenes expresses 
several virulence proteins which participate in evading the host innate immune response 
towards infection via impairing bacterial clearance by phagocytes. The expression of 
virulence determinants is highly regulated, in order to express certain virulence proteins when 
required, according to the conditions within the host. Various studies have reported the 
correlation between the pathophysiology of invasive deep tissue infections and a marked 
reduction in the infiltration of neutrophils at the site of infection (Bakleh et al., 2005; Chong 
and Burrows, 2002; Cockerill et al., 1998b; Taylor et al., 1999). Recent findings have shown 
that S. pyogenes expresses a large protein, ScpC, which is responsible for the lack of acute 
inflammatory response in the local area of infection due to its ability to cleave CXC 
chemokines (IL-8, MIP-2, GCP-2 and GROα) (Hidalgo-Grass et al., 2006; Sumby et al., 
2008). ScpC specifically cleaves IL-8, a major chemoattractant of neutrophils, between Gln59-
Arg60 in its C-terminal α-helix. This cleavage renders IL-8 biologically inactive, preventing 
neutrophil activation and infiltration into the infected tissue (Edwards et al., 2005; 
Zinkernagel et al., 2008). Experimental evidences have pointed towards the potential role of 
ScpC in the lack of acute inflammatory response frequently observed in necrotizing fasciitis 
patients. ScpC-mediated chemokine degradation have been implicated in the paucity of 
neutrophil recruitment in the mouse model of soft tissue streptococcal infection (Hidalgo-
Grass et al., 2006). In addition to that, the marked upregulation in the expression of ScpC by 
invasive isolate M1T1 have further validated the significant contribution of ScpC in S. 
pyogenes pathogenesis (Sumby et al., 2006). These findings instigated us to further evaluate 
the role of this virulence protein in S. pyogenes pathogenesis of invasive infections. 
It has been well recognized that S. pyogenes are capable of invading and surviving within 
cultured human epithelial and endothelial cells (Greco et al., 1995; Rohde et al., 2003; Talay 
et al., 2000). Invasion and transcytosis across host cells might represent the mechanism 
whereby S. pyogenes is able to enter the bloodstream and disseminate to the other tissues. 
Previous studies have reported that S. pyogenes are able to invade endothelial cells (Greco et 
al., 1995; Talay et al., unpublished; A. Nerlich, PhD thesis, 2006), however, the factors 
responsible for mediating the adherence to and invasion of endothelial cells by S. pyogenes 
remains unidentified. Studies showing the potential role of ScpC in retarding the IL-8-
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mediated transendothelial migration and recruitment of neutrophils into the infected tissue 
(Edwards et al., 2005; Zinkernagel et al., 2008) prompted us to investigate the interaction of 
ScpC with human endothelial cells. In the present study, we demonstrate that ScpC plays an 
essential role in the invasion process of M3 serotype S. pyogenes into human umbilical vein 
endothelial cells, in addition to cleaving the host-derived chemokines. We also show that, 
despite the observation that ScpC is secreted in the culture supernatant, it is also a cell surface 
located protein, which is able reassociate with the bacterial surface after being secreted into 
the extracellular environment. Additionally, this study was designed to identify the essential 
domains required for the functional activity of ScpC. Previous studies have shown the IL-8 
degrading activity of partially purified ScpC (also known as SpyCEP), which was isolated 
from the culture supernatant of S. pyogenes (Edwards et al., 2005). Although, it was highly 
desirable to have pure, biologically active ScpC to study the role of ScpC in S. pyogenes 
virulence, the active recombinant ScpC have been difficult to produce due to the large size 
and muti-domain structure of ScpC. In the present study, we have expressed the active 
recombinant full-length ScpC to aid the characterization of this important virulence factor. 
 
4.1 Localization of ScpC on the S. pyogenes cell surface  
 
The essential role of bacterial surface-anchored proteins in pathogenesis have been described 
by various reports (Lindahl et al., 2005; Niemann et al., 2004). In S. pyogenes, several cell 
wall-anchored proteins including the well known virulence factors M protein and Sfb1 have 
been shown to interact with host factors. Most of the surface-anchored proteins of S. pyogenes 
are multifunctional which can mediate the adherence to and invasion of host cells, binding to 
host cell extracellular proteins and/or resistance to phagocytosis by diverse strategies 
(Cunningham, 2000). Earlier studies have detected ScpC protease in the culture supernatant of 
S. pyogenes indicating that despite the presence of a C-terminal hydrophobic domain 
containing a cell wall-anchoring consensus motif (LPXTG) of Gram-positive bacteria, ScpC 
is secreted by S. pyogenes (Hidalgo-Grass et al., 2006; Edwards et al., 2005; Sumby et al., 
2008). However, the localization of ScpC on the S. pyogenes cell surface and the significance 
of cell surface-anchoring have not been previously described. By using highly reactive ScpC 
specific antiserum, it could be demonstrated in this study that ScpC is located on the cell 
surface of S. pyogenes. The cell surface localization of ScpC was revealed by both 
immunogold electron microscopy and fluorescence microscopy. The recognition of cell 
surface localized ScpC by anti-ScpC antibodies suggests that ScpC is exposed on the surface 
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of S. pyogenes and thus may allow the protein to interact directly with host cell receptors or 
extracellular matrix proteins to mediate the interaction of S. pyogenes with the host cells. 
Since the culture supernatant of S. pyogenes was able to cleave CXC chemokine, it can be 
anticipated that the degradation of host-derived chemokines does not require bacterial 
interaction with chemokines. However, the surface exposed ScpC may facilitate the direct 
interaction of ScpC with CXC chemokines to inactivate the chemokines in near vicinity of the 
bacterium.  
 
4.2 Reassociation of ScpC with the S. pyogenes cell surface  
 
S. pyogenes express many anchorless glycolytic proteins such as surface dehydrogenase 
(SDH) and surface enolase (SEN), which were shown to be localized on the cell surface via 
reassociation. These surface-associated proteins bind to the serum protein plasminogen and 
retain the protease activity on the surface of S. pyogenes which may potentially contribute to 
tissue invasion and the overall pathogenicity of S. pyogenes (Pancholi and Fischetti, 1997a). 
Bergmann et al. (2001) have shown that the secreted enloase (Eno) protein, a plasminogen 
binding protein of Streptococcus pneumoniae is displayed on the cell surface via 
reassociation. Similar to S. pyogenes, the binding of plasminogen on the cell surface of S. 
pneumoniae via Eno provides the proteolytic activity on the cell surface which may represent 
the mechanism whereby S. pneumoniae facilitate the penetration of bacteria through the 
extracellular matrix thus enhancing tissue invasion during invasive pneumococcal infections 
(Bergmann et al., 2003; Kolberg et al., 2006).  SDH acts as a virulence determinant of S. 
pyogenes and plays an important role in the invasion of S. pyogenes into host cells. Cell wall- 
bound SDH facilitates the interaction with the host cell receptors or other extracellular matrix 
components to trigger a signal transduction pathway via tyrosine phosphorylation of 
pharyngeal cell proteins, leading to the internalization of bacteria by host cells (Pancholi and 
Fischetti, 1997b). In this study, we demonstrated that ScpC can reassociate to the cell surface 
of S. pyogenes after being secreted into the extracellular environment as shown by the 
association of ScpC with the cell surface of both JS95 ∆scpC and A475 ∆scpC mutant strains 
after co-incubation with the culture supernatant of ScpC expressing wildtype (WT) JS95. 
Reassociation of ScpC onto the cell surface of JS95 ∆scpC and A475 ∆scpC mutant was 
confirmed by immunoelectron microscopy. Although the mechanism of reassociation is 
undetermined, the present study indicate that reassociation of ScpC with S. pyogenes cell 
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surface is not due to homotypic interaction, since binding back of ScpC has been 
demonstrated by using ∆scpC mutant strains.  
This interesting observation shows correlation with the previous findings of Zinkernagel et al. 
(2008) who have shown that the presence of ScpC expressing S. pyogenes strain is able to 
protect other vulnerable bacteria in the local environment. This has been shown by isolation 
of similar number of surviving M1T1 ∆scpC and WT M1T1 from the lesion generated after 
co-infecting the mice with the equal amount of these strains at the same lesion site. Since 
M1T1 ∆scpC mutant was observed to be less virulent and susceptible to killing when injected 
alone, these findings suggested that WT M1T1 S. pyogenes might have promoted the survival 
of M1T1 ∆scpC mutant when co-infected in the same lesion. Also, the presence of ScpC 
expressing M1T1 S. pyogenes facilitated the survival of vancomycin resistant Enterococcus 
faecalis in a murine model of polymicrobial infection. Although, the mechanism behind this 
protective ability of ScpC expressing S. pyogenes is undefined, the current concept suggested 
the chemokine cleavage by ScpC and subsequent destruction of chemokine gradient as a 
principle mechanism. However, the present data provide a new insight into this phenomenon, 
suggesting that the enhanced survival of M1T1 ∆scpC mutant and other species of bacteria in 
the presence of ScpC expressing strain may be attributed to the reassociation of the 
extracellular secreted ScpC on the surface of bacteria, which might protect bacteria either via 
mediating the enhanced chemokine degradation or by enabling the bacteria to interact with 
putative host cell receptors to colonize and invade the host cells. Thus, the present data 
indicate a distinct underlying mechanism for the trans action of ScpC to facilitate the survival 
of other bacteria in the local environment of infection. 
 
4.3 Potential role of ScpC in the invasion process of M3 S. pyogenes  
 
Further, we investigated the hypothesis that surface located ScpC might facilitate the 
interaction of S. pyogenes with host endothelial cells to mediate adherence to and invasion 
into endothelial cells. Invasion of S. pyogenes into host cells may contribute to the enhanced 
pathogenicity of S. pyogenes by providing an intracellular niche to protect bacteria from 
immune defense mechanisms and antibiotic therapy. Various studies have suggested that the 
ability of S. pyogenes to invade the host cells might contribute to the frequent failure of 
antibiotics to eradicate infection (Osterlund and Engstrand, 1997; Sela et al., 2000). In 
addition, the invasion and transmigration of epithelial and endothelial layers seem to be a 
precondition for the invasiveness of S. pyogenes. S. pyogenes expresses multiple cell surface-
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anchored adhesins and invasins, which mediate adherence to and invasion of bacteria into 
host cells (Kreikemeyer et al., 2004). The initial step of establishing infection is attachment to 
and colonization of host cells by S. pyogenes which is mediated by adhesins. Adhesive 
proteins interact with surface receptors of host cells, which are often involved in cell-matrix 
or cell-cell adherence. Many adhesins also act as invasin triggering the uptake of bacteria into 
host cells. The interaction of an adhesin with its host cell receptor triggers a cascade of signals 
within the host cells, subsequently leading to the internalization of bacteria into host cells. 
(Courtney et al., 2002). Many adhesins and invasins of S. pyogenes involved in the attachment 
and invasion of epithelial cells have been identified including Sfb1, M protein and C5a 
peptidase. However, the data concerning the virulence determinants involved in the invasion 
of S. pyogenes into endothelial cells is very limited.  
Endothelial cells line the interior surface of arteries, veins and post-capillary venules in the 
skin, forming an interface between blood and the underlying tissue. It has been widely 
reported that endothelial derived cytokines contribute significantly to the occurrence of 
inflammatory and immunological responses towards infection (Krishnaswamy et al., 1999). 
Breaching an endothelial barrier and/or modulation of endothelial function by S. pyogenes 
might contribute significantly to the outcome of invasive streptococcal infection. Many 
bacterial pathogenes such as Streptococcus agalactiae (GBS), Staphylococcus aureus and 
Neisseria meningitidis are able to invade endothelial cells (Menzies and Kourteva, 1998; 
Nassif et al., 2002). Reports showing the invasion into and transmigration of group B 
Streptococcus (GBS) across a cultured monolayer of immortalized human brain 
microvascular endothelial cells (BMEC) suggest that the invasion of GBS into the endothelial 
monolayer comprising the blood brain barrier can significantly contribute to the pathogenesis 
of GBS meningitis in neonates (Gibson et al., 1993; Nizet et al., 1997).  Previous studies have 
shown that M3 S. pyogenes are able to invade cultured human endothelial cells, via an 
internalization process involving the generation of host cell membrane protrusions around the 
streptococci to engulf the bacteria into the cells (Greco et al., 1995; Nerlich et al., 
unpublished).  
The present study indicates that ScpC plays an essential role in the invasion of M3 serotype S. 
pyogenes strain A475, isolated from a patient with invasive disease, into the cultured human 
umbilical vein endothelial cells (HUVEC). The scpC deletion mutant of M3 S. pyogenes 
strain A475 showed significantly reduced ability to invade endothelial cells in comparison to 
the WT A475, at the initial time points of infection (30 min post-infection). The growth rate 
of WT A475 and its isogenic ∆scpC mutant was similar, explaining that the difference in the 
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invasion of A475 and its isogenic ∆scpC mutant is not a result of a difference in the growth 
behavior of the bacteria. ScpC per se was able to trigger the invasion process. This was 
indicated by the efficient adherence to and subsequent internalization of purified recombinant 
ScpC coated latex beads by HUVEC. Late endosomes/lysosomes were identified as terminal 
intracellular compartment of ScpC coated beads as indicated by the co-localization of ScpC 
coated beads with the late endosomal/lysosomal marker LAMP-1 at 2 h post-incubation. 
Efficient internalization of EC-PR (putative catalytic domain containing catalytic triad Asp-
His-Ser) coated beads by HUVEC indicated that the minimal domain of ScpC required to 
mediate the invasion of endothelial cells is restricted to the N-terminal PR domain.  
However, since the uptake of A475 ∆scpC mutant by HUVEC was not completely abolished, 
it cannot be excluded that other factors are also involved in the invasion of S. pyogenes into 
endothelial cells. Similar to the invasion mechanism of other bacteria such a Yersinia, Listeria 
and Shigella ssp. (Cossart et al., 2003; Cossart and Sansonetti, 2004), the S. pyogenes 
adhesion to and invasion into the host cells can be mediated by multiple cell surface-bound 
factors (Courtney et al., 2002). It might be possible that ScpC, along with other invasins, 
mediates the invasion of S. pyogenes into endothelial cells. Interestingly, the results of this 
study using M3 S. pyogenes and endothelial cells differ from the previous report showing the 
enhanced adherence to and invasion of M1T1 ∆scpC mutant strain into human pharyngeal 
epithelial cells (HEp-2) in comparison to WT M1T1 S. pyogenes (Zinkernagel et al., 2008). It 
is likely that epithelial cells do not express the receptors which are required for the interaction 
with ScpC. This may explain the specific interaction of ScpC with endothelial cells but not 
with epithelial cells.  
Study of the kinetics of invasion of WT A475 and its isogenic ∆scpC mutant strain into 
HUVEC showed that the WT A475 established contact and started invading endothelial cells 
within 15 min of infection and many intracellular bacteria were observed at 30 min post-
infection. However, as incubation time was increased (2 h post-infection) the number of 
intracellular WT A475 decreased, while the number of intracellular A475 ∆scpC mutant 
increased drastically in a subpopulation of cells. It has been previously shown that M3 S. 
pyogenes can invade and subsequently promote its transcytosis across human endothelial cells 
via exocytosis of lysosomes (Talay et al., unpublished). Although lysosomes are considered as 
terminal compartments of the endocytic pathway, studies have shown that lysosomes can act 
as exocytotic vesicles (Gerasimenko et al., 2001). Regulated lysosomal exocytosis is a general 
physiological mechanism in all the cells in response to the membrane injury in order to reseal 
the membrane of injured cells (Reddy et al., 2001; Roy et al., 2004). Hakansson et al. (2005) 
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have also shown that damage to the keratinocyte plasma membrane by S. pyogenes virulence 
protein, streptolysin O (SLO) triggers the mobilization of lysosomes to the cell surface to fuse 
with the damaged areas of the membrane as a repair mechanism. In agreement with the 
previous studies of Talay et al. (unpublished), the present data indicated that after 1 h 
infection of HUVEC with WT A475, phagosomes containing A475 fused with LAMP-1 
positive compartments. At 2 h post-infection, a very few intracellular WT A475 were 
observed, although the WT A475 that were found intracellularly were observed to co-localize 
with LAMP-1 on the cell surface indicating that A475 escape from the endothelial cells via 
lysosomal exocytosis (Talay et al., unpublished; N. Petermann, Diploma thesis, 2003). 
However, A475 ∆scpC mutant confined inside the LAMP-1 positive compartments at 2 h 
post-infection. Based on these observations, our data suggests that the A475 ∆scpC mutant 
accumulated inside the cells possibly due to imparied exocytosis and thus mutant strain are 
unable to escape from endothelial cells. The role of ScpC in the transcytosis of S. pyogenes 
through endothelial monolayer can be further studied by analysing if the ability to 
transmigrate the endothelial cells is imparied in A475 ∆scpC mutant, using a transwell 
system.  
The accumulation of A475 ∆scpC in a subpopulation of endothelial cells may be attributed to 
the fact that the receptor involved in the internalization of S. pyogenes was expressed by a 
subset of cells. Heterogeneity among the host cells due to non-homogenous expression of the 
specific receptors involved in the interaction with other S. pyogenes invasins may explain why 
only subpopulation of cells were invaded by S. pyogenes. Damage to the host cell membrane 
by S. pyogenes virulence proteins can trigger lysosomal exocytosis thus releasing the 
lysosomal content to the extracellular environment (Hakansson et al., 2005), which might 
result in an acidic microenvironment in the host during streptococcal infection. This 
hypothesis correlates with the observation that an acidic environment triggered the interaction 
of ScpC with host cells. Also, it is likely that ScpC-mediated interaction of S. pyogenes with 
endothelial cell might also contribute to enhance the invasiness of S. pyogenes via modulating 
the endothelial cell function. Endothelial cells produce many cytokines including IL-8 and IL-
6 which are important in regulating the transmigration of leukocytes and the development of 
an inflammatory response (Chen and Manning, 1996). Since it has been previously described 
that the IL-8 expression by cultured endothelial cells was induced in response to the bacterial 
infections and endothelial derived IL-8 was sufficient to induce the in vitro transendothelial 
migration of neutrophils (Yao et al., 1996), it can be anticipated that endothelial-derived IL-8 
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may significantly contribute to facilitate the adhesion and transendothelial migration of 
neutrophils to sites of S. pyogenes infection.  
In contrast to the results of infection assay, the antibiotic protection assay showed significant 
reduction in the number of intracellular A475 ∆scpC mutant at 2 h post-infection in 
comparison to the number of intracellular WT A475, as quantified by counting the viable 
colony forming units of these strains released by infected cells. The observed difference in the 
invasion of WT A475 and A475 ∆scpC mutant into HUVEC may be attributed to the 
difference in the intracellular survival of these strains. Several factors may have contributed to 
this difference. Firstly, enhanced membrane damage due to the accumulation of A475 ∆scpC 
mutant inside the cells might have caused the leakage of antibiotics into the cells, which 
ultimately resulted in reduced viability of the A475 ∆scpC. Secondly, there may have been 
the enhanced intracellular killing of A475 ∆scpC mutant by the bactericidal activity of 
lysosomes, in comparison to WT parental strain, which is able to escape from the endothelial 
cells. Alternatively, the intracellular A475 ∆scpC might have induced the cell death releasing 
the intracellular bacteria free in the culture medium and exposed to the antibiotics in the 
medium. Marouni and Sela (2004) have shown that the internalization of S. pyogenes into 
epithelial cells induced the apoptosis of host cells suggesting that the induction of host cell 
death may be a means of releasing essential nutrients required for the bacterial growth. Many 
bacterial pathogenes such as Staphylococcus aureus and Shigella flexneri are capable of 
inducing the host cell death via apoptosis (Weinrauch and Zychlinsky, 1999). The 
intracellular S. aureus have also been shown to damage the endothelial cell monolayer by 
affecting the membrane integrity and consequently induced the apoptosis of endothelial cells 
(Menzies and Kourteva, 1998).  
Furthermore, this study demonstrated that the adherence to and internalization of ScpC coated 
latex beads by HUVEC was blocked by pre-incubation of ScpC coated beads with purified 
anti-ScpC IgG, indicating that the interaction of ScpC with endothelial cells can be efficiently 
blocked with anti-ScpC antibody, thus suggesting that specific antibody induced against ScpC 
can be a tool to inhibit the invasion mediating activity of ScpC. This finding additionally 
indicates the specificity of the interaction of ScpC with endothelial cells and suggests that 
ScpC interacts specifically with a receptor on HUVEC which is potentially involved in the 
entry of S. pyogenes into endothelial cells. Whereas, the pre-incubation of ScpC with anti-
ScpC antibody did not considerably effect its IL-8 proteolytic activity, indicating that 
different epitopes are involved in the IL-8 proteolytic activity and the invasion mediating 
activity of ScpC. Lei et al. (2000) have reported that patients with pharyngitis and invasive 
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diseases had specific antibodies against ScpC, indicating that ScpC is highly immunogenic in 
humans. Furthermore, a report showing that specific antibodies to ScpC are protective against 
streptococcal infection in mice (Rodriguez-Ortega et al., 2006) supports the biological 
significance of the surface location of ScpC and suggests that specific antibodies against ScpC 
are protective either due to its ability to opsonize S. pyogenes or by interfering with ScpC 
function. Inhibiting the invasion of S. pyogenes into host cells may as well play a significant 
role in blocking the invasiveness of S. pyogenes, thus anti-ScpC antibodies may prove to have 
a therapeutic use. However, preliminary results of antibiotic protection assay indicate that pre-
incubation of S. pyogenes A475 with purified anti-ScpC antibodies did not substantially 
reduce S. pyogenes adherence to and invasion into HUVEC (data not shown). 
S. pyogenes have evolved multiple mechanisms to invade a wide variety of host cells. Sfb1- 
mediated adherence to and invasion of S. pyogenes into epithelial cells involves specific 
interaction between the C-terminal fibronectin-binding repeat region of cell surface-bound 
Sfb1 protein and the extracellular matrix protein fibronectin, which acts as a bridge between 
bacteria and integrin receptor α5β1 present on host epithelial cells (Molinari et al., 1997). 
Rohde et al. (2003) have shown that Sfb1-expressing S. pyogenes follow a caveolae-mediated 
endocytic pathway to gain entry into epithelial as well as endothelial cells via fibronectin-
mediated interaction of Sfb1 with the cellular integrin α5β1. This interaction triggers the 
formation of membrane invaginations in the host cells, which leads to the internalization of 
the bacteria. In addition, the major virulence determinant of S. pyogenes, M1 protein mediates 
invasion of S. pyogenes into epithelial cells via binding to fibronectin which in turn binds to 
the integrins on host cells. A nonpeptide antagonist of integrin α5β1 inhibits fibronectin- 
mediated invasion of S. pyogenes into A549 as well as human tonsillar epithelial cells. 
However, it does not block the invasion of S. pyogenes via laminin-mediated interaction with 
α3β1 in lung epithelial A549 cells, suggesting that the interaction of bacterial cell surface-
bound M1 protein with multiple integrin sites may lead to the invasion of S. pyogenes into 
host cells (Cue et al., 1998; Cue et al., 2000).  
In order to identify the mechanism of ScpC-mediated invasion of S. pyogenes into endothelial 
cells, we tested the binding of the extracellular matrix proteins, fibrinogen, plasminogen and 
collagen with recombinant ScpC. In vitro analysis using recombinant ScpC indicated that 
ScpC did not bind to any of these extracellular matrix proteins on our experimental setup. 
Furthermore, a monoclonal antibody directed against human integrin β1 did not affect the 
adherence to and internalization of ScpC coated beads by endothelial cells. Intergrin β1 is a 
subunit of the heterodimeric eukaryotic cell surface receptor for various extracellular matrix 
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proteins including laminin, fibrinogen and collagen. This indicates that ScpC-mediated 
invasion of S. pyogenes into endothelial cells is independent of the potential to interact with 
these extracellular matrix proteins or with β1 integrin. Therefore, the identification of the 
receptor which is involved in the interaction of ScpC with endothelial cells requires further 
analysis. 
By recombinantly expressing several distinct domains of ScpC in E. coli, the functional 
domains of ScpC required for the IL-8 proteolytic activity were assessed. For characterization 
of the IL-8 degrading domain of ScpC, we investigated whether the putative catalytic domain 
(PR-domain) of ScpC, identified based on the homology to existing serine proteases, is 
essential and sufficient for its proteolytic activity. By monitoring the IL-8 degradation by 
recombinant fusion protein constructs encompassing full-length ScpC and distinct domains of 
ScpC, either expressed independently or with flanking domains, the results indicated that the 
recombinant full-length ScpC was functionally active to cleave IL-8 in vitro. The smaller 
fragment of ScpC, EC-PR+A encompassing the PR domain and the A-domain was sufficient 
to cleave IL-8. However, the PR-domain alone did not degrade IL-8, indicating that the PR-
domain is proteolytically inactive. Previous studies of Siezen et al. (1999) have shown that 
each domain of extracellular cell envelope proteases has a distinct function. The A-domain is 
conserved among most of extracellular cell envelope protease of lactic acid bacteria and it has 
been shown to play a role in defining the substrate specificity of PrtP, a cell envelope serine 
proteinase of Lactococcus lactis (Siezen et al., 1993). In line with this observation in L. lactis, 
the present data suggests that the A-domain is essential for the proteolytic activity of ScpC 
and acts in concert with the PR-domain for the cleavage of IL-8. Whereas, experiments 
performed to localize the minimal domain involved in the invasion mediating activity of ScpC 
showed that the PR-domain is sufficient for the adherence and internalization of ScpC coated 
latex beads by HUVEC suggesting that the invasion mediating activity of ScpC is 
independent of its proteolytic activity. 
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5 Summary and Outlook 
 
In summary, ScpC is a multi-functional cell surface located protein of S. pyogenes which 
significantly contributes to the invasion and transcytosis of M3 S. pyogenes through the 
endothelial monolayer. In addition to the contribution of the chemokine degrading proteolytic 
activity of ScpC, the invasion associated activity of ScpC might also have a substantial impact 
on S. pyogenes pathogenesis. This study provides valuable information about the properties of 
ScpC by defining the domains required for its functional activity, which may prove useful in 
understanding the complex pathogenic properties displayed by this virulence protein of S. 
pyogenes. Specific antibodies raised against ScpC demonstrated the inhibitory effect towards 
the adherence and internalization of ScpC coated beads by HUVEC, suggesting that the 
specific antibodies against ScpC may provide a useful tool in the prevention of the invasion of 
S. pyogenes into endothelial cells. Additionally, this study demonstrated that ScpC is able to 
reassociate to the S. pyogenes cell surface after being secreted into the extracellular 
environment, which may have a significance in facilitating the survival and dissemination of 
the bacteria in the host. Based on the multi-functional role of ScpC in S. pyogenes virulence 
and conserved nature of scpC in distinct M serotypes of S. pyogenes, it can be a potential 
target for use as a novel therapeutic agent against invasive S. pyogenes infections. Further 
investigations will involve the identification of the receptors required in the ScpC-mediated 
interaction of S. pyogenes with endothelial cells which can help in understanding the invasion 
mechanism of M3 S. pyogenes. 
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7 Appendix  
 
7.1 List of Abbreviations 
 
A     Absorbance 
Amp     Ampicillin 
APS     Ammonium persulfate 
BSA     Bovine serum albumin 
cfu     Colony-forming units 
dH2O     Distilled water 
DMEM    Dulbecco’s Modified Essential Medium 
DNA     Deoxyribonucleic acid 
DNase     Deoxyribonulcease 
dNTP     Deoxyribonulceotide-5’-phosphate 
EDTA     Ethylenediamine tetraacetic acid 
EGM     Endothelial cell growth medium 
ELISA     Enzyme-linked immunosorbant assay 
FACS     Fluorescence activated cell sorting 
FCS     Fetal calf serum 
Fn     Fibronectin 
GCP-2     Ganulocyte chemotactic protein 2 
GROα     Growth related oncogene α 
GST     Glutathione S-transferase 
h     Hour 
His     Histidine 
HPLC     High performanceliquid chromatography 
HRP     Horseradish peroxidase 
HUVEC    Human umbilical vein endothelial cells 
IgG     Immunoglobulin G 
IL-8     Interleukin 8 
IPTG     Isopropyl-b-D-thiogalactopyranoside 
Kan     Kanamycin 
LB     Luria-Bertani 
MALDI    Matrix assisted laser desorption/ionization 
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min     Minute 
PAGE     Polyacrylamide gelelectrophoresis 
PBS     Phosphate-buffered saline 
PBST     Phosphate buffer saline with 0.05% tween 
PCR     Polymerase Chain Reaction 
PMN     Polymorphonuclear leukocyte 
PMSF     Phenylmethansulfonylfluorid 
rScpC                   Recombinant ScpC 
RT     Room temperature 
ScpA     C5a peptidase 
ScpC     Streptococcal chemokine protease C 
SD     Standard deviation 
SDS     Sodiumdodecylsulfate 
sec     Second 
Sfb     Streptococcal fibrinectin binding protein  
SLO     Streptolysin O 
SLS                                               Streptolysin S 
TCS     Two-component system 
TEMED    Tetramethylethylenediamine 
THY     Todd-hewitt broth with yeast extract 
Tris     Trishydroxymethylaminomethane 
TSB     Tryptic soy broth 
U     Units 
UV     Ultraviolet light 
v/v     Volume per volume (volume percentage) 
w/v     Weight per volume (weight percentage) 
WT     Wildtype 
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